Hyperscale Data, Inc SC TO-I, filed Nov 20, 2026
Hyperscale Data, Inc. (GPUS)
Hyperscale Data is offering to exchange up to 192,308,000 shares of its Class A Common Stock for units of one share of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock and $2.00 in cash per 100 shares. Completion requires at least 100,000,000 shares to be exchanged. The offer expires at one minute after 11:59 p.m. New York City Time on December 18, 2026, unless extended or terminated. AI summary
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
Hyperscale Data, Inc.
(Name of Subject Company (Issuer))
Hyperscale Data, Inc.
(Names of Filing Persons (Issuer and Offeror))
Class A Common Stock, $0.001 par value per share
(Title of Class of Securities)
09175M879
(CUSIP Number of Class of Securities)
Henry Nisser
President and General Counsel
Hyperscale Data, Inc.
11411 Southern Highlands Pkwy, Suite 190
Las Vegas, NV 89141
Telephone: (949) 444-5464
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications on Behalf of Filing Persons)
With copies to:
Spencer G. Feldman, Esq.
Kenneth A. Schlesinger, Esq.
Olshan Frome Wolosky LLP
1325 Avenue of the Americas, 15th Floor
New York, New York 10019
Tel: (212) 451-2300
| ☐ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates:
| ☐ | third-party tender offer subject to Rule 14d-1. |
| ☒ | issuer tender offer subject to Rule 13e-4. |
| ☐ | going-private transaction subject to Rule 13e-3. |
| ☐ | amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
| ☐ | Rule 13e-4(i) (Cross-Border Issuer Tender Offer) |
| ☐ | Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) |
Items 1 through 9, and Item 11.
This Issuer Tender Offer Statement on Schedule TO (this “Schedule TO”) relates to the offer by Hyperscale Data, Inc., a Delaware corporation (the “Company”), pursuant to Rule 13(e)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to exchange up to 192,308,000 shares of its outstanding Class A Common Stock, par value $0.001 per share (the “Common Stock”), for units consisting of (a) its 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (“Series I Preferred Stock”) and (b) cash, with each 100 shares of Common Stock being exchangeable in the Offer for units consisting of (i) one share of Series I Preferred Stock having a liquidation preference of $24.00 per share of Series I Preferred Stock and (ii) $2.00 in cash (the “Exchange Offer”). To avoid issuing fractional shares, Common Stock may only be tendered in increments of 100 shares. The Exchange Offer will be upon the terms and subject to the conditions set forth in the Offer to Exchange, dated November 20, 2026 (as amended and supplemented from time to time, the “Offer to Exchange”) and the related Exchange Offer materials (as amended and supplemented from time to time, the “Exchange Offer Documents”).
This Schedule TO is intended to satisfy the disclosure requirements of Rule 13(e)(4) under the Exchange Act.
The information set forth in the Offer to Exchange, and in the related Exchange Offering Documents, copies of which are attached hereto as Exhibits, are hereby expressly incorporated herein by reference in response to all of the items of this Schedule TO, except those items as to which information is specifically provided herein.
Item 10. Financial Statements.
| (a) | Financial Information |
The information set forth in the Offer to Exchange in the sections entitled (1) “Historical and Unaudited Pro Forma Financial Data” and (2) “Incorporation Of Documents By Reference” (namely, (A) the Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed by the Company with the SEC on April 15, 2026, and (B) the Quarterly Report on Form 10-Q for the period ended September 30, 2026, filed by the Company with the SEC on November 18, 2026).
| (b) | Pro Forma Information |
The information set forth in the Offer to Exchange in the sections entitled (1) “Historical and Unaudited Pro Forma Financial Data” and (2) “Incorporation Of Documents By Reference” (namely, (A) the Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed by the Company with the SEC on April 15, 2026, as amended, and (B) the Quarterly Report on Form 10-Q for the period ended September 30, 2026, filed by the Company with the SEC on November 18, 2026).
Item 12. Exhibits.
1
________________________
| * | Filed herewith |
Item 13. Information Required by Schedule 13E-3.
Not applicable.
2
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| HYPERSCALE DATA, INC. | |||
| Dated: November 20, 2026 | By: |
/s/ Henry Nisser | |
| Name: | Henry Nisser | ||
| Title: | President and General Counsel | ||
3
Exhibit (a)(1)(A)
HYPERSCALE DATA, INC.
OFFER TO EXCHANGE
up to 192,308,000 shares of its Common Stock (in 100 share increments)
FOR
12.00% Series I Cumulative REDEEMABLE Perpetual Preferred Stock AND CASH
| CUSIP No. | Consideration Offered | |
| Class A Common Stock, $0.001 par value per share (NYSE: GPUS) | 09175M879 | Units, consisting of (a) $2.00 and (b) one share of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock, per 100 shares of Class A Common Stock |
| THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON DECEMBER 18, 2026 UNLESS THE EXCHANGE OFFER IS EXTENDED OR TERMINATED. |
Hyperscale Data, Inc. (“Hyperscale,” the “Company,” “our,” “we” or “us”) is offering (the “Exchange Offer”) to exchange (1) newly issued shares of its 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (“Series I Preferred Stock”); and (2) cash, on the terms and conditions set forth in this Offer to Exchange (the “Offer to Exchange”) and in the related letter of transmittal, for up to 192,308,000 shares of its outstanding Class A Common Stock, par value $0.001 per share (the “Common Stock”) (NYSE: GPUS). Common Stock may only be tendered in increments of 100 shares. The exchange of at least 100,000,000 shares of Common Stock in the Exchange Offer is a closing condition to the Exchange Offer.
The amount of cash and the number of shares of Series I Preferred Stock to be exchanged for each 100 shares of Common Stock is fixed. The Exchange Offer is subject to the conditions discussed under “The Exchange Offer—Conditions of the Offer”, including the exchange of at least 100,000,000 shares of Common Stock.
As of November 16, 2026, 236,013,427 shares of Common Stock were outstanding.
We are making the Exchange Offer to holders of Common Stock in reliance upon the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), afforded by Section 3(a)(9) of the Securities Act.
We are offering to acquire up to 192,308,000 shares of Common Stock in 100 share increments for units (the “Units”), with each Unit consisting of:
(1) $2.00 in cash for each 100 shares of Common Stock validly tendered, and
(2) one share of Series I Preferred Stock for each 100 shares of Common Stock validly tendered.
The exchange of Common Stock for Units, with each Unit consisting of $2.00 in cash and one share of Series I Preferred Stock, may not be suitable for you. By exchanging Common Stock for Units in the Exchange Offer, a holder would be exchanging a security with voting rights for cash and a fixed yield preference security with limited voting rights. If all conditions to the Exchange Offer are satisfied or waived, we will acquire up to 192,308,000 shares of Common Stock from all validly tendering holders. The settlement date is expected to occur promptly after the expiration date although the date is subject to change as described elsewhere in this Offer to Exchange. See “The Exchange Offer—Extension, Termination and Amendment.”
|
The Information Agent for the Exchange Offer is:
51 West 52nd Street, 6th Floor New York, NY 10019
Shareholders, Banks and Brokers
Call Toll Free: (888) 355-8425
The date of this Offer to Exchange is November 20, 2026 |
The Exchange Offer will expire at one minute after 11:59 p.m., New York City Time, on December 18, 2026, unless extended or terminated by us. The term “expiration date” means one minute after 11:59 p.m., New York City Time, on December 18, 2026, unless we extend the period of time for which the Exchange Offer is open, in which case the term “expiration date” means the latest time and date on which the Exchange Offer, as so extended, expires.
The Depository Trust Company (“DTC”) and its direct and indirect participants, will establish their own cutoff dates and times to receive instructions to tender in this Exchange Offer, which will be earlier than the expiration date. You should contact your broker or other securities intermediary to determine the cutoff date and time applicable to you.
The Exchange Agent for the Offer is Computershare Trust Company, N.A. (“Computershare”) and the Information Agent for the Offer is Georgeson.
The last reported sales price of the Common Stock on the NYSE American LLC (the “NYSE American”) on November 16, 2026 was $0.1583 per share.
See “Risk Factors” beginning on page 10 for a discussion of issues that you should consider with respect to the Exchange Offer.
You must make your own decision whether to tender Common Stock in the Exchange Offer and, if so, how many shares of Common Stock to tender. Neither we, our Board of Directors (the “Board of Directors”), the Information Agent, the Exchange Agent, the Transfer Agent, nor any affiliate of any of the foregoing or any other person is making any recommendation as to whether or not you should tender your shares of Common Stock in the Exchange Offer. We have not authorized any person to make such a recommendation. You are urged to discuss your decision with your own tax advisor, financial advisor and/or broker.
We are making the Exchange Offer only to holders of Common Stock in reliance upon the exemption from the registration requirements of the Securities Act, afforded by Section 3(a)(9) of the Securities Act. We have no contract, arrangement or understanding relating to, and will not, directly or indirectly, pay any commission or other remuneration to any broker, dealer, salesperson, agent or any other person for soliciting tenders in the Exchange Offer. In addition, no broker, dealer, salesperson, agent or any other person is engaged or authorized to express any statement, opinion, recommendation or judgment with respect to the relative merits and risks of the Exchange Offer.
The Exchange Offer has not been approved or disapproved by the Securities and Exchange Commission (the “SEC”), any state securities commission, or the similar commission or governmental agency of any foreign jurisdiction, nor has the SEC, any state securities commission, or the similar commission or governmental agency of any foreign jurisdiction determined whether the information in this Offer to Exchange is truthful or complete. Any representation to the contrary is a criminal offense.
ii
Table of Contents
Page
| Summary Term Sheet | 1 |
| Questions and Answers About the Exchange Offer | 4 |
| Risk Factors | 10 |
| Statement Regarding Forward-Looking Information | 13 |
| The Exchange Offer | 14 |
| Interests of Directors And Executive Officers; Transactions and Arrangements Concerning the Shares | 25 |
| Unaudited Pro Forma Financial Data | 33 |
| Market Price And Dividend Information | 35 |
| Description Of Hyperscale’s Common Stock | 36 |
| Description Of Series I Preferred Stock | 37 |
| Comparison Of Rights Between The Common Stock And The Series I Preferred Stock | 45 |
| Certain U.S. Federal Income Tax Considerations | 46 |
| Miscellaneous | 52 |
| Certain Securities Laws Considerations | 52 |
| Where You Can Find More Information | 52 |
| Incorporation By Reference | 52 |
iii
|
SUMMARY TERM SHEET
The following is a summary of the terms of the Exchange Offer being provided for your convenience. It highlights certain material information in the Offer to Exchange, but before you make any decision with respect to the Exchange Offer, we urge you to read carefully this entire Offer to Exchange, including the section entitled “Risk Factors,” the related letter of transmittal, the descriptions of Series I Preferred Stock and Common Stock and the documents incorporated by reference into this Offer to Exchange. Our Annual Report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”) is available online at the SEC website (www.sec.gov) and our website (www.hyperscaledata.com), and is also available from us upon request. See “Where You Can Find More Information.” The following summary is qualified in its entirety by the more detailed information appearing elsewhere in this Offer to Exchange and the related letter of transmittal. |
||||
| The Company | Hyperscale Data, Inc., a Delaware corporation. | |||
| Common Stock Subject to the Exchange Offer | Up to 192,308,000 shares of Common Stock (in 100 share increments). | |||
| The Exchange Offer |
We are offering to acquire shares of Common Stock for one Unit, consisting of (a) $2.00 in cash and (b) one share of Series I Preferred Stock, for each 100 shares of Common Stock validly tendered and not properly withdrawn. To avoid issuing fractional Units, the Exchange Offer is structured in increments of 100 shares of Common Stock such that every 100 shares of Common Stock is exchangeable into one Unit.
If all conditions to the Exchange Offer are satisfied or waived, we will acquire 192,308,000 outstanding shares of Common Stock from tendering holders.
See “The Exchange Offer—Terms of the Exchange Offer.” |
|||
| No Recommendation |
Neither we, our Board of Directors, the Information Agent, the Exchange Agent, the Transfer Agent, nor any affiliate of any of the foregoing or any other person is making any recommendation as to whether or not you should tender your shares of Common Stock in the Exchange Offer. We have not authorized any person to make such a recommendation. You must make your own investment decision regarding the Exchange Offer based upon your own assessment of the market value of the Common Stock and the Series I Preferred Stock, your liquidity needs, your investment objectives and any other factors you deem relevant.
The exchange of Common Stock (in 100 share increments) for Units, with each such Unit consisting of (a) $2.00 in cash and (b) one share of Series I Preferred Stock in the Exchange Offer may not be suitable for you. By exchanging your Common Stock for Units, you will be exchanging a security with voting rights for cash and a security with fixed distribution rights and limited voting rights. The Series I Preferred Stock represent perpetual equity interests in us and will be entitled only to their stated distribution preference, irrespective of the size, growth or success of the Company. The Common Stock, conversely, is a common equity interest in the Company and is generally entitled to participate, pro rata with all other common equity holders, in the future operations and business results of the Company.
You should consider carefully all of the information set forth in this Offer to Exchange and, in particular, you should evaluate the specific factors set forth under “Risk Factors” before deciding whether to participate in the Exchange Offer. |
|||
1
| Conditions to Consummation of the Exchange Offer | The consummation of the Exchange Offer is subject to certain conditions, including the exchange of at least 100,000,000 shares of Common Stock in the Exchange Offer. We may waive any and all conditions of the Exchange Offer. If any condition to the Exchange Offer is not satisfied or waived by us, we will not accept any shares of Common Stock validly tendered and not properly withdrawn in the Exchange Offer. See “The Exchange Offer—Conditions of the Exchange Offer.” | |||
| Minimum Tender Condition | We will require a minimum of 100,000,000 shares of Common Stock to be exchanged in the Exchange Offer. This represents approximately 42.4% of our outstanding Common Stock as of November 16, 2026. If fewer than 100,000,000 shares are tendered, then we may terminate the Exchange Offer, subject to our right to waive any closing conditions. | |||
| Expiration Date | The Exchange Offer will expire at one minute after 11:59 p.m., New York City Time, on December 18, 2026, unless extended or earlier terminated. DTC and its direct and indirect participants will establish their own cutoff dates and times to receive instructions to tender in this Exchange Offer, which will be earlier than the expiration date. You should contact your broker or other securities intermediary to determine the cutoff date and time applicable to you. | |||
| How to Tender Your Shares of Common Stock |
If your shares of Common Stock are registered in your name in the record books of the Company’s transfer agent, Computershare Trust Company, N.A., you must indicate on the enclosed letter of transmittal the number of shares of Common Stock (in 100 share increments) you wish to tender and mail the completed and signed letter of transmittal and any other required documents in the envelope provided, evidencing your shares of Common Stock, if any, to be received prior to the time the Exchange Offer expires.
Shares of Common Stock held in a securities account with a broker or other securities intermediary can be tendered by your broker or other securities intermediary through DTC upon your request.
If you tender your shares of Common Stock without indicating the number of shares of Common Stock you wish to tender, it will be assumed that you are tendering all shares of Common Stock (in 100 share increments) owned by you.
If you own fewer than 100 shares of Common Stock you may not participate in the Exchange Offer. If you desire to participate in the Exchange Offer, then you must purchase more shares of Common Stock such that you own at least 100 such shares. Upon owning 100 shares of Common Stock you may participate in the Exchange Offer, subject to the terms and conditions of the Exchange Offer.
If you have questions, you should call the Information Agent at the toll-free number below. See “The Exchange Offer—Procedure for Tendering.” |
|||
2
| Fractional Units | To avoid issuing fractional Units, the Exchange Offer is structured in increments of 100 shares of Common Stock such that every 100 shares of Common Stock is exchangeable into one Unit, consisting of one share of Series I Preferred Stock and $2.00 in cash. | |||
| Withdrawal of Tendered Common Stock | You may withdraw previously tendered shares of Common Stock at any time before the expiration of the Exchange Offer. Any shares of Common Stock properly withdrawn or not accepted by us will be credited back to the appropriate account promptly following the expiration or termination of the Exchange Offer. In addition, after the expiration of the Exchange Offer, you may withdraw any shares of Common Stock that you tendered that are not accepted by us within 40 business days after the commencement of the Exchange Offer. See “The Exchange Offer—Withdrawal of Tenders.” | |||
| No Appraisal Rights | No appraisal rights are available to holders of Common Stock with the Exchange Offer. | |||
| Certain U.S. Federal Income Tax Considerations | See “Certain U.S. Federal Income Tax Considerations.” | |||
| Information Agent | Georgeson, LLC | |||
| Exchange Agent | Computershare Trust Company, N.A. | |||
| Additional Documentation; Further Information; Assistance |
Any requests for assistance concerning the Exchange Offer may be directed to the Information Agent at its address or telephone number set forth on the back cover page of this document. Beneficial owners may also contact their broker or other securities intermediary.
Any requests for additional copies of this Offer to Exchange and the related letter of transmittal may be directed to the Information Agent. |
|||
| You should read this entire Offer to Exchange and the related letter of transmittal carefully before deciding whether or not to tender your shares of Common Stock. You should consult with your personal financial advisor or other legal, tax or investment professional(s) regarding your individual circumstances. | ||||
3
|
QUESTIONS AND ANSWERS ABOUT THE EXCHANGE OFFER
The following are questions regarding the Exchange Offer that you may have as a holder of Common Stock and the answers to those questions. We urge you to read carefully this entire Offer to Exchange, including the section entitled “Risk Factors,” the section entitled “Comparison of Rights Between the Common Stock and the Series I Preferred Stock,” the related letter of transmittal, and the other documents incorporated by reference into this Offer to Exchange. See “Where You Can Find More Information.”
What is the purpose of the Exchange Offer?
The exchange of Common Stock (in 100 share increments) for Units pursuant to this Exchange Offer, affords an alternative to holders of our shares of Common Stock by providing an exchanging holder with fixed payments of the Series I Preferred Stock and liquidity through a cash payment. In addition, those who tender will hold Shares of Series I Preferred Stock that:
|
| · | have a liquidation preference equivalent to $24.00 per share of Series I Preferred Stock (equivalent to $0.24 per share of Common Stock); | |||
| · | have cumulative dividends of 12.00% per annum; | |||
| · | the consideration for each Unit, equivalent to $0.26 per share of Common Stock, represents a 64.2% premium over the last reported sales price of our Common Stock as of November 16, 2026, on the NYSE American. |
|
Those who do not exchange may benefit more from future share value accretion as a result of the reduced number of shares outstanding.
Accordingly, while we believe the Exchange Offer offers benefits to the Company and the holders of Common Stock, the Exchange Offer is not equally suitable for all holders of Common Stock, and the decision as to whether to tender shares of Common Stock in the Exchange Offer will not be the same for all holders.
Neither we, our Board of Directors, the Information Agent, the Exchange Agent, the Transfer Agent, nor any affiliate of any of the foregoing or any other person is making any recommendation as to whether or not you should tender your shares of Common Stock in the Exchange Offer. We have not authorized any person to make such a recommendation. You must make your own investment decision regarding the Exchange Offer based upon your own assessment of the market value of the Common Stock and the Series I Preferred Stock, your liquidity needs, your investment objectives and any other factors you deem relevant. See “Risk Factors” in this Offer to Exchange and the other risks contained in our Annual Report incorporated by reference herein.
Who is offering to buy my shares of Common Stock?
Hyperscale Data, Inc., a Delaware corporation and issuer of the Common Stock is offering to acquire up to 192,308,000 shares of Common Stock.
What will I receive in the Exchange Offer if I tender my shares of Common Stock and they are accepted?
Holders of Common Stock are being offered the opportunity to exchange each 100 shares of Common Stock they own for Units, with each such Unit consisting of: (a) $2.00 in cash and (b) one share of Series I Preferred Stock having a liquidation preference equal to $24.00 per share (collectively equivalent to $0.26 per share of Common Stock) (the “Exchange Ratio”), provided that (1) Common Stock must be tendered in increments of 100 shares, and (2) the aggregate value of consideration of cash and Series I Preferred Stock issued to all tendering stockholders in the Offer will not exceed $50,000,000, upon the terms and subject to the conditions set forth in this Offer to Exchange. To avoid issuing fractional Units, the Offer is structured in increments of 100 shares of Common Stock such that every 100 shares of Common Stock is exchangeable into one Unit.
In the event that a number of shares of Common Stock is tendered in the Offer that would require us to issue in excess of $50,000,000 aggregate liquidation preference of Series I Preferred Stock and cash, then all tenders will be accepted on a pro rata basis (based on increments of 100 shares) such that the aggregate liquidation preference of the Series I Preferred Stock issued in the Offer and the aggregate cash payment does not exceed $50,000,000. See “The Exchange Offer —Prorating.” |
||
4
|
Is the Exchange Offer suitable for everyone?
The exchange of Common Stock (in 100 share increments) for Units in the Exchange Offer may not be suitable for you. By exchanging your Common Stock for Units, you will be exchanging the growth potential and voting rights of the Common Stock for cash and the fixed distribution rights of the Series I Preferred Stock. It should be noted that the Company’s Class B Common Stock have the right to 10 votes for every one share of Class B Common Stock. The Series I Preferred Stock represent perpetual equity interests in us and will be entitled to their stated distribution preference, irrespective of the size, growth or success of the Company. The Common Stock (including the Class B Common Stock, which is convertible into Common Stock on a one-for-one basis at the holder’s election at any time), conversely, is a common equity interest in the Company and is generally entitled to participate, pro rata with all other common equity holders, in the future operations and business results of the Company.
You should carefully consider all of the information set forth in or incorporated by reference into this Offer to Exchange and, in particular, you should evaluate the specific factors set forth under “Risk Factors” before deciding whether to participate in the Exchange Offer.
What are the tax consequences of the Exchange Offer to me?
The U.S. federal income tax consequences to you of participating in the Exchange Offer are complex, particularly because you will receive a combination of shares of Series I Preferred Stock and cash, as well due to other facts and circumstances. Even if you do not participate in the Exchange Offer, there may be U.S. federal income tax consequences to you. See “Risk Factors— The U.S. federal income tax consequences of the Exchange Offer are complex and may vary depending on each stockholder’s particular facts and circumstances” and “Certain U.S. Federal Income Tax Considerations” in this Offer to Exchange. Because the U.S. federal income tax consequences of the Exchange Offer are complex, you are urged to consult with your own tax advisor.
Will the Series I Preferred Stock to be issued in the Exchange Offer be listed for trading?
We intend to file an application to list the Series I Preferred Stock on the NYSE American. If this application is approved, trading in the Series I Preferred Stock is expected to commence within a 30-day period after the approval of listing. However, we cannot assure you that the NYSE American will list the Series I Preferred Stock or that any trading market will develop for the Series I Preferred Stock. If the application is not approved, we intend to file an application to admit the Series I Preferred Stock for trading on the OTC. If a trading market does develop, we cannot assure you as to any price at which the Series I Preferred Stock will trade. See “Risk Factors — There may not be an active trading market for Series I Preferred Stock”.
Will the shares of Series I Preferred Stock received by tendering holders of Common Stock be freely tradable under the federal securities laws?
Yes, if the shares of Common Stock you tender were freely tradable and you are not an affiliate of ours. The Exchange Offer is being made pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), contained in Section 3(a)(9) of the Securities Act. Accordingly, shares of Series I Preferred Stock received in exchange for Common Stock tendered pursuant to the Exchange Offer will not be restricted securities for purposes of the Securities Act and will be freely tradable without regard to any holding period by those tendering holders who are not our “affiliates” (as defined in the Securities Act). Shares of Series I Preferred Stock issued pursuant to the Exchange Offer to a holder of Common Stock who is deemed to be our affiliate may be sold or transferred only in accordance with the requirements of Rule 144 or other available exemption under the Securities Act. If the Common Stock tendered in the exchange is restricted, the Series I Preferred Stock will be restricted to the same degree. For more information, see “Certain Securities Laws Considerations.”
|
5
Will the Common Stock remain listed on the NYSE American following the consummation of the Exchange Offer?
Yes. It is a closing condition to the Exchange Offer that the consummation of the Exchange Offer will not result in the Common Stock being delisted from the NYSE American. However, if the Exchange Offer is consummated, the number of shares of outstanding Common Stock, and likely the trading volume and liquidity of the Common Stock, will be reduced.
Are you making a recommendation regarding whether I should tender in the Exchange Offer?
No. Neither we, our Board of Directors, the Information Agent, the Exchange Agent, the Transfer Agent, nor any affiliate of any of the foregoing or any other person is making any recommendation as to whether or not you should tender your shares of Common Stock in the Exchange Offer. We have not authorized any person to make such a recommendation. You must make your own investment decision regarding the Exchange Offer based upon your assessment of the market value of the Common Stock and Series I Preferred Stock, your liquidity needs, your investment objectives and any other factors you deem relevant. You should carefully read this entire Offer to Exchange, the related letter of transmittal, and our Annual Report, before deciding whether or not to tender your shares of Common Stock. You should consult with your personal financial advisor or other legal, tax or investment professionals regarding your individual circumstances.
Are our directors and officers participating in the Exchange Offer?
Our directors and executive officers are entitled to participate in the Exchange Offer in the same manner as all other stockholders. All of our directors and executive officers and Ault & Company, Inc., an affiliate of Mr. Ault, have informed us that they do not intend to participate in the Exchange Offer. Assuming the completion of the Exchange Offer, the relative ownership interest in the Company held by our directors and executive officers, and their affiliates, will increase.
What is the maximum number of shares of Common Stock the Company will acquire in the Exchange Offer?
We will accept up to 192,308,000 shares of Common Stock. This represents approximately 81.5% of our outstanding Common Stock as of November 16, 2026. If more than 192,308,000 shares are tendered, we will only accept 192,308,000 shares of Common Stock, to be allocated among the tendering stockholders on a pro rata basis (based on increments of 100 shares).
What is the minimum number of shares of Common Stock the Company will acquire in the Exchange Offer?
We will require a minimum of 100,000,000 shares of Common Stock to be exchanged in the Exchange Offer. This represents approximately 42.4% of our outstanding Common Stock as of November 16, 2026. If fewer than 100,000,000 shares are tendered, then we may terminate the Exchange Offer, subject to our right to waive any closing conditions.
When and how will I receive the Units in exchange for my tendered shares of Common Stock?
If all of the conditions for consummation of the Exchange Offer are satisfied or waived, we will issue shares of Series I Preferred Stock and make a cash payment in exchange for all validly tendered and not properly withdrawn shares of Common Stock promptly after the expiration date of the Exchange Offer. We refer to the date on which such exchange is made as the “settlement date.” The settlement date is expected to occur promptly after the expiration date. We reserve the right to delay settlement pending receipt of any required governmental or regulatory approvals.
We will issue shares of Series I Preferred Stock in exchange for Common Stock that are validly tendered (in 100 share increments), not properly withdrawn, and accepted by us by delivering the shares of Series I Preferred Stock to the Exchange Agent, which will act as your agent for purposes of receiving the shares of Series I Preferred Stock from us and transmitting such shares of Series I Preferred Stock to you. We will pay cash in exchange for your Common Stock that are validly tendered, not properly withdrawn, and accepted by us by wire transfer to the Exchange Agent, which will then be paid to you. See “The Exchange Offer—Tender of Shares of Common Stock; Acceptance of Shares of Common Stock.”
In all cases, the issuance of Units in exchange for tendered Common Stock will be made only after timely receipt by the Exchange Agent of validly tendered and not properly withdrawn shares of Common Stock and any required documents in respect of such shares of Common Stock.
|
6
May I tender only a portion of the shares of Common Stock that I hold?
Yes. You may choose to tender any portion or all of your shares of Common Stock, subject to the requirement that all tenders are in increments of 100 shares.
Who may participate in the Exchange Offer?
All holders of the shares of Common Stock who hold at least 100 shares of Common Stock may participate in the Exchange Offer. See “The Exchange Offer — Terms of the Offer”. However, we are not making the Exchange Offer to, and will not accept any tendered shares of Common Stock from, stockholders in any jurisdiction where it would be illegal to do so. See “Miscellaneous”. If you own fewer than 100 shares of Common Stock you may not participate in the Exchange Offer. If you desire to participate in the Exchange Offer, then you must purchase more shares of Common Stock such that you own at least 100 shares. Upon owning 100 shares of Common Stock you may participate in the Exchange Offer, subject to the terms and conditions of the Exchange Offer.
If I am a holder of vested stock options, how do I participate in the Offer?
If you are a holder of vested options to purchase shares of Common Stock, subject to Company policies and practices, you may exercise your vested options to purchase shares and tender such shares in the Exchange Offer (in increments of 100 shares); however, we suggest that you exercise your vested options at least five business days prior to the date on which the expiration date is initially scheduled to occur (which, unless the Offer is extended, will require you to exercise such options no later than 5:00 p.m., New York City time, on December 11, 2026) in order to provide you with sufficient time to validly tender the shares in the Exchange Offer. Exercises of options cannot be revoked even if some or all of the shares received upon the exercise thereof and tendered in the Exchange Offer are not purchased pursuant to the Exchange Offer for any reason.
If I am a holder of securities convertible into shares of Common Stock, how do I participate in the Offer?
If you are a holder of Company securities that are convertible into shares of Common Stock and are currently convertible pursuant to the terms of such security, then you may convert such securities into shares of Common Stock upon their terms and tender any of the shares (in 100 share increments) issuable upon such conversion. You must convert your convertible securities sufficiently in advance of the expiration date so that you receive shares in time to tender them in the Exchange Offer prior to the expiration date. An exercise of a conversion right cannot be revoked, however, if shares received upon exercise thereof and tendered in the Exchange Offer are not purchased in the Exchange Offer for any reason.
What will happen if I do not tender my Common Stock and the Exchange Offer is successfully consummated?
If you currently hold shares of Common Stock and do not tender them or if your shares of Common Stock are not accepted in the Offer because of prorating, your shares of Common Stock will continue to be issued and outstanding. See “The Exchange Offer — Terms of the Offer” and “The Exchange Offer — Prorating”.
Is the Exchange Offer subject to any conditions?
Yes. The Exchange Offer is conditioned upon the satisfaction or waiver of a number of conditions described in the section of this Offer to Exchange entitled “The Exchange Offer—Conditions of the Offer,” including a minimum number of shares of Common Stock outstanding being validly tendered. We may waive any and all of the conditions of the Exchange Offer. If all of the conditions to the Exchange Offer are not satisfied or waived, the Company may, in its sole discretion, terminate the Exchange Offer.
When will the Exchange Offer expire?
The Exchange Offer is currently scheduled to expire at one minute after 11:59 p.m., New York City Time, on December 18, 2026, unless extended or terminated by us. We may extend the expiration date in our sole discretion, including in order to permit the satisfaction or waiver of any or all conditions to the Exchange Offer. We will also extend the expiration date of the Exchange Offer if required by applicable law or regulation.
|
7
DTC and its direct and indirect participants will establish their own cutoff dates and times to receive instructions to tender in this Exchange Offer, which will be earlier than the expiration date. You should contact your broker or other securities intermediary to determine the cutoff date and time applicable to you. See “The Exchange Offer—Extension, Termination and Amendment.”
Under what circumstances may the Exchange Offer be terminated, and what happens to my tendered shares of Common Stock if that occurs?
We have the right to terminate or withdraw, in its sole discretion, the Exchange Offer at any time if any of the conditions of the Exchange Offer are not satisfied or waived by us by the expiration date. We reserve the right, subject to applicable law, to (i) waive any and all conditions of the Exchange Offer at any time prior to the expiration date of the Exchange Offer or (ii) amend the terms of the Exchange Offer. In the event that the Exchange Offer is terminated, withdrawn or otherwise not consummated on or prior to its expiration, no consideration will be paid or become payable to holders who have validly tendered and not properly withdrawn their shares of Common Stock pursuant to the Exchange Offer. In any such event, the shares of Common Stock previously tendered pursuant to the Exchange Offer will be promptly returned to the tendering holders. See “The Exchange Offer—Extension, Termination and Amendment.”
How will I be notified if the Exchange Offer is extended, amended or terminated?
We, in our sole discretion, may extend the Expiration Date for any reason. If the Exchange Offer is extended, amended or terminated, we will promptly make a public announcement by issuing a press release or filing an amendment to the Schedule TO with the SEC. In the case of an extension, the announcement will be issued no later than 9:00 a.m., New York City time, on the next business day after the previously scheduled expiration date of the Exchange Offer. See “The Exchange Offer—Extension, Termination and Amendment.”
Will I have to pay any fees or commissions for participating in the Exchange Offer?
You will not pay any fees to the Company, the Information Agent, the Exchange Agent or the Transfer Agent to participate in the Exchange Offer. Any fees due for cancellation of tendered shares of Common Stock will be paid by the Company. If you hold shares of Common Stock through a broker or other securities intermediary, and your broker or other securities intermediary tenders the shares of Common Stock on your behalf, your broker, dealer or other securities intermediary may charge you a fee for doing so. You should consult your broker, dealer or other nominee to determine whether any charges will apply. See “The Exchange Offer—Terms of the Exchange Offer” and “The Exchange Offer—Expenses.”
How do I tender my shares of Common Stock?
If your shares of Common Stock are registered in your name, you must indicate on the enclosed letter of transmittal the number of shares of Common Stock you wish to tender, and mail the completed and signed letter of transmittal, evidencing the shares of Common Stock and any other documents required to be completed and delivered by you in the envelope provided to be received no later than the time the expiration date of the Exchange Offer.
Shares of Common Stock held in a securities account with a broker or other securities intermediary can be tendered by your broker or other securities intermediary through DTC upon your request.
If you tender your shares of Common Stock without indicating the number of shares of Common Stock you wish to tender, it will be assumed that you are tendering all shares of Common Stock owned by you.
If you have questions, you should call the Information Agent at the toll-free number on the back cover of this Offer to Exchange. See “The Exchange Offer—Procedure for Tendering.”
What must I do if I want to withdraw my shares of Common Stock from the Exchange Offer?
You may withdraw previously tendered shares of Common Stock at any time before the expiration date of the Exchange Offer. Any shares of Common Stock that are properly withdrawn will be credited back to the appropriate account promptly following such withdrawal. In addition, after the expiration of the Exchange Offer, you may withdraw any shares of Common Stock that you tendered that are not accepted by us within 40 business days after the commencement of the Exchange Offer. See “The Exchange Offer—Withdrawal of Tenders.”
|
8
If your shares of Common Stock are registered in your name, in order to properly withdraw your shares of Common Stock from the Exchange Offer, you must deliver a written notice of withdrawal to the Exchange Agent at the appropriate address specified on the back cover of this Offer to Exchange prior to the expiration date of the Exchange Offer or, after the expiration date of the Exchange Offer, you may withdraw any shares of Common Stock that you tendered that are not accepted by us within 40 business days after the commencement of the Exchange Offer. Your notice of withdrawal must comply with the requirements set forth in this Offer to Exchange. If you have questions, you should call the Information Agent at the toll-free number below.
If you tendered your shares of Common Stock through DTC, a withdrawal of your shares of Common Stock will be effective if you and your broker or other securities intermediary comply with the appropriate procedures of DTC’s automated system prior to the expiration of the Exchange Offer or after the expiration of 40 business days after the commencement of the Exchange Offer. Any notice of withdrawal must identify the shares of Common Stock to be withdrawn, including, if held through DTC, the name and number of the account at DTC to be credited and otherwise comply with the procedures of DTC. You should contact your broker or other securities intermediary to assist you with properly withdrawing your previously tendered shares of Common Stock. See “The Exchange Offer—Withdrawal of Tenders.”
What happens if I do not participate in the Exchange Offer, or if my shares of Common Stock are not accepted in the Exchange Offer because of prorating?
If you currently hold shares of Common Stock and do not tender them or if your shares of Common Stock are not accepted in the Offer because of prorating, your shares of Common Stock will continue to be issued and outstanding. See “The Exchange Offer — Terms of the Exchange Offer” and “The Exchange Offer — Prorating”.
Whom do I call if I have any questions on how to tender my shares of Common Stock or any other questions relating to the Exchange Offer?
Questions related to the terms of the Exchange Offer and requests for assistance, as well as for additional copies of this Offer to Exchange, the related letter of transmittal or any other documents relevant to the Exchange Offer, may be directed to the Information Agent using the contact information set forth on the back cover of this Offer to Exchange or by telephone at (888) 355-8425.
Where can I find more information about Hyperscale Data, Inc.?
For more information, see our Annual Report, which is available online at the SEC website (www.sec.gov) and our website (www.hyperscaledata.com), and is also available from us upon request. See “Where You Can Find More Information.”
|
9
RISK FACTORS
You should carefully consider the risks and uncertainties described throughout this Offer to Exchange, including those described below, and any other risk factors and cautionary statements described in the documents we file from time to time with the SEC, including those discussed in our Annual Report on Form 10-K under the headings “Risk Factors”, “Legal Proceedings”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and otherwise identified or discussed in our Annual Report on Form 10-K, and our Quarterly Reports on Form 10-Q under the headings “Risk Factors,” “Legal Proceedings,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and otherwise identified or discussed in our Quarterly Reports on Form 10-Q, which are incorporated by reference into this Offer to Exchange, which risk factors are incorporated by reference herein, before you decide whether to tender your shares of Common Stock in the Exchange Offer.
Risks Related to Our Business
For a discussion of risks associated with our business, please see the discussion of risks related to our business under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2026, June 30, 2026 and September 30, 2026.
Risks Relating to the Exchange Offer and the Series I Preferred Stock
The Exchange Offer is subject to certain contingencies and may not be completed.
The Exchange Offer is subject to certain contingencies that are not within the control of the Company. The Exchange Offer is conditioned on the closing conditions described under “The Exchange Offer — Conditions of the Exchange Offer”. We will not be required, but we reserve the right, to waive any of the conditions of the Exchange Offer (to the extent permitted by applicable law) and accept for exchange any shares of Common Stock tendered (or, alternatively, we may elect to terminate the Offer) if any of the conditions of the Offer as described under “The Exchange Offer — Conditions of the Exchange Offer” remain unsatisfied. For instance, the Exchange Offer requires the consent of JGB and waiver from Esousa (defined below) and may require certain approvals or consents from government regulatory agencies, self-regulatory organizations, and/or other third parties. There can be no assurance that all required conditions, consents, or regulatory approvals will be obtained or achieved in a timely manner. Moreover, the Exchange Offer may be modified or withdrawn in certain circumstances subject to the discretion of the Company’s Board of Directors. See “The Exchange Offer — Conditions of the Exchange Offer”.
There may not be an active trading market for the Series I Preferred Stock.
No market currently exists for the Series I Preferred Stock. Although the Company intends to apply to list the Series I Preferred Stock on the NYSE American, this is not a condition to the completion of the Exchange Offer and there is no assurance that such listing will be accomplished or, if the Series I Preferred Stock is so listed, that trading will develop in the Series I Preferred Stock. If the application is not approved, we intend to file an application to admit the Series I Preferred Stock for trading on the OTC. If the Series I Preferred Stock is not listed or if a robust market does not develop, even if listed, it may impair a holder’s ability to resell the Series I Preferred Stock or the prices at which they may trade. Accordingly, no assurance can be given as to the liquidity of the Series I Preferred Stock after their issuance, or the prices at which they may trade, or that a trading market will develop.
The Units do not reflect any independent valuation of the shares of the Common Stock or the Series I Preferred Stock.
We are not making a recommendation as to whether holders of shares of Common Stock should exchange their shares for Units. We have not retained and do not intend to retain any unaffiliated representative for purposes of preparing a report concerning the fairness of the Exchange Offer. We cannot assure holders of shares of Common Stock that the value of the Units received in the Exchange Offer will in the future equal or exceed the value of the shares of Common Stock tendered and we do not take a position as to whether you should participate in the Exchange Offer. If you tender your shares of Common Stock, you may or may not receive more than or as much value as you may receive if you choose to keep such shares of Common Stock.
10
If you do not tender your shares of Common Stock in the Exchange Offer, those shares will be subordinate in right of payment and distribution upon liquidation to the Series I Preferred Stock.
If you do not tender your shares of Common Stock in the Exchange Offer, you will continue to hold such shares. If the Exchange Offer is consummated, there will be fewer shares of our Common Stock held by the Company’s stockholders, and there may therefore be fewer transactions in the shares of Common Stock. A lack of an active trading market may have an adverse effect on the trading price of our Common Stock. Additionally, the Series I Preferred Stock has a cumulative dividend rate of 12.00% unlike the Common Stock, and the Common Stock is junior to the Series I Preferred Stock in respect of distributions upon liquidation.
The completion of the Exchange Offer is likely to result in management holding a larger share of the Company’s equity and voting power.
As of November 16, 2026, the Company’s Executive Chairman, and his affiliates, beneficially owned 467,191,158 shares of Common Stock or approximately 67.9% of the total shares of Common Stock outstanding, after giving effect to the conversion of Class B Common Stock and other convertible securities held by such persons. Assuming that the Exchange Offer is fully subscribed by persons other than Mr. Ault and his affiliates, following consummation of the Offer, the Executive Chairman would beneficially own approximately 94.2% of the outstanding Common Stock, after giving effect to the conversion of Class B Common Stock and other convertible securities held by such persons. The interests of Mr. Ault and his affiliates may be different than the interests of stockholders in general, and the increased ownership percentage may make it easier for Mr. Ault and his affiliates to approve (or disapprove) transactions to which a majority of the other stockholders are opposed (or in favor of).
Hyperscale may not have sufficient cash to pay dividends on the Series I Preferred Stock.
Hyperscale conducts substantially all of its business through its subsidiaries. Accordingly, Hyperscale’s ability to pay dividends on the Series I Preferred Stock depends on the earnings of and distribution of funds from its subsidiaries. Each of these subsidiaries is a distinct legal entity and, under certain circumstances, legal and contractual restrictions may limit Hyperscale’s ability to obtain cash from them.
The Series I Preferred Stock do not require Hyperscale to achieve or maintain minimum financial results, refrain from incurring additional debt or limit its ability to take specified actions. The lack of any of these provisions could negatively impact holders of the Series I Preferred Stock.
The terms of the Amended and Restated Certificate of Designation, Rights and Preferences of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (the “Certificate of Designation”) do not require Hyperscale to achieve or maintain any minimum financial results relating to its financial position or results of operations. In addition, the Certificate of Designation does not contain any operating covenants, restrict Hyperscale from incurring additional debt or restrict Hyperscale from paying dividends, incurring liens or repurchasing any of its indebtedness or capital stock. Hyperscale will not be required to redeem the Series I Preferred Stock in the event Hyperscale undergoes a change of control. Hyperscale’s ability to take any of these actions could diminish its ability to pay dividends on the Series I Preferred Stock when due.
The Series I Preferred Stock ranks junior to all of our liabilities and will not limit our ability to incur indebtedness and other liabilities that will rank senior to the Series I Preferred Stock.
The Series I Preferred Stock ranks junior to all of our liabilities. In the event of our bankruptcy, liquidation or winding-up, our assets will only be available to make payments of dividends on and liquidation preference of the Series I Preferred Stock after all of our indebtedness and other liabilities have been paid. As of September 30, 2026, we had approximately $268.3 million of total liabilities. In addition, the Series I Preferred Stock will rank structurally junior to all existing and future liabilities of our subsidiaries and the rights of any equity holders (other than us) of those subsidiaries. As discussed above under “Hyperscale may not have sufficient cash to pay dividends on the Series I Preferred Stock,” we are a holding company and our ability to pay dividends or otherwise make payments in respect of the Series I Preferred Stock may be limited. If we are forced to liquidate our assets to pay our creditors, we may not have sufficient assets remaining to pay amounts due on any or all of the Series I Preferred Stock then issued and outstanding. We and our subsidiaries may incur substantial amounts of additional debt and other obligations that will rank senior to the Series I Preferred Stock, and the terms of the Series I Preferred Stock will not limit the amount of such debt or other obligations that we may incur. In addition, our subsidiaries may issue capital stock or other ownership interests to third parties.
11
The Series I Preferred Stock ranks junior as to dividend rights and rights upon liquidation to all other series of our Preferred Stock.
As of September 30, 2026, there were 7,040 outstanding shares of Series A Convertible Preferred Stock (the “Series A Preferred Stock”), 3,000 outstanding shares of Series B Convertible Preferred Stock (the “Series B Preferred Stock”), 50,000 outstanding shares of Series C Convertible Preferred Stock (the “Series C Preferred Stock”), 668,978 outstanding shares of Series D Cumulative Redeemable Perpetual Preferred Stock (the “Series D Preferred Stock”), 649,998 outstanding shares of Series E Cumulative Redeemable Perpetual Preferred Stock (the “Series E Preferred Stock”), 998,577 outstanding shares of Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”), 960 outstanding shares of Series G Preferred Stock (the “Series G Preferred Stock”) and 4,000 outstanding shares of Series H Convertible Preferred Stock (the “Series H Preferred Stock”). The Series I Preferred Stock will rank junior to the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock, the Series D Preferred Stock, the Series E Preferred Stock, the Series F Preferred Stock, the Series G Preferred Stock and the Series H Preferred Stock with respect to liquidation and dividend rights. The outstanding shares of the senior preferred stock could have the effect of reducing the amounts available to the Series I Preferred Stock upon our liquidation, dissolution or winding up.
Volatility in the market price and trading volume of our Common Stock could adversely impact the trading prices for the Series I Preferred Stock.
The stock market in recent years has experienced significant price and volume fluctuations that have often been unrelated to the operating performance of companies. The market price of our Common Stock could fluctuate significantly for many reasons, including in response to the risks described in this section, elsewhere in this Offer to Exchange or the documents incorporated by reference in this Offer to Exchange or for reasons unrelated to our operations, such as future issuances of securities by us, reports by industry analysts, investor perceptions or negative announcements by our customers, competitors or suppliers regarding their own performance, as well as industry conditions and general financial, economic and political instability. A decrease in the market price of our Common Stock would likely adversely impact the trading price of the Series I Preferred Stock.
Our ability to issue preferred stock in the future could adversely affect the rights of holders of the Series I Preferred Stock and our Common Stock.
Our Board of Directors is authorized to issue additional series of preferred stock senior to, on parity with, or junior to, the Series I Preferred Stock with respect to the payment of dividends and rights upon liquidation, dissolution or winding up, without any action on the part of holders of our Series I Preferred Stock or our Common Stock. Our Board of Directors also has the power, without stockholder approval, to set the terms of any such series of preferred stock that may be issued, including voting rights, conversion rights, dividend rights, preferences over our Common Stock with respect to dividends or if we liquidate, dissolve or wind up our business and other terms. If we issue preferred stock in the future that has preference over our Series I Preferred Stock or Common Stock with respect to the payment of dividends or upon our liquidation, dissolution or winding up, or if we issue preferred stock with voting rights that dilute the voting power of our Common Stock, the market price of our Common Stock could decrease, adversely affecting the value of the Series I Preferred Stock.
We may not have sufficient earnings and profits in order for distributions on the Series I Preferred Stock to be treated as dividends.
The dividends payable by us on the Series I Preferred Stock may exceed our current or accumulated earnings and profits, as calculated for U.S. federal income tax purposes, at the time of payment. If that were to occur, it would result in the amount of dividends that exceed our earnings and profits being treated first as a return of capital to the extent of the holder’s adjusted tax basis in the Series I Preferred Stock and then, to the extent of any excess over such adjusted tax basis, as capital gain. See “Certain U.S. Federal Income Tax Considerations.”
12
Increases in market interest rates may adversely affect the market price of the Series I Preferred Stock.
One of the factors that will influence the market price of the Series I Preferred Stock is the annual yield from dividends on the Series I Preferred Stock as compared to yields on other financial instruments. An increase in market interest rates generally will result in higher yields on other financial instruments, which could adversely affect the market price of the Series I Preferred Stock.
The U.S. federal income tax consequences of the Exchange Offer are complex and may vary depending on each stockholder’s particular facts and circumstances
The U.S. federal income tax consequences to you of participating in the Exchange Offer are complex and will vary depending on certain facts and circumstances. We intend to treat the exchange of Common Stock for Series I Preferred Stock and cash as a “recapitalization” pursuant to Section 368(a)(1)(E) of the Code. However, because you will receive cash in addition to Series I Preferred Stock, you may be required to recognize gain, if any, but not loss, in an amount not exceeding the cash received in the Exchange Offer. We have not sought, and do not intend to seek, a ruling from the IRS with respect to the U.S. federal income tax consequences of the Exchange Offer, and we cannot assure you that the IRS will agree with the treatment described herein. See “Certain U.S. Federal Income Tax Considerations” in this Offer to Exchange.
STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This Offer to Exchange contains statements concerning our future operating results and future financial performance. These statements relate to future events or our future financial performance. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “expects,” “can,” “continue,” “could,” “estimates,” “intends,” “may,” “plans,” “potential,” “predict,” “should” or “will” or the negative of these terms or other comparable terminology. These statements are only predictions; uncertainties and other factors may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels or activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Offer to Exchange, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
You should read the section titled “Risk Factors” set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. These factors are not necessarily all of the important factors that could cause our actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could cause our actual results to differ materially from those expressed in any of our forward-looking statements.
Given these uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements are made only as of the date of this Offer to Exchange, we cannot assure you that the forward-looking statements in this Offer to Exchange will prove accurate. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.
You should read this Offer to Exchange with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. We qualify all forward-looking statements by these cautionary statements.
13
THE EXCHANGE OFFER
No Recommendation
THE EXCHANGE OF SHARES OF COMMON STOCK FOR UNITS IN THE EXCHANGE OFFER MAY NOT BE SUITABLE FOR YOU. NEITHER WE, OUR BOARD OF DIRECTORS, THE INFORMATION AGENT, THE EXCHANGE AGENT, THE TRANSFER AGENT, NOR ANY AFFILIATE OF ANY OF THE FOREGOING OR ANY OTHER PERSON IS MAKING ANY RECOMMENDATION AS TO WHETHER OR NOT YOU SHOULD TENDER YOUR SHARES OF COMMON STOCK IN THE EXCHANGE OFFER. WE HAVE NOT AUTHORIZED ANY PERSON TO MAKE SUCH A RECOMMENDATION. YOU MUST MAKE YOUR OWN INVESTMENT DECISION REGARDING THE EXCHANGE OFFER BASED UPON YOUR OWN ASSESSMENT OF THE MARKET VALUE OF THE COMMON STOCK, YOUR LIQUIDITY NEEDS, YOUR INVESTMENT OBJECTIVES AND ANY OTHER FACTORS YOU DEEM RELEVANT. BEFORE YOU MAKE YOUR DECISION, WE URGE YOU TO CAREFULLY READ THIS OFFER TO EXCHANGE IN ITS ENTIRETY, INCLUDING THE INFORMATION SET FORTH UNDER “RISK FACTORS” AND THE INFORMATION IN OUR ANNUAL REPORT, WHICH IS INCORPORATED BY REFERENCE HEREIN, INCLUDING THE INFORMATION SET FORTH UNDER “RISK FACTORS” THEREIN. WE ALSO URGE YOU TO CONSULT YOUR OWN FINANCIAL AND TAX ADVISORS IN MAKING YOUR OWN DECISIONS ON WHAT ACTION, IF ANY, TO TAKE IN LIGHT OF YOUR OWN PARTICULAR CIRCUMSTANCES.
Terms of the Exchange Offer
We are offering to acquire up to 192,308,000 shares of our Common Stock for Units, which consist of up to (a) $46,153,846 aggregate liquidation preference of Series I Preferred Stock and (b) $3,846,154 in cash. Each 100 shares of Common Stock being exchangeable in the Exchange Offer for one Unit, consisting of (a) one share of Series I Preferred Stock having a liquidation preference equal to $24.00 per share and (b) $2.00 in cash.
To avoid the issuance of fractional Units, Common Stock may only be tendered in increments of 100 shares. If you own fewer than 100 shares of Common Stock you may not participate in the Exchange Offer. If you desire to participate in the Offer, then you must purchase more shares of Common Stock such that you own at least 100 shares. Upon owning 100 shares of Common Stock you may participate in the Exchange Offer, subject to the terms and conditions of the Exchange Offer.
In the event that a number of shares of Common Stock is tendered in the Offer that would require us to issue in excess of $46,153,846 aggregate liquidation preference of Series I Preferred Stock and $3,846,154 in cash, then all tenders will be accepted on a pro rata basis (based on increments of 100 shares) such that the aggregate liquidation preference of the Series I Preferred Stock issued in the Exchange Offer does not exceed $46,153,846 and the aggregate cash payment in the exchange offer does not exceed $3,846,154. See “The Exchange Offer — Prorating”.
We are making the Exchange Offer only to holders of shares of Common Stock in reliance upon the exemption from the registration requirements of the Securities Act, afforded by Section 3(a)(9) of the Securities Act. We have no contract, arrangement or understanding relating to, and will not, directly or indirectly, pay any commission or other remuneration to any broker, dealer, salesperson, agent or any other person for soliciting tenders in the Exchange Offer. In addition, no broker, dealer, salesperson, agent or any other person is engaged or authorized to express any statement, opinion, recommendation or judgment with respect to the relative merits and risks of the Exchange Offer.
Georgeson, LLC is acting as Information Agent, and Computershare Trust Company, N.A. is acting as Exchange Agent in connection with the Exchange Offer. The Information Agent may contact holders of Common Stock by mail, telephone, facsimile and/or other customary means and may request brokers and other securities intermediaries to forward materials relating to the Exchange Offer to beneficial owners. The Information Agent and the Exchange Agent will each receive reasonable and customary compensation for their respective services and will be reimbursed by us for reasonable out-of-pocket expenses. The Information Agent and the Exchange Agent will be indemnified against certain liabilities in connection with the Exchange Offer, including certain liabilities under the federal securities laws.
14
In addition, we will request that brokers and other securities intermediaries forward copies of this Offer to Exchange to the beneficial owners of shares of Common Stock, and will provide reimbursement for the cost of forwarding such material. We will not pay any fees or commissions to brokers, other securities intermediaries or other persons (other than as described above) for soliciting tenders of shares of Common Stock in connection with the Exchange Offer.
You should rely only on the information contained in this Offer to Exchange and the related letter of transmittal. Except as described above, we have no arrangements for and have no understanding with any dealer, salesperson, agent or any other person regarding the solicitation of tenders hereunder. Neither we, the Exchange Agent, the Information Agent, or the Transfer Agent, nor any affiliate of the foregoing, has authorized any other person to provide you with any additional information. If anyone provides you with any additional information, you should not rely on it. Neither the delivery of this Offer to Exchange nor any exchange made hereunder shall, under any circumstances, create any implication that there has been no change in the affairs of the Company or its subsidiaries since the respective dates as of which information is given in this Offer to Exchange. We are offering to acquire shares of Common Stock only in U.S. jurisdictions where the offers or tenders are permitted pursuant to the laws of such jurisdiction.
Registered holders who tender their shares of Common Stock directly to us through the Exchange Agent will not have to pay any fees or commissions. Any fees due for cancellation of validly tendered shares of Common Stock will be paid by the Company. Holders who tender their shares of Common Stock through a broker or other securities intermediary may be charged a fee by their broker or other securities intermediary for doing so. Such holders should consult their broker or other securities intermediary to determine whether any charges will apply.
The term “expiration date” means one minute after 11:59 p.m., New York City Time, on December 18, 2026, unless we extend the period of time for which the Exchange Offer with respect to shares of Common Stock will remain open, in which case the term “expiration date” means the latest time and date on which the Exchange Offer with respect to the shares of Common Stock, as so extended, expires.
DTC and its direct and indirect participants will establish their own cutoff dates and times to receive instructions to tender in this Exchange Offer, which will be earlier than the expiration date. You should contact your broker or other securities intermediary to determine the cutoff date and time applicable to you.
If the Exchange Offer expires or terminates without any shares of Common Stock being accepted by us following the expiration or termination of the Exchange Offer, you will continue to hold your shares of Common Stock.
Information Relating to the Series I Preferred Stock
Dividends on the Series I Preferred Stock shall accrue daily and be cumulative from, and including, the date that is twelve (12) months from the date of the initial issuance of the Series I Preferred Stock (the “Initial Issuance Date”) and shall be payable monthly within eight (8) business days following the last day of each month beginning on the last day of the 13th month following the Initial Issuance Date, when, as and if declared by our Board of Directors. Dividends will be payable out of amounts legally available therefor at a rate equal to 12.00% per annum per $24.00 of stated liquidation preference per share, or $0.24 per share of Series I Preferred Stock per month. However, holders of Series I Preferred Stock will not otherwise participate in any dividends or distributions of cash or other property paid in respect of our Common Stock with holders of the Common Stock. See “Description of Series I Preferred Stock — Dividends” for additional detail.
The Series I Preferred Stock will rank junior to the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock with respect to payment of dividends and amounts upon liquidation, dissolution or winding up. Following the last day of the 13th month following the Initial Issuance Date, we may redeem, at our option, the Series I Preferred Stock, in whole or in part, at any time or from time to time, at a redemption price of $24.00 per share of Series I Preferred Stock, plus any accumulated and unpaid dividends (whether or not declared) on the Series I Preferred Stock up to, but not including, the date of such redemption, upon written notice, as described in the section entitled “Description of the Series I Preferred Stock — Redemption — Redemption Procedures.” The Series I Preferred Stock is perpetual and has no stated maturity date, will not be subject to any sinking fund or other mandatory redemption, and will not be convertible into or exchangeable for any of our other securities.
15
Accordingly, because our Series I Preferred Stock will have no maturity date, and we will not be required to redeem our Series I Preferred Stock at any time, our Series I Preferred Stock will remain outstanding indefinitely unless we decide to redeem it.
Conditions of the Exchange Offer
Notwithstanding any other provision of the Exchange Offer, or any extension of the Exchange Offer, we shall not be required to accept for exchange any shares of Common Stock, issue any Series I Preferred Stock or make any cash payment, and we may terminate or amend the Exchange Offer at any time prior to acceptance for exchange of the shares of Common Stock if we determine, in our reasonable judgment, that any of the following conditions has not been satisfied on or before the expiration date:
| · | the Series I Preferred Stock shall be eligible for deposit with the Depositary Trust Company; |
| · | there shall have been validly tendered and not withdrawn at least 100,000,000 shares of Common Stock; |
| · | we shall have received the consent of JGB Capital, LP, a Delaware limited partnership, JGB Partners, LP, a Delaware limited partnership and JGB (Cayman) Buckeye LTD., a Cayman Islands exempted company (collectively, “JGB”) and a waiver under certain agreements from Esousa Group Holdings, LLC (“Esousa”) with respect to the Exchange Offer; |
| · | there shall not have occurred or be likely to occur any event that could reasonably be expected to materially adversely affect our business, financial condition, income, operations, properties or prospects, or materially impair the contemplated benefits of the Exchange Offer, or the settlement of the Exchange Offer; |
| · | there shall not have been any action taken or any statute, rule, regulation, judgment, order, stay, decree or injunction promulgated, enacted, entered, enforced or deemed applicable to the Exchange Offer or the exchange of shares of Common Stock for Units pursuant to the Exchange Offer, by or before any court or governmental regulatory or administrative agency or authority, tribunal, domestic or foreign, that challenges the making of the Exchange Offer or might reasonably be expected to, directly or indirectly, prohibit, prevent, restrict or delay settlement of, or might otherwise reasonably be expected to adversely affect in any material manner, the Exchange Offer; |
| · | the closing price of the Common Stock shall not have materially exceeded the offering price in the Exchange Offer; |
| · | there shall not have occurred (i) any general suspension of, or limitation on prices for, trading in securities in the United States securities or financial markets, (ii) a decrease of more than 15% in the sale price of the shares on the NYSE American or decrease of more than 10% in the general level of market prices for equity securities in the United States of the New York Stock Exchange Index, the Dow Jones Industrial Average, the Nasdaq Global Market Composite Index or Standard & Poor’s Composite Index of 500 Industrial Companies, in each case measured from the close of trading on November 16, 2026, the last full trading day prior to the commencement of the Offer, (iii) a material impairment in the trading market for debt securities in the United States, (iv) a declaration of a banking moratorium or any systemic suspension of payments in respect to banks in the United States or other major financial markets that is material to the Company, (v) any limitation (whether or not mandatory) by any government or governmental, administrative or regulatory authority or agency, domestic or foreign, or other event that might affect the extension of credit by banks or other lending institutions, (vi) a commencement of a war, armed hostilities, terrorist acts or other national or international calamity directly involving the United States or indirectly involving the United States, which results in material involvement by the United States, or (vii) in the case of any of the foregoing existing on the date hereof, a material acceleration or worsening thereof; |
16
| · | the SEC shall not have determined that the tender offer is subject to Rule 13e-3 under the Exchange Act; |
| · | that (i) the Common Stock remains listed on the NYSE American through the duration of the Exchange Offer and (ii) the consummation of the Exchange Offer will not result in the Common Stock being delisted from the NYSE American. |
The foregoing conditions are for the Company’s benefit and may be asserted by the Company or may be waived by the Company, in whole or in part at any time, and from time to time, on or prior to the expiration date, in its sole discretion. In addition, the Company may terminate the Exchange Offer if any condition is not satisfied or waived on or before the expiration date. Under the Exchange Offer, if any of the foregoing conditions is not satisfied or waived, the Company may (i) not accept shares of Common Stock tendered by you, (ii) extend the Exchange Offer and retain all tendered shares of Common Stock until the expiration of the extended Exchange Offer, or (iii) amend the Exchange Offer in any respect by giving oral or written notice of such amendment to the Exchange Agent and making public disclosure of such amendment to the extent required by applicable law.
The Company has not made a decision as to what circumstances would lead the Company to waive any such condition, and any such waiver would depend on circumstances prevailing at the time of such waiver. Although the Company has no present plans or arrangements to do so, the Company reserves the right to amend, at any time, the terms of the Exchange Offer. The Company will give holders such notice of such amendments as may be required by applicable law.
Extension, Termination and Amendment
We have the right to terminate or withdraw the Exchange Offer, in our sole discretion, if the conditions to the Exchange Offer set forth under “The Exchange Offer—Conditions of the Exchange Offer” are not met prior to the expiration date. We reserve the right, subject to applicable law, to (i) waive any and all of the conditions of the Exchange Offer on or prior to the expiration date or (ii) amend the terms of the Exchange Offer.
Subject to the applicable regulations of the SEC, we expressly reserve the right, in our sole discretion, at any time and from time to time, and regardless of whether any events preventing satisfaction of the conditions to the Exchange Offer shall have occurred or shall have been determined by us to have occurred, to extend the period during which the Exchange Offer is open by giving oral (to be confirmed in writing) or written notice of such extension to the Exchange Agent and by making public disclosure by press release or other appropriate means of such extension to the extent required by law at any time prior to 9:00 a.m. New York City time, on the first business day after the previously scheduled expiration date. During any extension of the Exchange Offer, all shares of Common Stock previously tendered and not withdrawn will remain subject to the Exchange Offer and may, subject to the terms and conditions of the Exchange Offer, be accepted for exchange by us.
Any waiver, amendment or modification of the Exchange Offer will apply to all shares of Common Stock tendered pursuant to the Exchange Offer.
If we materially change the terms of the Exchange Offer or the information concerning the Exchange Offer, we will extend the Exchange Offer to the extent required by Rules 13e-4(d)(2), 13e-4(e)(3), 13e-4(f)(1) and 14e-1(b) under the Exchange Act. These rules and certain related releases and interpretations of the SEC provide that the minimum period during which the Exchange Offer must remain open following material changes in the terms of the Exchange Offer or information concerning the Exchange Offer (other than a change in price or a decrease in percentage of shares of Common Stock sought, as discussed below) will depend on the facts and circumstances, including the relative materiality of such terms or information. If we:
| · | increase or decrease the consideration to be paid for the shares of Common Stock; or |
17
| · | decrease the principal amount of shares of Common Stock we are seeking to purchase, |
then the Exchange Offer must remain open, or will be extended, until at least ten business days from, and including, the date that notice of any such change is first published, sent or given in the manner described below. For purposes of the Exchange Offer, a “business day” means any day other than a Saturday, Sunday or United States federal holiday and consists of the time period from 12:01 a.m. through 12:00 midnight, New York City time.
We may, in our sole discretion, terminate or withdraw the Exchange Offer at any time if any condition is not satisfied on or after the expiration date. In any such event, the shares of Common Stock previously tendered pursuant to the Exchange Offer will be promptly returned to the tendering holders.
There can be no assurance that we will exercise our right to extend, terminate or amend the Exchange Offer. During any extension, and irrespective of any amendment to the Exchange Offer, all shares of Common Stock previously tendered and not properly withdrawn will remain subject to the Exchange Offer and may be accepted thereafter for exchange by us, subject to compliance with applicable law. In addition, we may waive conditions without extending the Exchange Offer in accordance with applicable law.
Tender of Shares of Common Stock; Acceptance of Shares of Common Stock
Upon the terms and subject to the conditions of the Exchange Offer, including any amendment to or extension of the Exchange Offer, we will acquire the validly tendered and not properly withdrawn shares of Common Stock by accepting such shares promptly after the expiration date. The settlement date is expected to occur promptly after the expiration date, although such date is subject to change as discussed elsewhere in this Offer to Exchange. In addition, subject to the applicable rules of the SEC, we expressly reserve the right to delay acceptance of, or any shares of Common Stock in order to comply with any applicable law. The reservation of this right to delay the acceptance or acquisition of, or payment for, the shares of Common Stock is subject to the provisions of Rule 14e-1(c) under the Exchange Act, which requires us to pay the consideration offered or to return the shares of Common Stock deposited by, or on behalf of, holders, promptly after the termination or withdrawal of the Exchange Offer.
For purposes of the Exchange Offer, we will be deemed to have accepted the shares of Common Stock validly tendered and not properly withdrawn, if and when we notify the Exchange Agent of our acceptance of the validly tendered and not properly withdrawn shares of Common Stock pursuant to the Exchange Offer. Upon the terms and subject to the conditions of the Exchange Offer, we will deliver the Units, consisting of shares of Series I Preferred Stock and cash, in exchange for shares of Common Stock to the Exchange Agent, which will act as agent for tendering holders for the purpose of receiving the shares of Series I Preferred Stock and cash from us and transmitting such shares of Series I Preferred Stock and cash through a book-entry transfer or otherwise to such tendering holders whose shares of Common Stock have been accepted. Shares of Series I Preferred Stock delivered to tendering registered holders of shares of Common Stock will be registered as requested in those holders’ letter of transmittal in uncertificated form and the transfer agent for our Series I Preferred Stock will send written confirmations of that registration to the person registered as holder.
Series I Preferred Stock delivered to tendering holders of shares of Common Stock that hold through securities accounts with direct or indirect participants in DTC will be registered in the name of DTC’s nominee and security entitlements will be allocated by DTC and DTC participants to those holders’ securities accounts. Cash paid to tendering registered holders of shares of Common Stock will be paid by mailing checks payable as requested in their letter of transmittal. Cash paid to tendering holders of shares of Common Stock that hold through participants in DTC will be paid to DTC and allocated by DTC and DTC participants to those holders’ securities accounts.
Under no circumstances will we pay interest on the consideration payable for shares of Common Stock, regardless of any delay in making such delivery or extension of the expiration date. If, prior to the expiration date, we increase or decrease the consideration to be paid for the shares of Common Stock validly tendered and not properly withdrawn pursuant to this Exchange Offer, we will pay or deliver such increased or decreased consideration for all shares of Common Stock acquired pursuant to the Exchange Offer, whether or not shares of Common Stock were validly tendered prior to such increase or decrease in consideration. If certain events occur and, as a result, any Condition to Exchange Offer is not satisfied or waived by us, we will not be obligated to accept validly tendered and not properly withdrawn shares of Common Stock pursuant to the Exchange Offer. See “The Exchange Offer—Conditions of the Exchange Offer.”
18
In all cases, delivery to a tendering holder of the consideration for shares of Common Stock accepted pursuant to the Exchange Offer will be made only after timely receipt by the Exchange Agent of (i) the letter of transmittal (or a manually signed photocopy), properly completed and duly executed, and any other documents required by the letter of transmittal or (ii) where applicable, the confirmation of a book-entry transfer of the shares of Common Stock into the designated account at DTC (the book-entry transfer facility) (a “Book-Entry Confirmation”) pursuant to the procedures set forth in “The Exchange Offer—Procedure for Tendering.”
If we do not accept any tendered shares of Common Stock pursuant to the terms and conditions of the Exchange Offer for any reason, those shares of Common Stock will be credited back to the appropriate account promptly following expiration or termination of the Exchange Offer.
All shares of Common Stock that are validly tendered, not properly withdrawn and accepted by us in the Exchange Offer will, upon our instruction, be surrendered by the Exchange Agent to the Transfer Agent for cancellation, and the shares of Common Stock will be delivered by the Transfer Agent to us for cancellation.
Fractional Units
Fractional Units (including fractional shares of Series I Preferred Stock) will not be issued in exchange for shares of Common Stock exchanged in the Exchange Offer.
Procedure for Tendering
Registered Holders. In order for a holder that holds shares of Common Stock on the record books of the Transfer Agent to validly tender the shares of Common Stock pursuant to the Exchange Offer, the letter of transmittal (or a manually signed photocopy), properly completed and duly executed, and any other documents required by the letter of transmittal must be received by the Exchange Agent at the address set forth on the back cover of this Offer to Exchange prior to the expiration date.
If you tender your shares of Common Stock without indicating the number of shares of Common Stock you wish to tender, it will be assumed that you are tendering all shares of Common Stock owned by you.
Holders in DTC. In order for a holder that holds shares of Common Stock in a securities account with a broker or other securities intermediary to validly tender shares of Common Stock pursuant to the Exchange Offer, the shares of Common Stock must be tendered pursuant to the procedure for book-entry transfer described below and a Book-Entry Confirmation must be received by the Transfer Agent prior to the expiration date. The Transfer Agent will designate accounts with respect to the shares of Common Stock at DTC, the book-entry transfer facility, for purposes of the Exchange Offer within one business day after the date of this Offer to Exchange. Any securities intermediary that is a participant in the system of DTC may make a book-entry delivery of shares of Common Stock by causing DTC to transfer those shares of Common Stock into a designated account at DTC in accordance with DTC’s procedures for transfer. The securities intermediary must also send the Exchange Agent an “Agent’s Message”, which is a message transmitted to the Exchange Agent by the tendering DTC participant confirming that the participant has received a copy of the Offer to Exchange and the related letter of transmittal and that the Company may enforce the terms of the Exchange Offer against the participant.
Procedures for Stock Options. We are not offering, as part of the tender offer, to acquire any outstanding stock options, and tenders of stock options will not be accepted. If you are a holder of vested options to purchase shares of our Common Stock, subject to Company policies and practices, you may exercise your vested options to purchase shares and tender such shares (in 100 share increments) in the Exchange Offer; however, we suggest that you exercise your vested options at least five business days prior to the date on which the expiration date is initially scheduled to occur (which, unless the Exchange Offer is extended, will require you to exercise such options no later than 5:00 p.m., New York City time, on December 11, 2026) in order to provide you with sufficient time to validly tender the shares in the Exchange Offer. Exercises of options cannot be revoked even if some or all of the shares received upon the exercise thereof and tendered in the Exchange Offer are not purchased pursuant to the Exchange Offer for any reason.
19
If you are a holder of vested but unexercised options, you should evaluate the terms of this Exchange Offer carefully to determine if participation would be advantageous to you, based on the exercise prices of your stock options, the date of your stock option grants, the remaining term during which you may exercise your options, and the provisions for priority, proration and the conditions of purchases described in this Offer to Exchange. You should consult your own tax advisor to understand the particular tax consequences of such exercise to you.
Convertible Securities. We are not offering, as part of the Exchange Offer, to acquire any outstanding convertible securities that are convertible into shares of Common Stock, and tenders of convertible securities will not be accepted. If you are a holder of Company securities that are convertible into shares of Common Stock and are currently convertible pursuant to the terms of such security, then you may convert such securities into shares of Common Stock upon their terms and tender any of the shares of Common Stock (in 100 share increments) issuable upon such conversion. You must convert your convertible securities sufficiently in advance of the expiration date so that you receive shares in time to tender them in the Exchange Offer prior to the expiration date. An exercise of a conversion right cannot be revoked, however, if shares received upon exercise thereof and tendered in the Exchange Offer are not purchased in the Exchange Offer for any reason.
If you are a holder of securities convertible into shares of Common Stock, you should evaluate the terms of this Exchange Offer carefully to determine if participation would be advantageous to you, based on the conversion prices of your securities, the date of issuance for such securities, the remaining term during which you may convert your securities, and the provisions for priority, proration and the conditions of purchases described in this Offer to Exchange. You should consult your own tax advisor to understand the particular tax consequences of such conversion to you.
Fees. If you are the record owner of shares of Common Stock and you tender your shares of Common Stock directly to the Exchange Agent, you will not be obligated to pay any charges or expenses of the Transfer Agent or any brokerage commissions. If you own your shares of Common Stock through a broker or other securities intermediary, and your broker or other securities intermediary tenders the shares of Common Stock on your behalf, such institution may charge you a fee for doing so. You should consult your broker or other securities intermediary to determine whether any charges will apply.
Guaranteed Delivery. Any record holder or Nominee who cannot complete the procedure for book-entry transfer on a timely basis, may tender his, her or its shares of Common Stock by satisfying each of the requirements set forth below:
| · | such tender must be made through a financial institution (including most commercial banks, savings and loan associations and brokerage houses) that is a member in good standing of a recognized Medallion Program approved by the Securities Transfer Association, Inc., including the Security Transfer Agents Medallion Program, the New York Stock Exchange Medallion Signature Program and the Stock Exchanges Medallion Program (each, an “Eligible Institution”), |
| · | prior to one minute following 11:59 P.M. (12:00 midnight), Eastern time, on the expiration date, the Exchange Agent must receive from such Eligible Institution a properly completed and duly executed Notice of Guaranteed Delivery, substantially in the form provided by the Company (by mail or overnight delivery), setting forth the name and address of the holder and the amount of shares of Common Stock tendered, stating that the tender is being made thereby and guaranteeing that within one trading day after the date of execution of the Notice of Guaranteed Delivery, the certificates for all physically tendered shares of Common Stock (if any), in proper form for transfer, or a Book-Entry Confirmation, as the case may be, together with a properly completed and duly executed Letter of Transmittal with any required signature guarantees and any other documents required by the Letter of Transmittal will be deposited by the Eligible Institution with the Exchange Agent, and |
| · | a Book-Entry Confirmation, together with a properly completed and duly executed Letter of Transmittal with any required signature guarantees and all other documents required by the Letter of Transmittal, are received by the Exchange Agent within one trading day after the date of execution of the Notice of Guaranteed Delivery. |
20
Effect of Letter of Transmittal. Subject to and effective upon the acceptance for exchange of and exchange of validly tendered shares of Common Stock, by executing and delivering a Letter of Transmittal, you (i) irrevocably sell, assign and transfer, upon the order of the Company, all right, title and interest in and to all the tendered shares of Common Stock, (ii) waive any and all rights with respect to the shares of Common Stock tendered, and (iii) release and waive any and all claims or causes of action of any kind whatsoever, whether known or unknown that, directly or indirectly, arise out of or are in any manner connected with your or your successors’ and assigns’ ownership or acquisition of the shares of Common Stock, including any related transaction, event, circumstance, action, failure to act or occurrence of any sort or type, in each case, that you, your successors and your assigns have, may have or may have had against us or any of our affiliates, directors, officers, associates, counsel or agents or representatives, whether current or former.
Letters of Transmittal must be sent only to the Exchange Agent. Do not send Letters of Transmittal to the Company.
THE METHOD OF DELIVERY OF SHARES OF COMMON STOCK, THE LETTER OF TRANSMITTAL AND ALL OTHER REQUIRED DOCUMENTS, INCLUDING DELIVERY THROUGH DTC, IS AT THE ELECTION AND RISK OF THE TENDERING STOCKHOLDER. DELIVERY OF ALL SUCH DOCUMENTS WILL BE DEEMED MADE ONLY WHEN ACTUALLY RECEIVED BY THE EXCHANGE AGENT (INCLUDING IN THE CASE OF A BOOK-ENTRY TRANSFER, BY BOOK-ENTRY CONFIRMATION). IF SUCH DELIVERY IS BY MAIL, IT IS RECOMMENDED THAT THE MAILING BE BY REGISTERED MAIL, PROPERLY INSURED, WITH RETURN RECEIPT REQUESTED, MADE SUFFICIENTLY IN ADVANCE OF THE EXPIRATION DATE TO PERMIT DELIVERY TO THE EXCHANGE AGENT PRIOR TO ONE MINUTE FOLLOWING 11:59 P.M., EASTERN TIME, ON THE EXPIRATION DATE.
Transfer Taxes. We will pay any transfer taxes imposed by the United States or any jurisdiction therein with respect to the exchange of shares of Common Stock pursuant to the Exchange Offer (for the avoidance of doubt, transfer taxes do not include income or back-up withholding taxes). If a transfer tax is imposed for any reason other than the exchange of shares of Common Stock pursuant to the Exchange Offer, or by any jurisdiction outside the United States, then the amount of such transfer tax (whether imposed on the registered holder or any other person) will be payable by the tendering holders.
Prorating
The maximum number of shares of Common Stock that may be exchanged for Units is 192,308,000. The Company is exchanging shares of Common Stock in 100 share increments and is paying an effective liquidation preference of $46,153,846 of Series I Preferred Stock and $3,846,154 in cash, thus, for each increment of 100 shares, a shareholder will receive one Unit, consisting of one share of Series I Preferred Stock and $2.00 in cash. If the number of shares of Common Stock designated by all tendering holders of shares of Common Stock making valid tender exceeds 192,308,000, then the shares of Common Stock will be exchanged for Units, subject to prorating as follows:
| · | The number of increments of 100 shares of Common Stock to be converted into Series I Preferred Stock and cash will be determined by multiplying the “Proration Factor” by the total number of increments of 100 shares of Common Stock validly tendered with the result rounded to the nearest whole number; provided that amounts fewer than one will be rounded up to one. The “Proration Factor” is determined by dividing 192,308,000 by the product of the total number of increments of 100 shares of Common Stock validly tendered and not withdrawn by holders of shares of Common Stock and 100. |
Effects of Tenders
By tendering your shares of Common Stock as set forth above, you irrevocably appoint the Company and their respective designees as your attorneys-in-fact and proxies, each with full power of substitution, to the full extent of your rights with respect to your shares of Common Stock validly tendered, not properly withdrawn and accepted by us, including to (i) transfer the tendered Series shares of Common Stock to, or to the order of, the Company, and (ii) surrender the tendered shares of Common Stock and instruct the Transfer Agent to deliver the shares of Common Stock to, or to the order of, the Company. Such appointment will be automatically revoked if we do not accept the shares of Common Stock that you have tendered. All such powers and proxies shall be considered coupled with an interest in the tendered shares of Common Stock and therefore shall not be revocable; provided that the shares of Common Stock tendered pursuant to the Exchange Offer may be withdrawn at any time on or prior to the expiration date, as it may be extended by us, and unless theretofore accepted and not returned as provided for herein, may also be withdrawn after the expiration of 40 business days after the commencement of the Exchange Offer, subject to the withdrawal rights and procedures set forth below. Upon the effectiveness of such appointment, all prior proxies given by you will be revoked, and no subsequent proxies may be given (and, if given, will not be deemed effective) unless the tendered shares of Common Stock are properly withdrawn.
21
We will determine all questions as to the validity, form, eligibility (including time of receipt) and acceptance of any tender of shares of Common Stock in the Exchange Offer, and our determination shall be final and binding, subject to a holder challenging our determination in a court of competent jurisdiction and such court issuing a judgment to the contrary. We reserve the right to reject any and all tenders of shares of Common Stock in the Exchange Offer determined by us not to be in proper form or the acceptance or acquisition of which may, in our opinion, be unlawful. No alternative, conditional or contingent tenders will be accepted and no fractional shares of Common Stock will be purchased.
Subject to the applicable rules and regulations of the SEC, we also reserve the right to waive, prior to the expiration date, in our sole discretion, any of the conditions to the Exchange Offer, including the absolute right to waive any defect or irregularity in the tender of any shares of Common Stock in the Exchange Offer. No tender of Series B Preferred Shares in the Exchange Offer will be deemed to have been made until all defects and irregularities in the tender of such shares of Common Stock in the Exchange Offer have been cured or waived. Neither we, the Exchange Agent, the Information Agent nor any other person will be under any duty to give notification of any defects or irregularities in the tender of any shares of Common Stock in the Exchange Offer or will incur any liability for failure to give any such notification. Our interpretation of the terms and conditions of the Exchange Offer and the related letter of transmittal (including the instructions hereto) will be final and binding, subject to a challenge to our determination in a court of competent jurisdiction and such court issuing a judgment to the contrary.
Rule 14e-4 “Net Long Position” Requirement
It is a violation of Rule 14e-4 (promulgated under the Exchange Act) for a person, directly or indirectly, to tender securities in a partial tender offer for their own account unless the person so tendering their securities (a) has a net long position equal to or greater than the aggregate principal amount of the securities being tendered and (b) will cause such securities to be delivered in accordance with the terms of the Exchange Offer. Rule 14e-4 provides a similar restriction applicable to the tender or guarantee of a tender on behalf of another person.
A tender of shares of Common Stock in the Exchange Offer under any of the procedures described above will constitute the tendering holder’s representation and warranty that (a) such holder has a net long position in the shares of Common Stock being tendered pursuant to the Exchange Offer within the meaning of Rule 14e-4 under the Exchange Act and (b) the tender of such shares of Common Stock complies with Rule 14e-4.
The tender of Series shares of Common Stock, pursuant to any of the procedures described above, will constitute a binding agreement between you and us upon the terms and subject to the conditions of the Exchange Offer.
Withdrawal of Tenders
You may properly withdraw shares of Common Stock that you tender at any time prior to the expiration date of the Exchange Offer, which is one minute 11:59 p.m., New York City Time, on December 18, 2026, unless we extend the Exchange Offer, in which case you may withdraw shares of Common Stock previously tendered by you at any time prior to the expiration date, as extended. Any shares of Common Stock that are properly withdrawn will be credited back to the appropriate account promptly following such withdrawal. In addition, after the expiration of the Exchange Offer, you may properly withdraw any shares of Common Stock that you validly tendered that are not accepted by us within 40 business days after the commencement of the Exchange Offer.
22
For a withdrawal to be effective, you must deliver a written notice of withdrawal to the Exchange Agent at the appropriate address specified on the back cover of this Offer to Exchange prior to the expiration date or, if your shares of Common Stock are not previously accepted by us, after the expiration of 40 business days after the commencement of the Exchange Offer. Any notice of withdrawal must identify the beneficial owner of the shares of Common Stock to be withdrawn, including the name of the beneficial owner of the shares of Common Stock, the name of the person who tendered the shares of Common Stock, if different, and the number of shares of Common Stock to be withdrawn. Your notice of withdrawal must comply with the requirements set forth in this Offer to Exchange. If you validly tendered shares of Common Stock pursuant to the procedures for a book-entry transfer, a withdrawal of shares of Common Stock will only be effective if you comply with the appropriate DTC procedures prior to the expiration date of the Exchange Offer or, if your shares of Common Stock are not previously accepted by us, after the expiration of 40 business days after the commencement of the Exchange Offer.
If you withdraw shares of Common Stock, you will have the right to re-tender them prior to the expiration date in accordance with the procedures described above for tendering outstanding shares of Common Stock. A holder who validly withdraws previously tendered shares of Common Stock prior to the expiration date and does not validly re-tender shares of Common Stock prior to the expiration date will not receive consideration in the Exchange Offer. A holder of shares of Common Stock who validly withdraws previously tendered shares of Common Stock prior to the expiration date and validly re-tenders shares of Common Stock prior to the expiration date and whose shares of Common Stock are accepted in connection with the Offer to Exchange will receive the consideration in the Exchange Offer.
All questions as to the validity, form and eligibility, including time of receipt, of notices of withdrawal will be determined by us. Our determination will be final and binding on all parties, subject to a holder challenging our determination in a court of competent jurisdiction and such court issuing a judgment to the contrary. We will not accept or give consideration for any properly withdrawn shares of Common Stock, unless the shares of Common Stock so withdrawn are subsequently validly re-tendered and not properly withdrawn. Properly withdrawn shares of Common Stock may be re-tendered by following the procedures described above under “The Exchange Offer—Procedure for Tendering” at any time prior to the expiration date of the Exchange Offer.
Neither we, the Exchange Agent, the Information Agent, the Transfer Agent, or any affiliate of the foregoing, or any other person will be under any duty to give notification of any defects or irregularities in any notice of withdrawal or will incur any liability for failure to give any such notification. Any shares of Common Stock properly withdrawn will be deemed to not have been validly tendered for purposes of the Exchange Offer.
Source and Amount of Funds
The Exchange Offer is not conditioned upon our receipt of financing. We intend to fund all cash payments to the holders of shares of Common Stock pursuant to the Exchange Offer with available cash on hand.
Liquidity; Listing; Other Plans
The Common Stock is currently listed and traded on the NYSE American. No market currently exists for the Series I Preferred Stock. Although the Company intends to apply to list the Series I Preferred Stock on the NYSE American, this is not a condition to the completion of the Exchange Offer and there is no assurance that such listing will be accomplished or, if the Series I Preferred Stock is so listed, that trading will develop in the Series I Preferred Stock. If the application is not approved, we intend to file an application to admit the Series I Preferred Stock for trading on the OTC. If the Series I Preferred Stock is not listed or if a robust market does not develop, even if listed, it may impair a holder’s ability to resell the Series I Preferred Stock or the prices at which they may trade. Accordingly, no assurance can be given as to the liquidity of the Series I Preferred Stock after their issuance, or the prices at which they may trade, or that a trading market will develop.
23
Except as otherwise disclosed in this Offer to Exchange, we currently have no plans, proposals or negotiations underway that relate to or would result in:
| · | any extraordinary transaction, such as a merger, reorganization or liquidation, involving us or any of our subsidiaries; |
| · | any purchase, sale or transfer of an amount of our assets or any of our subsidiaries’ assets which is material to us and our subsidiaries, taken as a whole; |
| · | any change in our present board of directors or management or any plans or proposals to change the number or the term of directors or to fill any vacancies on the Board of Directors or to change any material term of the employment contract of any executive officer; |
| · | any material change in our present dividend rate or policy, our indebtedness or capitalization, our corporate structure or our business; |
| · | any class of our equity securities to be delisted from the NYSE American or ceasing to be authorized to be quoted on NYSE American; |
| · | any class of our equity securities becoming eligible for termination of registration under Section 12(g) of the Exchange Act; |
| · | the suspension of our obligation to file reports under Section 15(d) or Section 13 of the Exchange Act; |
| · | the acquisition or disposition by any person of our securities; or |
| · | any changes in our charter or by-laws that could impede the acquisition of control of us. |
Although we currently do not have any plans other than as disclosed in this Offer to Exchange that relate to or would result in any of the events discussed above, as we evaluate opportunities, we may undertake or plan actions that relate to or could result in one or more of these events.
Appraisal Rights
No appraisal rights are available to holders of the Common Stock in connection with the Exchange Offer.
Certain Legal and Regulatory Matters
Except as set forth in this Offer to Exchange, we are not aware of any material filing, approval or other action by or with any governmental authority or administrative or regulatory agency that would be required to accept validly tendered and not properly withdrawn shares of Common Stock from participating holders in the Exchange Offer. We intend to make all required filings under the Exchange Act.
Exchange Agent
Computershare Trust Company, N.A. is serving as the Exchange Agent. We will pay the Exchange Agent reasonable and customary compensation for its services in connection with the Exchange Offer and reimburse it for its reasonable out-of-pocket expenses.
Information Agent
Georgeson, LLC is serving as Information Agent in connection with the Exchange Offer. The Information Agent will assist with the mailing of this Offer to Exchange and related materials to holders of Common Stock, respond to inquiries of and provide information to holders of Common Stock in connection with the Exchange Offer, and provide other similar services as we may request from time to time. Questions regarding the terms of the Exchange Offer, and requests for assistance or for additional copies of this Offer to Exchange and any other required documents, may be directed to the Information Agent at the address and telephone numbers set forth on the back cover of this Offer to Exchange.
24
Expenses
We expect to incur reasonable and customary fees and expenses in connection with the Exchange Offer. We also will pay brokers and other securities intermediaries the reasonable out-of-pocket expenses incurred by them in forwarding copies of this Exchange Offer, the related letter of transmittal and other documents to the beneficial owners of shares of Common Stock and in handling or forwarding tenders of shares of Common Stock by their customers.
In connection with the Exchange Offer, our officers, directors and employees may solicit tenders of Common Stock by use of the mails, personally or by telephone, facsimile, telegram, electronic communication or other similar methods, but will not receive additional compensation from us for such services.
No brokerage commissions will be payable by tendering holders of Common Stock to us, the Information Agent or the Exchange Agent. The Company will pay any fees due to the Exchange Agent for the cancellation of the tendered shares of Common Stock. Holders of shares of Common Stock participating in the Exchange Offer through a broker or other securities intermediary should contact such institution as to whether it charges any service fees.
Additional Information
Pursuant to Exchange Act Rule 13e-4, we have filed with the SEC a Tender Offer Statement on Schedule TO (the “Schedule TO”), which contains additional information with respect to the Exchange Offer. We will file an amendment to the Schedule TO to report any material changes in the terms of the Exchange Offer and to report the final results of the Exchange Offer as required by Exchange Act Rule 13e-4(c)(3) and 13e-4(c)(4). The Schedule TO, including the exhibits and any amendments thereto, may be examined, and copies may be obtained, at the same places and in the same manner as is set forth under “Where You Can Find More Information.”
INTERESTS OF DIRECTORS AND EXECUTIVE OFFICERS; TRANSACTIONS AND ARRANGEMENTS CONCERNING THE SHARES
Directors and Executive Officers. The following persons are the directors and/or executive officers of the Company:
|
Name |
Position | |
| Milton C. Ault, III | Executive Chairman of the Board | |
| William B. Horne | Chief Executive Officer, Vice Chairman and Director | |
| Henry Nisser | President, General Counsel and Director | |
| Kenneth S. Cragun | Chief Financial Officer | |
| Robert O. Smith | Lead Independent Director | |
| Moti Rosenberg | Director | |
| Jeffrey A. Bentz | Director | |
| Michael H. Lorber | Director |
Our directors and executive officers are entitled to participate in the Exchange Offer in the same manner as all other stockholders. All of our directors and executive officers and Ault & Company, Inc, an affiliate of Mr. Ault, have informed us that they do not intend to participate in the Exchange Offer. Assuming the completion of the Exchange Offer, the relative ownership interest in the Company held by our directors and executive officers, and their affiliates, will increase.
Share Ownership. The following table sets forth certain information as of November 16, 2026 with respect to the beneficial ownership of our shares by:
| · | each person, or group of affiliated persons, who is known by us to beneficially own more than 5% of our shares; |
| · | each of our directors; |
| · | each of our executive officers; and |
25
| · | all of our current executive officers and directors as a group. |
Beneficial ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power of that security, or has the right to acquire beneficial ownership of that security within 60 days. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares that they beneficially owned, subject to community property laws where applicable.
Our calculation of the percentage of beneficial ownership is based on 236,013,427 shares outstanding on November 16, 2026. Shares issuable under stock options that are currently exercisable or exercisable within 60 days of November 16, 2026 are deemed beneficially owned, and such shares are used in computing the percentage ownership of the person holding these options or restricted stock awards and the percentage ownership of any group of which the holder is a member but are not deemed outstanding for computing the percentage of any other person.
This table is based upon information supplied by our officers, directors and principal stockholders and Schedules 13D and 13G filed with the SEC.
| Number of | ||||||||
| shares | Approximate | |||||||
| beneficially | percent | |||||||
| Name and address of beneficial owner(1) | owned | of class | ||||||
| Greater than 5% Beneficial Owners: | ||||||||
| Ault & Company, Inc. | 465,930,404 | (2) | 67.7 | % | ||||
| Directors and Officers: | ||||||||
| Milton C. Ault, III | 467,191,158 | (3) | 67.9 | % | ||||
| William Horne | 778,349 | (4) | * | |||||
| Henry Nisser | 459,735 | (5) | * | |||||
| Ken Cragun | 237,228 | (6) | * | |||||
| Robert Smith | 33,334 | (7) | * | |||||
| Mordechai Rosenberg | 33,334 | (7) | * | |||||
| Jeffrey A. Bentz | 33,334 | (7) | * | |||||
| Michael Lorber | 33,334 | (7) | * | |||||
| All directors and executive officers as a group (eight persons) | 468,799,806 | 68.0 | % | |||||
| * | Fewer than one percent. |
| (1) | Unless otherwise indicated, the business address of each of the individuals is c/o Hyperscale Data, Inc., 11411 Southern Highlands Pkwy, Suite 190, Las Vegas, NV 89141. |
| (2) | Represents (i) 13,925,566 shares of Common Stock, (ii) 15,686,550 shares of Common Stock issuable upon conversion of 15,686,550 shares of Class B Common Stock (“Class B Shares”), (iii) 396,825,396 shares of Common Stock issuable upon conversion of 50,000 shares of Series C Convertible Preferred Stock, (iv) 7,619,047 shares of Common Stock issuable upon conversion of 960 shares of Series G Convertible Preferred Stock, (v) 31,746,032 shares of Common Stock issuable upon conversion of 4,000 shares of Series H Convertible Preferred Stock and (vi) 127,813 shares of Common Stock issuable upon exercise of outstanding warrants. |
| (3) | Represents (i) 465,930,404 shares of Common Stock beneficially owned by Ault & Company, as disclosed in footnote 2 above, (ii) 266,667 shares of Common Stock issuable upon exercise of stock options that are currently exercisable or exercisable within 60 days of November 16, 2026, (iii) 962,500 shares of Common Stock and (iv) 31,587 shares of Common Stock issuable upon conversion of 31,587 Class B Shares. Mr. Ault is the Chief Executive Officer of Ault & Company. |
26
| (4) | Represents (i) 266,667 shares of Class A Common Stock issuable upon exercise of stock options that are currently exercisable or exercisable within 60 days of November 16, 2026, (ii) 500,000 shares of Common Stock and (iii) 11,682 shares of Common Stock issuable upon conversion of 11,682 Class B Shares. |
| (5) | Represents (i) 200,000 shares of Common Stock issuable upon exercise of stock options that are currently exercisable or exercisable within 60 days of November 16, 2026 (ii) 250,000 shares of Common Stock and (iii) 9,735 shares of Common Stock issuable upon conversion of 9,735 Class B Shares. |
| (6) | Represents (i) 133,334 shares of Common Stock issuable upon exercise of stock options that are currently exercisable or exercisable within 60 days of November 16, 2026, (ii) 100,000 shares of Common Stock and (iii) 3,894 shares of Common Stock issuable upon conversion of 3,894 Class B Shares. |
| (7) | Represents shares of Common Stock issuable upon exercise of stock options that are currently exercisable or exercisable within 60 days of November 16, 2026. |
Recent Securities Transactions
Based on our records and on information provided to us by our directors, executive officers, affiliates and subsidiaries, neither we nor any of our directors, executive officers, affiliates or subsidiaries, nor, to the best of our knowledge, any person controlling the Company or any executive officer or director of any such controlling entity or of our subsidiaries, has effected any transactions involving the shares during 60 days prior to the date hereof, except for the following:
Milton C. Ault, III
| Nature of the Transaction | Amount of Securities Purchased/Sold |
Price | Date of Transaction | |||
| Purchase of Common Stock | 500 | $0.1826 | 09/21/2026 | |||
| Purchase of Common Stock | 2,200 | $0.1791(1) | 09/22/2026 | |||
| Purchase of Common Stock | 2,000 | $0.1718 | 09/23/2026 | |||
| Purchase of Common Stock | 33,000 | $0.1723(2) | 09/24/2026 | |||
| Purchase of Common Stock | 56,600 | $0.1649(3) | 09/25/2026 | |||
| Purchase of Common Stock | 1,600 | $0.1662 | 09/29/2026 | |||
| Purchase of Common Stock pursuant to the SPA | 10,000,000 | $0.50 | 09/30/2026 | |||
| Purchase of Class B Common Stock pursuant to the SPA | 389,404 | $0.50 | 09/30/2026 | |||
| Purchase of Common Stock | 311,874 | $0.1639 | 09/30/2026 |
(1) The Common Stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.1791. The range of purchase prices on the transaction date was $0.1787 to $0.1804 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
27
(2) The Common Stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.1723. The range of purchase prices on the transaction date was $0.1700 to $0.1798 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
(3) The Common Stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.1649. The range of purchase prices on the transaction date was $0.16 to $0.1686 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Ault & Company, Inc.
| Nature of the Transaction | Amount of Securities Purchased/Sold | Price | Date of Transaction | |||
| Purchase of Common Stock | 100,000 | $0.1778(1) | 09/23/2026 | |||
| Purchase of Common Stock | 100,000 | $0.1819(2) | 09/24/2026 | |||
| Purchase of Common Stock | 500,000 | $0.1685 | 09/25/2026 | |||
| Purchase of Common Stock pursuant to the SPA | 10,000,000 | $0.50 | 09/30/2026 | |||
| Purchase of Class B Common Stock pursuant to the SPA | 389,404 | $0.50 | 09/30/2026 | |||
| Purchase of Common Stock | 311,874 | $0.1639 | 09/30/2026 |
(1) The Common Stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.1778. The range of purchase prices on the transaction date was $0.1758 to $0.1797 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
(2) The Common Stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.1819. The range of purchase prices on the transaction date was $0.178 to $0.183 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
William B. Horne
| Nature of the Transaction | Amount of Securities Purchased/Sold | Price | Date of Transaction | |||
| Purchase of Common Stock | 100,000 | $0.168 | 09/29/2026 | |||
| Purchase of Common Stock | 100,000 | $0.163 | 09/30/2026 |
28
Agreements and Arrangements
Stock Incentive Plans.
The Company maintains equity incentive plans to provide long-term incentives to directors, officers, employees and consultants and to align their interests with those of stockholders.
On July 31, 2025, the Company adopted the 2025 Stock Incentive Plan (the “2025 Plan”), which was subsequently approved by the Company’s stockholders. The 2025 Plan, as adjusted for the reverse stock split effected in August of 2026, authorizes the issuance of up to 1.6 million shares of Common Stock pursuant to stock options, restricted stock, restricted stock units, stock appreciation rights and other stock-based awards. The 2025 Plan is the Company’s primary equity compensation plan.
In connection with the adoption of the 2025 Plan, no additional awards will be granted under prior equity compensation plans, including the Company’s 2016 Stock Incentive Plan, 2018 Stock Incentive Plan and 2022 Stock Incentive Plan.
The purpose of the Company’s equity incentive plans is to attract and retain qualified personnel, provide additional incentives to employees, directors and consultants, and promote the success of the Company’s business by aligning compensation with stockholder interests.
Other Compensatory Arrangements. The Company’s practices with respect to equity awards to its directors and executive officers as well as its equity ownership guidelines, compensation recovery policy for executive officers and limitations on hedging and pledging are described more fully in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on April 15, 2026. The Company also provides other compensatory arrangements to its employees, including officers, and directors, certain of which are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
From time to time the Company enters into offer letters of employment upon the hiring of certain executive officers which provide for the grant of equity awards, and the Company has entered into employment agreements with all of its executive officers but Kenneth Cragun that provide for accelerated vesting of equity awards in certain circumstances, as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Class A Warrants. On December 30, 2021, we issued to certain sophisticated investors five-year warrants to purchase an aggregate of 2 shares of Common Stock at an exercise price of $3,281,250, subject to adjustment.
November 2022 Warrants. On November 7, 2022 we issued to JGB Partners, LP and JGB (Cayman) Buckeye Ltd (i) four-year warrants to purchase an aggregate of 2 shares of Common Stock at an exercise price of $590,625 per share, subject to adjustment; and (ii) four-year warrants to purchase an aggregate of 2 shares of Common Stock at an exercise price of $984,375 per share, subject to adjustment.
October 2023 Warrants. On October 13, 2023, we issued to A&C warrants (the “October 2023 Warrants”) to purchase 10,899 shares of Common Stock in connection with the purchase of a senior secured convertible promissory note in the principal amount of $17,519,832. The exercise price of the October 2023 Warrants is $803.69, subject to adjustment, which represented 110% of the closing price of the Common Stock on the closing date.
Series C Preferred Stock Purchase Agreement. In December 2024, pursuant to a securities purchase agreement, dated November 3, 2023 (the “November 2023 SPA”), between the Company and A&C, we sold an aggregate of 3,020 shares of Series C Convertible Preferred Stock and warrants to purchase an aggregate of 5,102 shares of Common Stock at an exercise price of $591.9375 per share, subject to adjustment, to A&C, for an aggregate purchase price of $3.0 million. As of the date of this Offer to Exchange, A&C has purchased an aggregate of 50,000 shares of Series C Convertible Preferred Stock and warrants to purchase an aggregate of 84,470 shares of Common Stock, for an aggregate purchase price of $50.0 million.
29
Each share of Series C Convertible Preferred Stock has a stated value of $1,000.00 and is convertible into shares of Common Stock at a conversion price equal to the greater of (i) $0.10 per share, and (ii) the lesser of 105% of the volume weighted average price of the Common Stock during the ten trading days immediately prior to (A) the trading day immediately preceding the execution date of the November 2023 SPA or (B) the date of conversion into shares of Common Stock. The conversion price of the Series C Convertible Preferred Stock, which is subject to adjustment in the event of an issuance of Common Stock at a price per share lower than the conversion price then in effect, as well as upon customary stock splits, stock dividends, combinations or similar events, is $0.126 per share. The holders of Series C Convertible Preferred Stock are entitled to cumulative cash dividends at an annual rate of 9.5%, or $95.00 per share, based on the stated value per share. Dividends shall accrue for 10 years from the date of issuance of such shares of Series C Convertible Preferred Stock and are payable monthly in arrears. For the first two years, we may elect to pay the dividend amount in shares of Common Stock rather than cash. The holders of the Series C Convertible Preferred Stock are entitled to vote with the Common Stock as a single class on an as-converted basis.
Series G Preferred Stock Purchase Agreement. On December 21, 2024, we entered into a securities purchase agreement (the “December 2024 SPA”) with Ault & Company, pursuant to which we agreed to sell to Ault & Company, in one or more closings, up to 25,000 shares of Series G convertible preferred stock (“Series G Convertible Preferred Stock”) and warrants to purchase up to 844,881 shares of Common Stock at an exercise price of $29.59 per share, subject to adjustment (the “Series G Warrants”) for a total purchase price of up to $25.0 million. The December 2024 SPA provides that the financing may be conducted through one or more closings. Pursuant to the December 2024 SPA, we have sold to A&C 960 shares of Series G Convertible Preferred Stock and Series G Warrants to purchase 32,444 shares of Common Stock, for a purchase price of $1.0 million.
Each share of Series G Convertible Preferred Stock has a stated value of $1,000.00 and is convertible into shares of Common Stock at a conversion price equal to the greater of (i) $0.10 per share, and (ii) the lesser of (A) $6.74 or (B) 105% of the volume weighted average price of the Common Stock during the ten trading days immediately prior to the date of conversion. The conversion price of the Series G Convertible Preferred Stock, which is subject to adjustment in the event of an issuance of Common Stock at a price per share lower than the conversion price then in effect, as well as upon customary stock splits, stock dividends, combinations or similar events, is $0.126 per share. The holders of Series G Convertible Preferred Stock are entitled to cumulative cash dividends at an annual rate of 9.5%, or $95.00 per share, based on the stated value per share. Dividends shall accrue for 10 years from the date of issuance of such shares of Series G Convertible Preferred Stock and are payable monthly in arrears. For the first two years, we may elect to pay the dividend amount in shares of Common Stock rather than cash. The holders of the Series G Convertible Preferred Stock are entitled to vote with the Common Stock as a single class on an as-converted basis.
SJC Exchange Agreement. On March 21, 2025, we entered into an exchange agreement pursuant to which we issued to SJC Lending, LLC a convertible note in the amount of $4.9 million in exchange for the cancellation of (i) a term note issued by us on January 14, 2025, with outstanding principal and accrued but unpaid interest of $2.6 million, (ii) a promissory note issued by us on March 7, 2025, with outstanding principal and accrued but unpaid interest of $0.5 million, (iii) a promissory note issued by us on March 12, 2025, with outstanding principal and accrued but unpaid interest of $1.5 million, and (iv) a promissory note issued by us on March 13, 2025, with outstanding principal and accrued but unpaid interest of $0.3 million. As amended, the convertible note issued pursuant to the exchange agreement matures on December 31, 2026.
Series B Preferred Stock Purchase Agreement. On March 31, 2025, we entered into a securities purchase agreement (the “March 2025 SPA”) with an institutional investor pursuant to which we agreed to sell up to 50,000 shares of Series B Convertible Preferred Stock (“Series B Convertible Preferred Stock”) for a total purchase price of up to $50.0 million. The March 2025 SPA provides that the transaction shall be conducted through 49 separate tranche closings, provided, however, that the investor has the ability, exercisable in its sole discretion, to purchase any number of shares of Series B Convertible Preferred Stock prior to the dates of the tranche closings provided for in the March 2025 SPA. The initial tranche closing occurred on May 21, 2025, which consisted of the sale and issuance to the investor of 2,000 shares of Series B Convertible Preferred Stock for an aggregate of $2.0 million. Subsequently, the investor has purchased an additional 30,414 shares of Series B Convertible Preferred Stock. Of such 32,414 shares of Series B Convertible Preferred Stock, the investor has converted approximately 29,506.22 shares of Series B Convertible Preferred Stock into 50.3 million shares of Common Stock as of the date of this Offer to Exchange. Pursuant to the March 2025 SPA, provided certain closing conditions have been met, the investor shall purchase up to an aggregate of 4,800 shares of Series B Convertible Preferred Stock, with the investor being required to purchase 1,000 shares per month. As of the date of this Offer to Exchange, purchases by the investor have not been made in accordance with the contractual monthly purchase schedule set forth in the March 2025 SPA. The Company continues to assess the status of the arrangement and its rights thereunder.
30
Each share of Series B Convertible Preferred Stock has a stated value of $1,000 and is convertible into shares of Common Stock at a conversion price equal to the greater of (i) $0.40 per share, which floor price shall not be adjusted for stock dividends, stock splits, stock combinations and other similar transactions and (ii) 75% of the lowest VWAP (as defined in the note) of our Common Stock on any trading day during the five trading days immediately prior to the date of conversion into shares of Common Stock, but not greater than $10.00 per share (the “Maximum Price”), which Maximum Price shall be adjusted for stock dividends, stock splits, stock combinations and other similar transactions.
The holders of Series B Convertible Preferred Stock are entitled to cumulative cash dividends at an annual rate of 15%, or $150 per share, based on the stated value per share. Dividends shall accrue for as long as any shares of Series B Convertible Preferred Stock remain issued and outstanding and are payable monthly in arrears. For the first two years, we may elect to pay the dividend amount in additional shares of Series B Convertible Preferred Stock rather than cash. The holders of the Series B Convertible Preferred Stock are entitled to vote with the Common Stock as a single class on an as-converted basis.
Series H Convertible Preferred Stock Purchase Agreement. On July 31, 2025, we entered into a securities purchase agreement (the “July 2025 SPA”) with Ault & Company, pursuant to which we agreed to sell to Ault & Company, in one or more closings, up to 100,000 shares of Series H convertible preferred stock (“Series H Convertible Preferred Stock”) for a total purchase price of up to $100 million. On November 7, 2025, we and Ault & Company entered into an amendment to the July 2025 SPA to extend its termination date. Under the amendment, the termination date will be extended to the later of (i) one year after we have a sufficient number of authorized shares of Common Stock to satisfy all conversion and share-reserve requirements under the July 2025 SPA or (ii) December 31, 2027. Through the date this Offer to Exchange, pursuant to the July 2025 SPA, we have sold 4,000 shares of Series H Convertible Preferred Stock to Ault & Company.
Each share of Series H Convertible Preferred Stock has a stated value of $1,000 and is convertible into shares of Common Stock at a conversion price equal to the greater of (i) $0.10 per share, and (ii) the lesser of (A) $0.79645 or (B) 105% of the volume-weighted average price of the Common Stock during the ten trading days immediately prior to the date of conversion. The conversion price of the Series H Convertible Preferred Stock, which is subject to adjustment in the event of an issuance of Common Stock at a price per share lower than the conversion price then in effect, as well as upon customary stock splits, stock dividends, combinations or similar events, is $0.126 per share. The holders of Series H Convertible Preferred Stock are entitled to cumulative cash dividends at an annual rate of 9.5%, or $95.00 per share, based on the stated value per share. Dividends shall accrue for 10 years from the date of issuance of such shares of Series H Convertible Preferred Stock and are payable monthly in arrears. For the first two years, we may elect to pay the dividend amount in shares of Common Stock rather than cash. The holders of the Series H Convertible Preferred Stock are entitled to vote with the Common Stock as a single class on an as-converted basis.
JGB Convertible Notes. On December 2, 2025, we issued to JGB Capital, LP, JGB Partners, LP and JGB Capital Offshore Ltd. (collectively, “JGB”) secured convertible promissory notes in the aggregate principal face amount of $12,768,000 (the “Convertible Notes”) in consideration for an aggregate of $12,000,000 paid to the Company. The Convertible Notes bear interest at 12.5% per annum, mature on December 2, 2027 and are convertible into shares of Common Stock (the “Conversion Shares”), at a conversion price equal to the lower of (i) $0.3235 per share and (ii) 85% of the lowest daily volume-weighted average price during the three (3) trading days immediately preceding and including the applicable conversion date, but not fewer than $0.30 per share (the “Floor Price”). The outstanding principal and accrued interest on the JGB Convertible Notes was paid in full on November 16, 2026.
ATM Agreements. On December 19, 2025, we entered into an At-the-Market Issuance Sales Agreement with Spartan Capital Securities, LLC (“Spartan”), as sales agent to sell shares of our Common Stock, having an aggregate offering price of up to $50 million from time to time, through an “at the market offering” (the “2025 ATM Offering”) as defined in Rule 415 under the Securities Act. On December 19, 2025, we filed a prospectus supplement with the SEC relating to the offer and sale of up to $50 million of Common Stock in the ATM Offering.
31
On June 18, 2026, we entered into an At-the-Market Issuance Sales Agreement (“2026 ATM Agreement”) with Spartan Capital Securities, LLC, as sales agent to sell shares of Common Stock, having an aggregate offering price of up to $300,000,000 from time to time, through an “at the market offering” (the “2026 ATM Offering”) as defined in Rule 415 under the Securities Act. On June 18, 2026, the Company filed a prospectus supplement with the SEC relating to the offer and sale of up to $300,000,000 of Common Stock. On October 13, 2026, we filed a supplement to the above-mentioned prospectus supplement with the SEC to decrease the amount of Common Stock that may be offered and sold in the 2026 ATM Offering under the 2026 ATM Agreement to $100,000,000 in the aggregate.
Through November 16, 2026, we have sold 127.2 million shares of our Common Stock under the 2025 ATM Offering and 2026 ATM Offering for gross proceeds of approximately $50.6 million.
On February 13, 2026, we entered into an At-the-Market Issuance Sales Agreement with Wilson Davis, as sales agent to sell shares of our 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share (the “Series D Preferred”), having an aggregate offering price of up to $35.4 million from time to time, through an “at the market offering” (the “Series D Preferred ATM Offering”) as defined in Rule 415 under the Securities Act. On February 13, 2026, we filed a prospectus supplement with the SEC relating to the offer and sale of up to $35.4 million of Series D Preferred in the Series D Preferred ATM Offering. Through November 16, 2026, we have sold 83,365 shares of our Series D Preferred under the Series D Preferred ATM Offering for gross proceeds of approximately $1.6 million.
PPA Agreement. On June 11, 2026 (the “Effective Date”), we entered into a Pre-Paid Advance Agreement (the “PPA”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”). In accordance with the terms of the PPA, the Company will receive a pre-paid advance of $15,958,000 from Yorkville (the “Pre-Paid Advance”). The Pre-Paid Advance will be purchased by Yorkville at 94% of the face amount of the Pre-Paid Advance. The Pre-Paid Advance was purchased on the Effective Date by Yorkville, for net proceeds of $15,000,520. Interest shall accrue on the outstanding balance of the Pre-Paid Advance at an annual rate of 4%, subject to an increase to 18% upon events of default described in the PPA.
At any time that there is an outstanding balance under the Pre-Paid Advances, Yorkville may provide written notice (each, a “Purchase Notice”) requiring the Company to issue and sell shares of the Common Stock (the “PPA Shares”) to Yorkville, which shall be offset against and reduce the amounts outstanding under the Pre-Paid Advance, at a price per share equal to the lower of (a) $0.2153 (the “Fixed Price”) and (b) 90% of the lowest daily volume weighted average price (the “VWAP”) of the Common Stock on the NYSE American during the five (5) consecutive trading days immediately preceding the date on which Yorkville provides the Purchase Notice to the Company (the “Market Price”), but in no event shall the Market Price be fewer than $0.1721 per share (the “Floor Price”). Yorkville shall, in each Purchase Notice, select the number of shares to be issued, in its sole discretion, provided that the aggregate price for such shares may not exceed the balance outstanding under the Pre-Paid Advance or exceed other specified limits in the PPA. Amounts offset by the issuance of the PPA Shares shall be applied first toward accrued and unpaid interest, if any, and then toward outstanding principal under the Pre-Paid Advance.
November 2026 Notes. On November 6, 2026 (the “Execution Date”), we entered into a note purchase agreement (the “November 2026 Purchase Agreement”) with an institutional investor (the “Investor”) pursuant to which the Investor agreed to acquire, and the Company agreed to issue and sell in a registered direct offering to the Investor, a (i) $10,810,810.81 principal amount of convertible promissory note (the “Initial Note”), which Initial Note was issued and sold on the Execution Date, (ii) $5,405,405.41 principal amount of convertible promissory note (the “Second Note”), which Second Note was issued and sold on November 18, 2026, and (iii) potentially, a $10,810,810.81 principal amount of convertible promissory note issuable upon exercise of the Additional Investment Right (as defined in the November 2026 Purchase Agreement) (the “AIR Note” and with the Initial Note and the Second Note, the “November 2026 Notes” and with the Purchase Agreement, the “Transaction Documents”), which AIR Note would be issued and sold on or prior to the three (3) months of the sale of the Second Note, in each case subject to customary closing conditions and in the case of the AIR Note, provided that the Additional Investment Right is exercised. Such notes carry an original issue discount of 7.5%. The Initial Note is being sold to the Investor for a purchase price of $10,000,000, the Second Note is being sold to the Investor for a purchase price of $5,000,000, and the AIR Note would, if the AIR is exercised, be sold to the Investor for a purchase price of $10,000,000. The November 2026 Notes are convertible into shares of Common Stock at any time after NYSE approval of the Supplemental Listing Application at a conversion price equal to the lower of (A) $0.30 and (B) a 10% discount to the lowest daily volume-weighted average price during the five (5) Trading Days prior to the date of receipt of a conversion notice from the Investor, subject to a floor price of $0.1025.
32
The foregoing descriptions of agreements and arrangements involving the shares are qualified in their entirety by reference to the text of the respective agreements and arrangements, copies of which have been filed with the SEC.
Except as otherwise described herein, neither we nor, to the best of our knowledge, any of our affiliates, directors or executive officers, is a party to any contract, agreement, arrangement, understanding or relationship with any other person with respect to any of our securities.
UNAUDITED PRO FORMA FINANCIAL DATA
Summary Unaudited Pro Forma Financial Information
The following unaudited pro forma financial information has been derived from, and should be read in conjunction with, our historical consolidated financial statements incorporated by reference in this Offer to Exchange. The unaudited pro forma financial information set forth below gives effect to the financial impact of the settlement of the Exchange Offer as if it had occurred (i) on December 31, 2025 for the purposes of the unaudited pro forma balance sheet as of December 31, 2025 and the book value per share calculation as of such date, (ii) on January 1, 2025 for the purposes of the unaudited pro forma statement of comprehensive income and earnings per share for the fiscal year ended December 31, 2025, (iii) on September 30, 2026 for the purposes of the unaudited pro forma balance sheet as of September 30, 2026 and the book value per share calculation as of such date, (iv) on January 1, 2026 for the purposes of the unaudited pro forma statement of comprehensive income and earnings per share for the fiscal nine months ended September 30, 2026. The adjustments for the Exchange Offer on the unaudited pro forma financial information set forth below assume that an aggregate of 192,308,000 shares of Common Stock are tendered in the Exchange Offer in exchange for $46,153,846 aggregate liquidation preference of Series I Preferred Stock and $3,846,154 in cash pursuant to the terms of the Exchange Offer. The pro forma financial information set forth below does not give effect to any other changes to the accounts of Hyperscale Data since December 31, 2025 and only gives effect to the financial impact of the settlement of the Exchange Offer. The unaudited pro forma financial information is presented for illustrative purposes only and does not necessarily indicate the financial position or results that would have been realized had the Exchange Offer been completed as of the dates indicated. The unaudited pro-forma financial statements are for informational purposes only and are not indications of future performance.
| As of December 31, 2025 | ||||||||||||
| Actual | Adjustment | As Adjusted | ||||||||||
| Balance Sheet Data: | | | | |||||||||
| Cash and cash equivalents | $ | 13,076,000 | $ | (3,846,000 | ) | $ | 9,230,000 | |||||
| Total assets | $ | 313,707,000 | $ | (3,846,000 | ) | $ | 309,861,000 | |||||
| Total liabilities | $ | 187,850,000 | $ | — | $ | 187,850,000 | ||||||
| Preferred stock, $0.001 par value | $ | 2,000 | $ | 2,000 | $ | 4,000 | ||||||
| Class A Common Stock, $0.001 par value | $ | 323,000 | $ | (192,000 | ) | $ | 131,000 | |||||
| Additional paid-in capital | $ | 853,156,000 | $ | 46,152,000 | $ | 899,308,000 | ||||||
| Accumulated deficit | $ | (734,560,000 | ) | $ | (49,808,000 | ) | $ | (784,368,000 | ) | |||
| Total stockholders’ equity | $ | 125,857,000 | $ | (3,846,000 | ) | $ | 122,011,000 | |||||
33
| As of September 30, 2026 | ||||||||||||
| Actual | Adjustment | As Adjusted | ||||||||||
| Balance Sheet Data: | | | | |||||||||
| Cash and cash equivalents | $ | 17,295,000 | $ | (3,846,000 | ) | $ | 13,449,000 | |||||
| Total assets | $ | 393,530,000 | $ | (3,846,000 | ) | $ | 389,684,000 | |||||
| Total liabilities | $ | 268,251,000 | $ | — | $ | 268,251,000 | ||||||
| Preferred stock, $0.001 par value | $ | 2,000 | $ | 2,000 | $ | 4,000 | ||||||
| Class A Common Stock, $0.001 par value | $ | 219,000 | $ | (192,000 | ) | $ | 27,000 | |||||
| Additional paid-in capital | $ | 935,971,000 | $ | 46,152,000 | $ | 982,123,000 | ||||||
| Accumulated deficit | $ | (809,875,000 | ) | $ | (49,808,000 | ) | $ | (859,683,000 | ) | |||
| Total stockholders’ equity | $ | 125,279,000 | $ | (3,846,000 | ) | $ | 121,433,000 | |||||
| | For the year ended December 31, 2025 | |||||||||||
| Actual | Adjustment | As Adjusted | ||||||||||
| Statement of Comprehensive Loss and EPS | ||||||||||||
| Net loss attributable to common stockholders | $ | (75,039,000 | ) | $ | — | $ | (75,039,000 | ) | ||||
| Foreign currency translation adjustment | $ | 949,000 | $ | — | $ | 949,000 | ||||||
| Total comprehensive loss | $ | (74,090,000 | ) | $ | (5,538,000 | ) | $ | (74,090,000 | ) | |||
| Basic and diluted net loss per common share | $ | (3.02 | ) | nm(1) | nm(1) | |||||||
| | For the nine months ended September 30, 2026 | |||||||||||
| Actual | Adjustment | As Adjusted | ||||||||||
| Statement of Comprehensive Loss and EPS | ||||||||||||
| Net loss attributable to common stockholders | $ | (72,064,000 | ) | $ | — | $ | (72,064,000 | ) | ||||
| Foreign currency translation adjustment | $ | (371,000 | ) | $ | — | $ | (371,000 | ) | ||||
| Total comprehensive loss | $ | (72,435,000 | ) | $ | — | $ | (72,435,000 | ) | ||||
| Basic and diluted net loss per common share | $ | (0.64 | ) | nm(2) | nm(2) | |||||||
(1) The Company’s basic and diluted weighted average common shares outstanding did not exceed 192,308,000 shares on December 31, 2025 and September 30, 2026 for it to illustrate the impact of the Offering on basic and diluted net loss per common share.
| As of December 31, 2025 | ||||||||||||
| Actual | Adjustment | As Adjusted | ||||||||||
| Book value per share calculation | ||||||||||||
| Class A common shares outstanding | ||||||||||||
| at December 31, 2025 | 64,681,158 | (192,308,000 | ) | nm(2) | ||||||||
| Total stockholders’ equity | $ | 125,857,000 | $ | (3,846,000 | ) | $ | 122,011,000 | |||||
| Book value per share | $ | 1.95 | nm(2) | nm(2) | ||||||||
34
| As of September 30, 2026 | ||||||||||||
| | Actual | Adjustment | As Adjusted | |||||||||
| Book value per share calculation | ||||||||||||
| Class A common shares outstanding | ||||||||||||
| at September 30, 2026 | 218,897,197 | (192,308,000 | ) | nm(2) | ||||||||
| Total stockholders’ equity | $ | 125,279,000 | $ | (3,846,000 | ) | $ | 121,433,000 | |||||
| Book value per share | $ | 0.57 | nm(2) | nm(2) | ||||||||
(2) The Company’s common shares outstanding did not exceed 192,308,000 shares on December 31, 2025 and September 30, 2026 for it to illustrate the impact of the Offering on Class A common shares outstanding and book value per share.
MARKET PRICE AND DIVIDEND INFORMATION
Market Price of and Dividends on the Common Stock
Price Range of Shares. The shares are traded on the NYSE American under the symbol “GPUS.” The following table sets forth, for each of the periods indicated, the high and low sales prices per share as reported by the NYSE American based on published financial sources.
| High | Low | |||||||
| Year Ended December 31, 2024: | ||||||||
| First Quarter | $ | 427.25 | $ | 59.81 | ||||
| Second Quarter | 101.50 | 38.50 | ||||||
| Third Quarter | 59.50 | 33.25 | ||||||
| Fourth Quarter | 43.75 | 23.90 | ||||||
| Year Ended December 31, 2025: | ||||||||
| First Quarter | $ | 32.40 | $ | 10.85 | ||||
| Second Quarter | 49.90 | 6.15 | ||||||
| Third Quarter | 11.15 | 1.80 | ||||||
| Fourth Quarter | 3.65 | 0.90 | ||||||
| Year Ending December 31, 2026: | ||||||||
| First Quarter | $ | 2.00 | $ | 0.65 | ||||
| Second Quarter | 2.85 | 0.55 | ||||||
| Third Quarter | 0.80 | 0.16 | ||||||
| Fourth Quarter (through November 16, 2026) | 0.24 | 0.13 | ||||||
On November 6, 2026, the last trading day before we announced our intention to commence the Offer, the reported closing sales price of our shares on the NYSE American was $0.14 per share. On November 16, 2026, the last full trading day before commencement of the Offer, the reported closing sales price of our shares on the NYSE American was $0.1583 per share. We urge stockholders to obtain a recent market quotation for the shares before deciding whether to tender their shares.
We have not declared or paid any cash dividends on our Common Stock since our inception, and we do not intend to pay any cash dividends in the foreseeable future. The declaration of dividends in the future, if any, will be at the discretion of our Board and will depend, among other matters, upon our earnings, capital requirements and financial position.
35
DESCRIPTION OF HYPERSCALE’S COMMON STOCK
The following summary does not purport to be complete and is qualified in its entirety by reference to Hyperscale’s certificate of incorporation and bylaws, each as amended, and to the provisions of the General Corporation Law of the State of Delaware, as amended.
General
Hyperscale is authorized to issue 2,500,000,000 shares of Class A Common Stock, par value $0.001 per share, and 25,000,000 shares of Class B Common Stock, par value $0.001 per share. As of September 30, 2026, there were 218,897,194 shares of our Class A Common Stock issued and outstanding and 4,773,819 shares of Class B Common Stock issued and outstanding. The outstanding shares of Hyperscale’s common stock are validly issued, fully paid and nonassessable. In this Description of Hyperscale’s Common Stock, all references solely to “common stock” shall refer to both the Class A Common Stock and Class B Common Stock except where otherwise indicated. Hyperscale is authorized to issue up to 25,000,000 shares of preferred stock, par value $0.001 per share. Of these shares of preferred stock, 1,000,000 shares are designated as Series A Preferred Stock, 60,000 are designated as Series B Preferred Stock, 50,000 shares are designated as Series C Preferred Stock, 2,000,000 shares are designated as the Series D Preferred Stock, 2,500,000 shares are designated as Series E Preferred Stock, 1,000,000 shares are designated as Series F Preferred Stock, 25,000 shares are designated as Series G Preferred Stock and 100,000 shares are designated as Series H Preferred Stock. As of September 30, 2026, there were 7,040 shares of Series A Preferred Stock outstanding, 3,000 shares of Series B Preferred Stock outstanding, 50,000 shares of Series C Preferred Stock outstanding, 656,113 shares of Series D Preferred Stock outstanding, 649,998 shares of Series E Preferred Stock outstanding, 998,577 shares of Series F Preferred Stock outstanding, 960 shares of Series G Preferred Stock outstanding and 4,000 shares of Series H Preferred Stock outstanding.
Common Stock
Holders of Hyperscale’s shares of Class A Common Stock are entitled to one vote for each share on all matters submitted to a stockholder vote. Holders of Hyperscale’s shares of Class B Common Stock are entitled to ten votes for each share on all matters submitted to a stockholder vote. Holders of Hyperscale’s common stock do not have cumulative voting rights. Therefore, holders of a majority of the shares of Hyperscale’s common stock voting for the election of directors can elect all of the directors. Holders of Hyperscale’s common stock representing a majority of the voting power of our capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any meeting of stockholders. A vote by the holders of a majority of our outstanding shares is required to effectuate certain fundamental corporate changes such as liquidation, merger or an amendment to our certificate of incorporation.
Holders of Hyperscale’s common stock are entitled to share in all dividends that the Board of Directors of Hyperscale, in its discretion, declares from legally available funds. In the event of a liquidation, dissolution or winding up, each outstanding share entitles its holder to participate pro rata in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over our common stock. Hyperscale’s common stock has no preemptive, subscription or conversion rights and there are no redemption provisions applicable to Hyperscale’s common stock.
Transfer Agent and Registrar
The Transfer Agent and Registrar for Hyperscale Data’s common stock is Computershare, 8742 Lucent Blvd., Suite 225, Highlands Ranch, CO 80129.
36
DESCRIPTION OF SERIES I PREFERRED STOCK
The following summary does not purport to be complete and is qualified in its entirety by reference to Hyperscale’s certificate of incorporation and second amended and restated bylaws, each as amended, and to the provisions of the General Corporation Law of the State of Delaware, as amended.
The following summary of the material terms and provisions of the Series I Preferred Stock does not purport to be complete in all respects, and is qualified in its entirety by reference to the pertinent sections of our certificate of incorporation, including the certificates of designations for the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, copies of which are available upon request from us, and the applicable provisions of the Delaware General Corporation Law.
General
Hyperscale is authorized to issue up to 25,000,000 shares of preferred stock, par value $0.001 per share.
Our Board of Directors classified 2,000,000 shares of our authorized but unissued preferred stock, and has approved a Certificate of Designation creating a series of our preferred stock, designated as the “12.00% Series I Cumulative Redeemable Perpetual Preferred Stock”. If and when issued in accordance with this Offer to Exchange, the Series I Preferred Stock will be validly issued, fully paid and nonassessable.
No Maturity, Sinking Fund or Mandatory Redemption
The Series I Preferred Stock is perpetual, subject to redemption as described below, and has no stated maturity date and will not be subject to any sinking fund or mandatory redemption.
Ranking
With respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up, the Series I Preferred Stock will rank:
| (i) | senior to all of our common stock and any other equity securities that we may issue in the future, the terms of which specifically provide that such equity securities rank junior to the Series I Preferred Stock; |
| (ii) | in parity with any shares of equity securities that we may issue in the future, the terms of which specifically provide that such equity securities rank on par with such Series I Preferred Stock; |
| (iii) | junior to (a) our Series A Preferred Stock, (b) our Series B Preferred Stock, (c) our Series C Preferred Stock, (d) our Series D Preferred Stock, (e) our Series E Preferred Stock, (f) our Series F Preferred Stock, (g) our Series G Preferred Stock, (h) our Series H Preferred Stock and (g) all other equity securities we may issue, the terms of which specifically provide that such equity securities rank senior to the Series I Preferred Stock; and |
| (iv) | junior to all of our existing and future indebtedness. |
Dividends
Holders of shares of the Series I Preferred Stock are entitled to receive, when, as and if declared by our Board of Directors, out of funds legally available for the payment of dividends, cumulative cash dividends at an annual rate of 12.00%, which is equivalent to $2.88 per annum per share, based on the $24.00 liquidation preference (“Dividend Rate”) during the Fixed Term (as defined below). The Dividend Rate shall accrue from, and including, the date that shall be twelve (12) months from the date of initial issuance to, but not including, the date fixed for redemption (the “Fixed Term”).
Dividends on the Series I Preferred Stock shall accrue daily and be cumulative from, and including, the date that shall be twelve (12) months from Initial Issuance Date and shall be payable monthly within eight (8) business days following the Dividend Record Date (as defined herein) (each such payment date, a “Dividend Payment Date,” and each monthly period, a “Dividend Period”). Any dividend payable on the Series I Preferred Stock, including dividends payable for any partial Dividend Period, will be computed on the basis of a 360-day year consisting of twelve 30-day months. Dividends will be payable to holders of record as they appear in our stock records for the Series I Preferred Stock at the close of business on the applicable record date, which shall be the last day of each month beginning on the last day of the 13th month following the Initial Issuance Date (the “Initial Dividend Record Date”), whether or not a business day (each, a “Dividend Record Date”). The first dividend on the Series I Preferred Stock is scheduled to be paid within eight (8) business days following the Initial Dividend Record Date to the persons who are the holders of record of the Series I Preferred Stock at the close of business on the Initial Dividend Record Date.
37
No dividends on shares of Series I Preferred Stock will be authorized by our Board of Directors or paid or set apart for payment by us at any time when the payment thereof would be unlawful under the laws of the State of Delaware or when the terms and provisions of any of our agreements, including any agreement relating to our indebtedness (the “Limiting Documents”), prohibit the authorization, payment or setting apart for payment thereof or provide that the authorization, payment or setting apart for payment thereof would constitute a breach of the Limiting Documents or a default under the Limiting Documents, or if the authorization, payment or setting apart for payment shall be restricted or prohibited by law. You should review the information appearing above under “Risk Factors — We may not have sufficient earnings and profits in order for distributions on the Series I Preferred Stock to be treated as dividends” for information as to, among other things, other circumstances under which we may be unable to pay dividends on the Series I Preferred Stock.
Notwithstanding the foregoing, dividends on the Series I Preferred Stock will accrue, commencing on the date that is twelve (12) months from the Initial Issuance Date, regardless of whether (i) we have earnings, (ii) there are funds legally available for the payment of such dividends, or (iii) such dividends are declared by our Board of Directors. No interest, or sum in lieu of interest, will be payable in respect of any dividend payment or payments on the Series I Preferred Stock which may be in arrears, and holders of the Series I Preferred Stock will not be entitled to any dividends in excess of full cumulative dividends described above. Any dividend payment made on the Series I Preferred Stock shall first be credited against the earliest accumulated but unpaid dividend due with respect to those shares. Holders of Series I Preferred Stock shall not be entitled to any dividend in excess of all accumulated accrued and unpaid dividends on the Series I Preferred Stock as described above. Any dividend payment made on the Series I Preferred Stock shall first be credited against the earliest accumulated accrued and unpaid dividend due with respect to such shares which remains payable at the time of such payment.
Future distributions on our Common Stock and preferred stock, including the Series I Preferred Stock, will be at the discretion of our Board of Directors and will depend on, among other things, our results of operations, cash flow from operations, financial condition and capital requirements, any debt service requirements and any other factors our Board of Directors deems relevant. Accordingly, we cannot guarantee that we will be able to make cash distributions, or stock distributions, on our preferred stock or what the actual distributions will be for any future period.
Unless full cumulative dividends on the Series I Preferred Stock have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof is set apart for payment for all past Dividend Periods, no dividends (other than in shares of Common Stock, or in shares of any series of preferred stock that we may issue ranking junior to the Series I Preferred Stock as to dividends and upon liquidation) shall be declared or paid or set aside for payment upon equity securities ranking junior to the Series I Preferred Stock or equity securities ranking on par with the Series I Preferred Stock that we may issue.
When dividends are not paid in full (or a sum sufficient for such full payment is not so set apart) upon the Series I Preferred Stock and the shares of any other series of preferred stock that we may issue ranking on parity as to dividends with the Series I Preferred Stock, all dividends declared upon the Series I Preferred Stock and any other series of preferred stock that we may issue ranking on parity as to dividends with the Series I Preferred Stock will be declared pro rata so that the amount of dividends declared per share of Series I Preferred Stock and such other series of preferred stock that we may issue will in all cases bear to each other the same ratio that accrued dividends per share on the Series I Preferred Stock and such other series of preferred stock that we may issue (which will not include any accrual in respect of unpaid dividends for prior Dividend Periods if such preferred stock does not have a cumulative dividend) bear to each other. No interest, or sum of money in lieu of interest, will be payable in respect of any dividend payment or payments on the Series I Preferred Stock that may be in arrears.
38
Whenever dividends on any shares of Series I Preferred Stock are in arrears for six or more Dividend Periods, whether or not consecutive (a “Dividend Default”):
(i) the Dividend Rate shall be increased to 15% per annum (equivalent to $3.60 per annum per share) (as increased, the “Penalty Rate”), commencing on the first day after the Dividend Payment Date on which a Dividend Default occurs and for each subsequent Dividend Payment Date thereafter until such time we have paid all accumulated accrued and unpaid dividends on the Series I Preferred Stock in full, at which time the Dividend Rate shall revert to the rate of 12.00% of the $24.00 per share stated liquidation preference per annum (the “Stated Rate”), which is equivalent to $2.88 per share;
(ii) on the next Dividend Payment Date following the Dividend Payment Date on which a Dividend Default occurs, and continuing until such time as we have paid all accumulated accrued and unpaid dividends on the Series I Preferred Stock in full, we will pay all dividends on the Series I Preferred Stock, including all accumulated accrued and unpaid dividends, on each Dividend Payment Date either in cash or, if not paid in cash, by issuing to the holders thereof (i) if our Common Stock is then subject to listing on a national securities exchange, shares of freely tradeable Common Stock with a value equal to the amount of dividends being paid, calculated based on the then current market value of the Common Stock, plus cash in lieu of any fractional share of Common Stock, or (ii) if the Common Stock is not then subject to listing on a national securities exchange, additional shares of Series I Preferred Stock with a value equal to the amount of dividends being paid, calculated based on the stated $24.00 liquidation preference per share of the Series I Preferred Stock, plus cash in lieu of any fractional Series I Preferred Stock;
(iii) until such time as the Dividend Rate reverts to the Stated Rate pursuant to clause (a) above, the holders of Series I Preferred Stock will have the voting rights described below, see the section entitled “Series I Preferred Stock – Voting Rights” for further details; and
(iv) to the extent that we determine a shelf registration statement to cover resales of Common Stock or Series I Preferred Stock is required in connection with the issuance of, or for resales of, such Common Stock or Series I Preferred Stock issued as payment of a dividend, we will use our commercially reasonable efforts to file and maintain the effectiveness of such a shelf registration statement until such time as all shares of such stock have been resold thereunder or such shares are eligible for resale pursuant to Rule 144(b)(1) under the Securities Act.
Following any Dividend Default that has been cured by us as provided above, if we subsequently fail to pay cash dividends on the Series I Preferred Stock in full for any Dividend Period, such subsequent failure shall constitute a separate Dividend Default, and the foregoing shall immediately apply until such subsequent Dividend Default is cured as so provided.
Liquidation Preference
In the event of our voluntary or involuntary liquidation, dissolution or winding up, the holders of shares of Series I Preferred Stock will be entitled to be paid out of the assets we have legally available for distribution to our stockholders, subject to the preferential rights of the holders of any class or series of our capital stock we may issue ranking senior to the Series I Preferred Stock with respect to the distribution of assets upon liquidation, dissolution or winding up, a liquidation preference of $24.00 per share, plus an amount equal to all dividends (whether or not declared) accrued and unpaid thereon to and including the date of payment, before any distribution of assets is made to holders of our Common Stock or any other class or series of our capital stock we may issue that ranks junior to the Series I Preferred Stock as to liquidation rights.
In the event that, upon any such voluntary or involuntary liquidation, dissolution or winding up, our available assets are insufficient to pay the amount of the liquidating distributions on all outstanding shares of Series I Preferred Stock and the corresponding amounts payable on all shares of other classes or series of our capital stock that we may issue ranking senior to and on a parity with the Series I Preferred Stock, then after payment of the liquidating distribution on all outstanding stock senior to the Series I Preferred Stock, the holders of the Series I Preferred Stock and all other such classes or series of capital stock ranking on parity with the Series I Preferred Stock will share ratably in any such distribution of assets in proportion to the full liquidating distributions to which they would otherwise be respectively entitled.
The consolidation or merger of us with or into any other entity, or the sale, lease, transfer or conveyance of all or substantially all of our property or business, or a statutory share exchange will not be deemed to constitute the voluntary or involuntary liquidation, dissolution or winding up of us.
39
Optional Redemption
Following the initial issuance of the Series I Preferred Stock, we may, at our option, upon not less than thirty (30) days nor more than sixty (60) days’ written notice, redeem the Series I Preferred Stock, in whole or in part, at any time or from time to time, at a redemption price of $24.00 per share of Series I Preferred Stock, plus any accumulated and unpaid dividends (whether or not declared) on the Series I Preferred Stock up to, but not including, the date of such redemption, upon written notice as described herein. If we elect to redeem any shares of Series I Preferred Stock as described in this paragraph, we may use available cash to pay the redemption price.
Notice of redemption will be mailed upon not less than thirty (30) days nor more than sixty (60) days before the redemption date to each holder of record of Series I Preferred Stock at the address shown on our share transfer books. Each notice shall state: (i) the redemption date; (ii) the number of shares of Series I Preferred Stock to be redeemed; (iii) the redemption price of Series I Preferred Stock, plus any accumulated and unpaid dividends (whether or not declared) up to, but not including the date of redemption; (iv) the place or places where any certificates issued for Series I Preferred Stock other than through The Depository Trust Company (“DTC”) book entry described below, are to be surrendered for payment of the redemption price; (v) that dividends on the Series I Preferred Stock will cease to accrue on such redemption date; (vi) whether such redemption is being made pursuant to the optional redemption provisions described above; and (vii) any other information required by law or by the applicable rules of any exchange or market upon which the Series I Preferred Stock may be listed or admitted for trading. If fewer than all outstanding shares of Series I Preferred Stock are to be redeemed, the notice mailed to each such holder thereof shall also specify the number of shares of Series I Preferred Stock to be redeemed from each such holder.
At our election, on or prior to the redemption date, we may irrevocably deposit the redemption price (including accrued and unpaid dividends) of the Series I Preferred Stock so called for redemption in trust for the holders thereof with a bank or trust company, in which case the notice to holders of shares of Series I Preferred Stock will (i) state the date of such deposit, (ii) specify the office of such bank or trust company as the place of payment of the redemption price, and (iii) require such holders to surrender any certificates issued for shares of Series I Preferred Stock other than through the DTC book entry described below at such place on or about the date fixed in such redemption notice (which may not be later than such redemption date) against payment of the redemption price (including all accrued and unpaid dividends to the redemption date). Any interest or other earnings earned on the redemption price (including all accrued and unpaid dividends) deposited with a bank or trust company will be paid to us. Any monies so deposited that remain unclaimed by the holders of shares of Series I Preferred Stock at the end of six (6) months after the redemption date will be returned to us by such bank or trust company. If we make such a deposit, shares of Series I Preferred Stock shall not be considered outstanding for purposes of voting or determining shares entitled to vote on any matter on or after the date of such deposit.
On or after the date fixed for redemption, each holder of shares of Series I Preferred Stock that holds a certificate other than through the DTC book entry described below must present and surrender each certificate representing their Series I Preferred Stock to us at the place designated in the applicable notice and thereupon the redemption price of such shares will be paid to or on the order of the person whose name appears on such certificate representing the Series I Preferred Stock as the owner thereof, each surrendered certificate will be canceled and the shares will be retired and restored to the status of undesignated, authorized shares of preferred stock.
If we redeem any shares of Series I Preferred Stock and if the redemption date occurs after a Dividend Record Date and on or prior to the related Dividend Payment Date, the dividend payable on such Dividend Payment Date with respect to such shares called for redemption shall be payable on such Dividend Payment Date to the holders of record at the close of business on such Dividend Record Date, and shall not be payable as part of the redemption price for such shares.
Voting Rights
Series I Preferred Stock. Holders of the Series I Preferred Stock do not have any voting rights, except as set forth below or as otherwise required by law.
40
On each matter on which holders of Series I Preferred Stock are entitled to vote, each share of Series I Preferred Stock will be entitled to one vote. In any matter in which the Series I Preferred Stock may vote as a single class with any other series of preferred stock (as may be required by law), each share of Series I Preferred Stock shall be entitled to one vote per $24.00 of stated liquidation preference.
Whenever dividends on any shares of Series I Preferred Stock are in arrears for 6 or more monthly Dividend Periods, whether or not consecutive, the number of directors constituting our Board of Directors will be automatically increased by two (if not already increased by two by reason of the election of directors by the holders of any other class or series of our preferred stock we may issue upon which like voting rights have been conferred and are exercisable) and the holders of Series I Preferred Stock (voting together as a class with all other classes or series of preferred stock we may issue upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Series I Preferred Stock in the election of those two directors) will be entitled to vote for the election of those two additional directors (the “preferred stock directors”) at a special meeting called by us at the request of the holders of record of at least 40% of the outstanding shares of Series I Preferred Stock (unless the request is received fewer than 90 days before the date fixed for the next annual or special meeting of stockholders, in which case, such vote will be held at the earlier of the next annual or special meeting of stockholders). The directors elected at any such special meeting shall serve until all dividends accumulated on the Series I Preferred Stock for all past Dividend Periods and the then current Dividend Period have been fully paid or declared and a sum sufficient for the payment thereof has been set aside for payment. In that case, the right of holders of the Series I Preferred Stock to elect any directors will cease and, unless there are other classes or series of our preferred stock upon which like voting rights have been conferred and are exercisable, any preferred stock directors elected by holders of the Series I Preferred Stock will immediately resign and the number of directors constituting the Board of Directors will be reduced accordingly. In no event will the holders of Series I Preferred Stock be entitled under these voting rights to elect a preferred stock director that would cause us to fail to satisfy a requirement relating to director independence of any national securities exchange or quotation system on which any class or series of our capital stock is listed or quoted. For the avoidance of doubt, in no event will the total number of preferred stock directors elected by holders of the Series I Preferred Stock (voting separately as a class with all other classes or series of preferred stock we may issue upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Series I Preferred Stock in the election of such directors) under these voting rights exceed two.
If a special meeting is not called by us within 75 days after request from the holders of Series I Preferred Stock as described above, then the holders of record of at least 40% of the outstanding shares of Series I Preferred Stock may call the meeting in accordance with the notice provisions set forth in our second amended and restated bylaws, as amended.
If, at any time when the voting rights conferred upon the Series I Preferred Stock are exercisable, any vacancy in the office of a preferred stock director will occur, then such vacancy may be filled only by election by the Board of Directors, upon the nomination of the then-remaining preferred stock director or the successor of such remaining director, if any, to serve until the next annual meeting of the stockholders or special meeting held in place thereof and until their successors are duly elected and qualified, if such term shall not have previously terminated.
So long as any shares of Series I Preferred Stock remain outstanding, we will not, without the affirmative vote or consent of the holders of at least two-thirds of the votes entitled to be cast by the holders of the Series I Preferred Stock outstanding at the time, given in person or by proxy, either in writing or at a meeting (voting together as a single class with the holders of any other series of parity preferred stock that would be adversely affected in substantially the same manner) amend, alter, repeal or replace our certificate of incorporation or second amended and restated bylaws, including by way of a merger, consolidation or otherwise in which we may or may not be the surviving entity, so as to materially and adversely affect and deprive holders of Series I Preferred Stock of any right, preference, privilege or voting power of the Series I Preferred Stock. For purposes of the foregoing voting requirements, we may create additional series or classes of preferred stock that rank senior to, on par with, and junior to, the Series I Preferred Stock, increase the authorized number of shares of preferred stock, preferred stock that rank senior to, on par with (including Series I Preferred Stock), and junior to, the Series I Preferred Stock, and issue additional series of preferred stock that rank senior to, on par with (including Series I Preferred Stock), and junior to, the Series I Preferred Stock, without the consent of any holder of the Series I Preferred Stock. Each holder of Series I Preferred Stock, by acceptance of such shares, shall be deemed to have authorized, at the time the Series I Preferred Stock is created, the Board of Directors to take any of the actions described in the immediately preceding sentence without a further vote of the holders of Series I Preferred Stock.
41
The foregoing voting provisions will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required is effected, such outstanding shares of Series I Preferred Stock are subject to a notice of redemption pursuant to the redemption provisions described above and funds sufficient to pay the applicable redemption price, including accumulated and unpaid dividends, for all of such shares of Series I Preferred Stock called for redemption have been set aside for payment, provided, however, a vote of the holders of Series I Preferred Stock will be required if all or part of the shares of Series I Preferred Stock is being retired with proceeds from the sale of the new issue.
Except as expressly stated in the Certificate of Designation or as may be required by applicable law, the shares of Series I Preferred Stock do not have any relative, participating, optional or other special voting rights or powers and the consent of the holders thereof will not be required for the taking of any corporate action.
Information Rights
During any period in which we are not subject to Section 13 or 15(d) of the Exchange Act and any shares of Series I Preferred Stock are outstanding, we will use our best efforts to (i) transmit by mail (or other permissible means under the Exchange Act) to all holders of Series I Preferred Stock, as their names and addresses appear on our record books and without cost to such holders, copies of the Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q that we would have been required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act if we were subject thereto (other than any exhibits that would have been required) and (ii) promptly upon request, supply copies of such reports to any holders or prospective holder of Series I Preferred Stock. We will use our best effort to mail (or otherwise provide) the reports to the holders of the Series I Preferred Stock within 30 days after the respective dates by which a periodic report on Form 10-K or Form 10-Q, as the case may be, in respect of such information would have been required to be filed with the SEC, if we were subject to Section 13 or 15(d) of the Exchange Act, in each case, based on the dates on which we would be required to file such periodic reports if we were a “non-accelerated filer” within the meaning of the Exchange Act.
No Preemptive Rights
No holders of Series I Preferred Stock will, as holders of Series I Preferred Stock, have any preemptive rights to purchase or subscribe for our Common Stock or any other security.
Change of Control
Provisions in our certificate of incorporation, as amended, and second amended and restated bylaws, as amended and restated, may make it difficult and expensive for a third party to pursue a tender offer, change in control or takeover attempt, which is opposed by management and our Board of Directors.
Transfer Agent
The transfer agent and registrar for the Series I Preferred Stock is Computershare.
Book-Entry, Delivery and Form
Series I Preferred Stock issued to existing record holders of Common Stock will be issued initially in the form of one or more fully registered global certificates (the “Global Preferred Shares”), which shall be deposited on behalf of the purchasers represented thereby with the Company’s transfer agent, as custodian for DTC, or with DTC’s nominee, Cede & Co., or such other depositary of our choosing that is a “clearing corporation” within the meaning of the New York Uniform Commercial Code and a clearing agency under Section 17A of the Exchange Act (the “Depositary”) (or with such other custodian as the Depositary may direct), and registered in the name of the Depositary or its nominee, duly executed by us and authenticated by our transfer agent.
The number of shares of Series I Preferred Stock represented by Global Preferred Shares may from time to time be increased or decreased by adjustments made on the records of our transfer agent and the Depositary as hereinafter provided. Members of, or participants in, the Depositary (“Agent Members”) shall have no rights under these terms of the Series I Preferred Stock with respect to any Global Preferred Shares held on their behalf by the Depositary or by our transfer agent as the custodian of the Depositary or under such Global Preferred Shares, and the Depositary may be treated by us, our transfer agent and any of our agents or our transfer agent as the absolute owner of such Global Preferred Shares for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent us, our transfer agent or any of our agents or our transfer agent from giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair, as between the Depositary and its Agent Members, the operation of customary practices of the Depositary governing the exercise of the rights of a holder of a beneficial interest in any Global Preferred Shares.
42
The Series I Preferred Stock will be registered in book-entry form through the Direct Registration System (the “DRS”). The DRS is a system administered by DTC pursuant to which the depositary may register the ownership of uncertificated shares, which ownership shall be evidenced by periodic statements issued by the depositary to the holders of shares of Series I Preferred Stock entitled thereto. This direct registration form of ownership allows holders to have securities registered in their names without requiring the issuance of a physical stock certificate, eliminates the need for holders to safeguard and store certificates and permits the electronic transfer of securities to effect transactions without transferring physical certificates.
Depository Procedures
The following description of the operations and procedures of DTC, Euroclear and Clearstream are provided solely as a matter of convenience. These operations and procedures are solely within the control of the respective settlement systems and are subject to changes by them. We take no responsibility for these operations and procedures and urge stockholders to contact the system or their participants directly to discuss these matters. However, we will remain responsible for any actions DTC, Euroclear and Clearstream and their respective participants take in accordance with instructions provided by us.
DTC has advised us that DTC is a limited-purpose trust company created to hold securities for the participants and to facilitate the clearance and settlement of transactions in those securities between participants through electronic book-entry changes in accounts of its participants. The participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations. Access to DTC’s system is also available to other entities such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly (collectively, the “indirect participants”). Persons who are not participants may beneficially own securities held by or on behalf of DTC only through the participants or the indirect participants. The ownership interests in, and transfers of ownership interests in, each security held by or on behalf of DTC are recorded on the records of the participants and indirect participants.
DTC has also advised us that, pursuant to procedures established by it:
| · | upon deposit of the Global Preferred Shares, DTC will credit the accounts of participants that tendered Common Stock with portions of the aggregate number of shares represented by the Global Preferred Shares; and |
| · | ownership of these interests in the Global Preferred Shares will be shown on, and the transfer of ownership of these interests will be effected only through, records maintained by DTC (with respect to the participants) or by the participants and the indirect participants (with respect to other owners of beneficial interest in the Global Preferred Shares). |
Stockholders who are participants in DTC’s system may hold their interests therein directly through DTC. Stockholders who are not participants may hold their interests therein indirectly through organizations (including Euroclear and Clearstream) which are participants in such system. All interests in the Global Preferred Shares, including those held through Euroclear or Clearstream, may be subject to the procedures and requirements of DTC. Those interests held through Euroclear or Clearstream may also be subject to the procedures and requirements of such systems. Stockholders are advised that the laws of some states require that certain persons take physical delivery in definitive form of securities that they own. Consequently, the ability to transfer beneficial interests in Global Preferred Shares to such persons will be limited to that extent. Because DTC can act only on behalf of participants, which in turn act on behalf of indirect participants, the ability of a person having beneficial interests in Global Preferred Shares to pledge such interests to persons that do not participate in the DTC system, or otherwise take actions in respect of such interests, may be affected by the lack of a physical certificate evidencing such interests.
43
Payments in respect of dividends, if any, on Global Preferred Shares registered in the name of DTC or its nominee will be payable to DTC in its capacity as the registered holder. Under the terms of the Certificate of Designation, we will treat the Persons in whose names the shares of Series I Preferred Stock, including the Global Preferred Shares, are registered as the owners of the shares of Series I Preferred Stock for the purpose of receiving payments and for all other purposes. Consequently, neither we, nor any agent of ours has or will have any responsibility or liability for:
| · | any aspect of DTC’s records or any participant’s or indirect participant’s records relating to or payments made on account of beneficial ownership interest in the Global Preferred Shares or for maintaining, supervising or reviewing any of DTC’s records or any participant’s or indirect participant’s records relating to the beneficial ownership interests in the Global Preferred Shares; or. |
| · | any other matter relating to the actions and practices of DTC or any of its participants or indirect participants. |
DTC has advised us that its current practice, upon receipt of any payment in respect of securities such as the Series I Preferred Stock (including dividends), is to credit the accounts of the relevant participants with the payment on the payment date unless DTC has reason to believe it will not receive payment on such payment date. Each relevant participant is credited with an amount proportionate to its beneficial interest in the aggregate number of the shares represented by the Global Preferred Shares as shown on the records of DTC. Payments by the participants and the indirect participants to the beneficial owners of the Series I Preferred Stock will be governed by standing instructions and customary practices and will be the responsibility of the participants or the indirect participants and will not be the responsibility of DTC, or us. We will not be liable for any delay by DTC or any of its participants in identifying the beneficial owners of the Series I Preferred Stock, and we may conclusively rely on and will be protected in relying on instructions from DTC or its nominee for all purposes.
Transfers between participants in DTC will be effected in accordance with DTC’s procedures, and will be settled in same-day funds, and transfers between participants in Euroclear and Clearstream will be effected in accordance with their respective rules and operating procedures.
Cross-market transfers between the participants in DTC, on the one hand, and Euroclear or Clearstream participants, on the other hand, will be effected through DTC in accordance with DTC’s rules on behalf of Euroclear or Clearstream, as the case may be, by its respective depositary; however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (Brussels time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its respective depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the relevant Global Preferred Shares in DTC, and making or receiving payment in accordance with normal procedures for same-day funds settlement applicable to DTC. Euroclear participants and Clearstream participants may not deliver instructions directly to the depositories for Euroclear or Clearstream.
DTC has advised us that it will take any action permitted to be taken by a holder of Series I Preferred Stock only at the direction of one or more participants to whose account DTC has credited the interests in the Global Preferred Shares and only in respect of such portion of the aggregate number of shares of Series I Preferred Stock as to which such participant or participants has or have given such direction.
Although DTC, Euroclear and Clearstream have agreed to the foregoing procedures to facilitate transfers of interests in the Global Preferred Shares among participants in DTC, Euroclear and Clearstream, they are under no obligation to perform or to continue to perform such procedures, and may discontinue such procedures at any time. Neither we nor our agents will have any responsibility for the performance by DTC, Euroclear or Clearstream or their respective participants or indirect participants of their respective obligations under the rules and procedures governing their operations.
44
Listing
We will file an application to list the Series I Preferred Stock on the NYSE American. If this application is approved, of which there can be no assurance, trading in the Series I Preferred Stock is expected to commence within a 30-day period after the initial delivery of the Series I Preferred Stock. However, we cannot assure you that the NYSE American will list the Series I Preferred Stock or that any trading market will develop for the Series I Preferred Stock. If the application is not approved, we intend to file an application to admit the Series I Preferred Stock for trading on the OTC. Accordingly, no assurance can be given as to the liquidity of the Series I Preferred Stock after their issuance or that a trading market will develop. If the Series I Preferred Stock is not listed or if a robust market does not develop, even if listed, it may impair a holder’s ability to resell the Series I Preferred Stock or the prices at which they may trade.
COMPARISON OF RIGHTS BETWEEN
THE COMMON STOCK AND
THE Series I Preferred
Stock
The following is a description of the material differences between the rights of holders of shares of Common Stock and the Series I Preferred Stock. This summary may not contain all of the information that is important to you. You should carefully read this entire Offer to Exchange for a more complete understanding of the differences between being a holder of shares of Common Stock and Series I Preferred Stock.
|
Common Stock |
Series I Preferred Stock | |
| Ranking | ||
| In any liquidation or bankruptcy of the Company, Common Stock would rank below all claims against us by holders of any of our indebtedness and by holders of preferred stock. Holders of our Common Stock would not be entitled to receive any payment or other distribution of assets upon the liquidation or bankruptcy of the Company until after our obligations to creditors, and the liquidation preference of our preferred stock have been satisfied in full. | In any liquidation or bankruptcy of the Company, Series I Preferred Stock would rank below all claims against us by holders of any of our indebtedness and by the holders of any senior class of preferred stock. Holders of our Series I Preferred Stock would not be entitled to receive any payment or other distribution of assets upon the liquidation or bankruptcy of the Company until after our obligations to creditors and the liquidation preference of the senior classes of preferred stock have been satisfied in full. | |
| Voting Rights | ||
| At every meeting of the stockholders of the Company in connection with the election of directors and all other matters submitted to a vote of stockholders, every holder of shares of Common Stock is entitled to one vote in person or by proxy for each share of Common Stock registered in the name of the holder on the transfer books of the Company. | Holders of the Series I Preferred Stock do not have any voting rights, except for limited voting rights if dividends payable on the outstanding Series I Preferred Stock are in arrears for 6 or more consecutive or non-consecutive monthly dividend periods. See the section entitled “Series I Preferred Stock – Voting Rights” for further detail. | |
| Dividends/Distributions | ||
| Holders of Common Stock are entitled to receive dividends if and when declared by our Board of Directors. | Dividends on the Series I Preferred Stock are cumulative from the date that is twelve (12) months from the date of initial issue and will be payable within eight (8) business days following the last day of each month beginning on the last day of the 13th month following the initial issuance of the Series I Preferred Stock when, as and if declared by our Board of Directors. Dividends will be payable out of amounts legally available therefor at a rate equal to 12.00% per annum per $24.00 of stated liquidation preference per share, or $0.24 per share of Series I Preferred Stock per month. | |
|
Listing | ||
| The Common Stock trades on the NYSE American, under the ticker symbol “GPUS.” | We will file an application to list the Series I Preferred Stock on the NYSE American, although there can be no assurance that shares of Series I Preferred Stock will be listed on the NYSE American. | |
45
CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS
The following summary describes certain U.S. federal income tax consequences of the Exchange Offer. This summary does not discuss all of the aspects of U.S. federal income taxation that may be relevant to a beneficial owner in light of its particular investment or other circumstances. This summary only applies to a beneficial owner of shares of Common Stock that holds such Common Stock and will hold any Series I Preferred Stock received in exchange therefor as a capital asset (generally, investment property). This summary does not address U.S. federal income tax rules that may be applicable to certain categories of beneficial owners of Common Stock or Series I Preferred Stock, such as:
| · | dealers in securities, commodities or currencies; |
| · | traders in securities; |
| · | U.S. holders (as defined below) whose functional currency is not the U.S. dollar; |
| · | persons holding Common Stock or Series I Preferred Stock as part of a conversion, constructive sale, wash sale or other integrated transaction or a hedge, straddle or synthetic security; |
| · | persons subject to the alternative minimum tax; |
| · | U.S. expatriates; |
| · | banks or financial institutions; |
| · | insurance companies; |
| · | controlled foreign corporations, passive foreign investment companies, real estate investment trusts and regulated investment companies and shareholders of such entities; |
| · | entities that are tax-exempt for U.S. federal income tax purposes and retirement plans, individual retirement accounts and tax-deferred accounts; |
| · | pass-through entities, including partnerships and entities and arrangements classified as partnerships for U.S. federal income tax purposes, and beneficial owners of pass-through entities; and |
| · | persons that exercise appraisal rights with respect to their shares of Common Stock. |
In addition, this summary only addresses U.S. federal income tax consequences, and does not address other U.S. federal tax consequences, including, for example, estate or gift tax consequences or the Medicare tax on certain investment income. This summary also does not address any U.S. state or local or non-U.S. income or other tax consequences.
46
If an entity or arrangement classified as a partnership for U.S. federal income tax purposes holds Common Stock or Series I Preferred Stock, the U.S. federal income tax treatment of a partner in the partnership generally will depend upon the status of the partner, the activities of the partnership and certain determinations made at the partner level. Entities or arrangements classified as partnerships for U.S. federal income tax purposes, and partners in such partnerships, should consult their own tax advisors regarding the U.S. federal income tax consequences of the Exchange Offer.
This summary is based on U.S. federal income tax law, including the Internal Revenue Code of 1986, as amended (the “Code”), U.S. Treasury regulations, administrative rulings and judicial authority, all as in effect or in existence as of the date of this Offer to Exchange. Subsequent developments in U.S. federal income tax law, including changes in law or differing interpretations, which may be applied retroactively, could have a material effect on the U.S. federal income tax consequences of the Exchange Offer as set forth in this summary. We cannot assure you that the Internal Revenue Service (the “IRS”), will not challenge one or more of the tax consequences described in this summary, and we have not obtained, nor do we intend to obtain, any ruling from the IRS or opinion of counsel with respect to the tax consequences of the Exchange Offer.
Each beneficial owner of Common Stock should consult its own tax advisor regarding the particular U.S. federal, state and local and non-U.S. income and other tax consequences of the Exchange Offer.
U.S. Tax Treatment of the Common Stock
A beneficial owner of the Common Stock is generally treated, for U.S. federal income tax purposes, as the owner of the Common Stock.
U.S. Holders
The following discussion applies to you only if you are a “U.S. holder.” A U.S. holder is a beneficial owner of shares of Common Stock that is, for U.S. federal income tax purposes:
| · | an individual citizen or resident of the United States; |
| · | a corporation created or organized in, or under the laws of, the United States, any state thereof or the District of Columbia; |
| · | an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or |
| · | a trust, if (1) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more “United States persons” (within the meaning of the Code) has the authority to control all substantial decisions of the trust, or (2) the trust has a valid election in effect under applicable Treasury regulations to be treated as a “United States person.” |
Receipt of the Exchange Offer Consideration. We intend to treat the exchange of Common Stock for Series I Preferred Stock and cash as a “recapitalization” within the meaning of Section 368(a)(1)(E) of the Code. Assuming the Exchange so qualifies and the Series I Preferred Stock is not treated as “nonqualified preferred stock,” you generally will not recognize loss for U.S. federal income tax purposes. However, because you will receive cash in addition to Series I Preferred Stock, you will be required to recognize gain, if any, equal to the lesser of (i) the amount of cash that you receive; and (ii) the amount of gain that you realize in the exchange. The amount of gain that you realize will equal the excess, if any, of (a) the cash plus the fair market value of the Series I Preferred Stock that you receive over (b) your adjusted tax basis in the Common Stock that you tender. If none of the “dividend non-equivalence tests” described below are satisfied, any gain that you recognize generally will be treated as dividend income for U.S. federal income tax purposes, to the extent of our current or accumulated earnings and profits. Conversely, if any of the “dividend non-equivalence tests” described below are satisfied, any gain that you recognize generally will be treated as capital gain for U.S. federal income tax purposes. In either case, your tax basis in the Series I Preferred Stock that you receive generally will be the same as your tax basis in the Common Stock that you tender, increased by the amount of gain, if any, that you recognize and reduced by the amount of cash that you receive, and your holding period for the Series I Preferred Stock that you receive will include the holding period during which you held the Common Stock that you tender. If you tender more than one “block” of shares of Common Stock, that is, groups of shares of Common Stock that you purchased at different times or at different prices, you must calculate your recognized gain separately with respect to each block, and the results for each block may not be netted in determining your overall recognized gain. Instead, you will recognize gain on those shares on which gain is realized. If you tender more than one block of Common Stock, you are urged to consult your own tax advisor.
47
Nonqualified Preferred Stock. While generally an exchange of common stock for preferred stock may qualify as a recapitalization within the meaning of Section 368(a)(1)(E) of the Code, the receipt of any “nonqualified preferred stock” in such an exchange may not qualify as tax-free. “Nonqualified preferred stock” generally includes preferred stock that is callable for redemption by the issuer if the issuer is more likely than not to exercise the call right. At this time we have no intention to redeem the Series I Preferred Stock, and do not believe that it is more likely than not that we will redeem the Series I Preferred Stock. However, we cannot assure you that the IRS would not take into account all the facts and circumstances and argue that it is more likely than not that we will redeem the Series I Preferred Stock. If the IRS were successful in such argument, the receipt by a U.S. holder of Series I Preferred Stock and cash in exchange for Common Stock generally would constitute a sale or exchange of the Common Stock by the U.S. holder unless the transaction is viewed as having the effect of a distribution under Section 302 of the Code, in which case it may constitute a distribution taxable in whole or in part as a dividend as described below. If a U.S. holder’s receipt of Series I Preferred Stock and cash in exchange for Common Stock is treated as a sale or exchange, the U.S. holder will recognize capital gain, but not loss, in an amount equal to the lesser of (i) the fair market value of the Series I Preferred Stock plus the amount of cash received and (ii) the gain realized in the exchange, except to the extent treated as dividend income as described below.
Dividend Non-Equivalence Tests. Upon receiving a combination of Series I Preferred Stock and cash in exchange for your Common Stock in the Exchange Offer, the cash that you receive, or the gain that you are required to recognize, as the case may be, generally will be treated either as dividend income or capital gain for U.S. federal income tax purposes, depending on a determination of whether the cash that you receive, or the gain that you recognize, as the case may be, is considered to have the effect of a dividend distribution for U.S. federal income tax purposes.
In order to make this determination, upon receiving a combination of Series I Preferred Stock and cash in exchange for your shares of Common Stock in the Exchange Offer, you will be treated as if (i) you had not participated in the Exchange Offer and instead exchanged all of your shares of Common Stock for shares of Series I Preferred Stock and (ii) immediately thereafter we redeemed a portion of your Series I Preferred Stock in exchange for cash in an amount equal to the cash that you received in the Exchange Offer. If the deemed redemption meets any of the “dividend non-equivalence tests” described below, your recognized gain will be treated as capital gain for U.S. federal income tax purposes. If the deemed redemption does not meet any of the “dividend non-equivalence tests” described below, your recognized gain will be treated as a dividend for U.S. federal income tax purposes to the extent of our current or accumulated earnings and profits.
The “dividend non-equivalence tests” are as follows:
| · | your percentage of our total outstanding voting shares that you actually and constructively own immediately following the Exchange Offer is less than 80% of the percentage of our total outstanding voting shares that you actually and constructively own immediately before the Exchange Offer, you have a similar reduction in your percentage ownership of our total outstanding Common Stock, and you actually and constructively own less than 50% of the total combined voting power of our outstanding stock immediately following the Exchange Offer; |
| · | as a result of the Exchange Offer, you no longer actually or constructively own any of our outstanding shares of stock; or |
| · | the Exchange Offer results in a meaningful reduction of your proportionate interest in our stock (which is determined based on your particular facts and circumstances; however, in certain circumstances, in the case of a stockholder holding a small minority (e.g., less than 1%) of our stock who does not exercise meaningful control over the affairs of the Company, even a small reduction of your proportionate interest in our stock may satisfy this test). |
48
In determining whether any of the “dividend non-equivalence tests” is satisfied, you must take into account not only shares of our stock that you actually own, but also shares of our stock that you constructively own, including shares of our stock actually owned, and in some cases constructively owned, by certain related individuals and certain entities in which you have an interest, or that have an interest in you.
Contemporaneous dispositions or acquisitions of shares by you (or persons or entities related to you) may be deemed to be part of a single integrated transaction which will be taken into account in determining whether any of the “dividend non-equivalence tests” have been satisfied with respect to shares of our Common Stock exchanged pursuant to the Exchange Offer. For example, if you sell shares of our Common Stock to persons other than us at or about the time you participate in the Exchange Offer, and these transactions are part of an overall plan to reduce or terminate your proportionate interest in our stock, then the sales to persons other than us may, for U.S. federal income tax purposes, be integrated with your exchange of shares of our Common Stock pursuant to the Exchange Offer and, if integrated, should be taken into account in determining whether you satisfy any of the “dividend non-equivalence tests” described above.
If you are contemplating participating in the exchange offer, we urge you to consult your tax advisors regarding the “dividend non-equivalence tests” described above, including the effect of the constructive ownership rules and the possibility that a substantially contemporaneous sale of shares of Common Stock to persons other than us may assist in satisfying one or more of the “dividend non-equivalence tests.”
Amounts Treated as Capital Gain or Loss. Any gain that is treated pursuant to the discussion above as capital gain generally will be treated as long-term capital gain if your holding period for the Common Stock exchanged is greater than one year at the time of the exchange. You generally will not be permitted to recognize any loss realized in the Exchange Offer. Your ability to deduct capital losses against ordinary income is subject to limitations. Capital gain that you recognize generally will be treated as a U.S.-source capital gain for U.S. foreign tax credit purposes.
Amounts Treated as Dividend Income. Any gain that is treated pursuant to the discussion above as dividend income generally will be taxable to you as dividend income to the extent of your ratable share of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. For amounts treated as dividends, a corporate U.S. holder may be eligible for the dividends-received deduction, and a non-corporate U.S. holder may be eligible for taxation at preferential rates applicable to “qualified dividend income,” in each case subject to applicable holding period and other requirements.
Ownership of Series I Preferred Stock
Stock Distributions and Constructive Distributions. A distribution on the Series I Preferred Stock paid in Common Stock or additional Series I Preferred Stock may constitute a taxable distribution under Section 305(b) of the Code. If such a distribution is taxable, a U.S. holder generally would include the fair market value of the distributed stock in income as a dividend to the extent of our current or accumulated earnings and profits, notwithstanding that the holder receives no cash with which to pay the resulting tax.
Dividend Payments. Distributions with respect to the Series I Preferred Stock will constitute dividends for U.S. federal income tax purposes to the extent made out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current or accumulated earnings and profits, the excess will be treated as a non-taxable return of capital to the extent of a U.S. holder’s adjusted tax basis in the Series I Preferred Stock, causing a reduction in such adjusted tax basis, but not below zero. Any remaining excess will be treated as capital gain and will be treated as described below under “—Gain on Disposition of Series I Preferred Stock.” For amounts treated as dividends, a corporate U.S. holder may be eligible for the dividends-received deduction and a non-corporate U.S. holder may be eligible for taxation at preferential rates applicable to “qualified dividend income,” in each case subject to applicable holding period and other requirements.
Redemption of Series I Preferred Stock. Subject to the potential application of Section 306 of the Code to the Series I Preferred Stock, discussed below, a redemption of the Series I Preferred Stock for cash will be treated as a sale or exchange if, taking into account the constructive ownership rules of Section 318 of the Code, the redemption (a) results in a complete termination of the U.S. holder’s interest in the Company under Section 302(b)(3) of the Code, (b) results in a substantially disproportionate redemption of stock with respect to the U.S. holder under Section 302(b)(2) of the Code or (c) is “not essentially equivalent to a dividend” with respect to the U.S. holder under Section 302(b)(1) of the Code. If the redemption is not treated as a sale or exchange, it will be taxable as a distribution in accordance with the rules described above under “—Dividend Payments.”
49
Gain on Disposition of Series I Preferred Stock. Subject to the potential application of Section 306 of the Code to the Series I Preferred Stock, discussed below, if a U.S. holder sells or otherwise disposes of Series I Preferred Stock other than by redemption as discussed above, the U.S. holder generally will recognize capital gain or loss equal to the difference between the amount realized upon the disposition and the U.S. holder’s adjusted tax basis in the Series I Preferred Stock. Capital gain of a non-corporate U.S. holder generally is taxed at preferential rates if the U.S. holder has a holding period greater than one year. The deductibility of capital losses is subject to limitations.
Section 306 Stock. Section 306 of the Code generally will apply to a sale or other disposition of the Series I Preferred Stock if such stock is treated as “Section 306 stock” within the meaning of Section 306(c) of the Code. The IRS has ruled that stock is other than common stock for this purpose if the stock does not participate in corporate growth to any significant extent. If the Series I Preferred Stock is treated as stock other than common stock, the Series I Preferred Stock received by a U.S. holder in the Exchange Offer generally may be treated as Section 306 stock if, in a hypothetical transaction otherwise identical to the Exchange Offer in which the U.S. holder received an equivalent amount of cash as a substitute for the Series I Preferred Stock, taking into account the cash actually received in the Exchange Offer, the receipt of such cash would be treated as a dividend and not as a sale or exchange for U.S. federal income tax purposes. If the Series I Preferred Stock constitutes Section 306 stock, Section 306 of the Code may apply to prohibit capital gain treatment on a subsequent disposition of the Series I Preferred Stock received in the Exchange Offer, in which case the amount realized by a U.S. holder, without reduction by the U.S. holder’s tax basis in such stock, on a subsequent taxable disposition of such stock generally could be treated as dividend income, if such disposition is a redemption, to the extent of our available earnings and profits at such time, or as ordinary income, if such disposition is other than a redemption, to the extent that the U.S. holder’s earlier receipt of the Series I Preferred Stock and cash in the Exchange Offer would have been treated as a dividend if we had distributed cash in lieu of the Series I Preferred Stock in the Exchange Offer. However, even if the Series I Preferred Stock is treated as Section 306 stock, the foregoing treatment may not apply if the U.S. holder establishes to the satisfaction of the IRS that neither the Exchange Offer nor the subsequent disposition of the Series I Preferred Stock is pursuant to a plan of which the avoidance of U.S. federal income tax is one of the principal purposes. U.S. holders are urged to consult their own tax advisors regarding the potential application of Section 306 of the Code to the Series I Preferred Stock.
Non-U.S. Holders
The following discussion applies to you only if you are a “non-U.S. holder.” A non-U.S. holder is a beneficial owner of shares of Common Stock that is neither a U.S. holder (as defined above) nor an entity or arrangement classified as a partnership for U.S. federal income tax purposes.
If you tender shares of Common Stock in the Exchange Offer, the exchange generally will be treated in the same manner as if you were a United States person, as described above. However:
| · | Any amounts that are treated pursuant to the discussion above as dividend income generally will be subject to U.S. federal income tax withholding at the rate of 30% on the gross amount of any such amount unless either (i) a lower treaty rate applies and the non-U.S. holder furnishes a properly completed IRS Form W-8BEN or W-8BEN-E evidencing eligibility for that reduced rate to the applicable withholding agent or (ii)_the non-U.S. holder furnishes a properly completed IRS Form W-8ECI to the applicable withholding agent claiming that such amount is effectively connected income. |
| · | Any amounts that are treated pursuant to the discussion above as capital gain generally will not be subject to U.S. federal income tax or withholding tax; unless, |
| · | (A) the gain is effectively connected with your conduct of a trade or business in the United States (and, if you are entitled to the benefits of an applicable income tax treaty with the United States with respect to that gain, that gain is attributable to a permanent establishment maintained by you in the United States); or |
50
| · | (B) you are an individual who is present in the United States for 183 days or more during the taxable year in which the gain is recognized and certain other conditions are met. |
Any income or gain that is effectively connected with your conduct of a trade or business in the United States (or so treated) generally will be subject to U.S. federal income tax, net of certain deductions, at regular U.S. federal income tax rates. If you are a corporation, your earnings and profits that are attributable to the effectively connected income (subject to certain adjustments) may be subject to an additional U.S. branch profits tax at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty).
Any gain described in clause (B) of the second bullet point above (net of certain U.S.-source losses) will be taxed at a flat rate of 30% (or such lower rate as may be specified by an applicable income tax treaty).
In addition, non-U.S. holders could be subject to tax under the Foreign Investment in Real Property Tax Act of 1980 (“FIRPTA”) with respect to the exchange of Common Stock for Series I Preferred Stock if the Common Stock constitutes a “United States real property interest” within the meaning of FIRPTA. Generally, shares of a “United States real property holding corporation” are United States real property interests. However, shares of Common Stock generally will not be treated as United States real property interests, and a non-U.S. holder generally will not be subject to tax under FIRPTA with respect to shares of Common Stock exchanged in the Exchange Offer, if the Common Stock is “regularly traded” on an established securities market and such non-U.S. holder owned, actually and constructively, 5% or less of the Common Stock at all times during the applicable testing period. If gain on the exchange of Common Stock were taxed under FIRPTA, a non-U.S. holder generally would be taxed in the same manner as a U.S. holder with respect to such gain.
Section 306 Stock. A payment made to a non-U.S. holder disposing of the Series I Preferred Stock may be treated as a dividend, rather than as a payment in exchange for such stock, in the circumstances discussed above under “—Ownership of Series I Preferred Stock—Section 306 Stock,” in which case the payment would be subject to U.S. federal income tax in the manner described above under “—Non-U.S. Holders.”
Information Reporting and Backup Withholding
In general, if you are a non-corporate U.S. holder and you tender shares of Common Stock in the Exchange Offer, any cash and stock paid to you pursuant to the Exchange Offer may be subject to information reporting requirements. In addition, certain U.S. holders will be subject to information reporting with respect to the payment of dividends on Series I Preferred Stock and the payment of proceeds on the sale or other disposition of shares of Series I Preferred Stock. Backup withholding may apply unless the U.S. holder provides proof of an applicable exemption or a correct taxpayer identification number and otherwise complies with applicable requirements of the backup withholding rules.
If you are a non-U.S. holder, you may be required to establish your exemption from information reporting and backup withholding by certifying your non-U.S. status on IRS Form W-8BEN, W-8BEN-E, W-8ECI or W-8IMY, as applicable. Unless a non-U.S. holder complies with certification procedures to establish that it is not a U.S. person, information returns may be filed with the IRS in connection with dividends on Series I Preferred Stock or proceeds from a sale or other disposition, including redemption, of Series I Preferred Stock, and the non-U.S. holder may be subject to backup withholding on such payments.
Backup withholding tax is not an additional tax. Rather, you generally may obtain a refund of any amounts withheld under backup withholding rules that exceed your income tax liability by accurately completing and timely filing a refund claim with the IRS.
Consequences of Not Participating in the Exchange Offer
Stockholders who do not participate in the Exchange Offer generally are not expected to incur any U.S. federal income tax liability solely as a result of the consummation of the Exchange Offer.
51
MISCELLANEOUS
We are not aware of any jurisdiction in which the making of the Exchange Offer is not in compliance with applicable law. If we become aware of any U.S. jurisdiction in which the making of the Exchange Offer would not be in compliance with applicable state law, we will make a good faith effort to comply with any such state law. If, after such good faith effort, we cannot comply with any such law, the Exchange Offer will not be made to (nor will tenders of any share of Common Stock be accepted from or on behalf of) the holders residing in such U.S. jurisdiction. To the extent required under the laws of certain states, the offer is deemed to be made through Georgeson, LLC.
No person has been authorized to give any information or make any representation on our behalf not contained in this Exchange Offer or in the related letter of transmittal and, if given or made, such information or representation must not be relied upon as having been authorized.
Recipients of this Offer to Exchange and the accompanying materials should not construe the contents hereof or thereof as legal, business or tax advice. Each recipient should consult its own attorney, business advisor and tax advisor as to legal, business, tax and related matters concerning the Exchange Offer.
CERTAIN SECURITIES LAWS CONSIDERATIONS
The issuance of any shares of Series I Preferred Stock upon exchange of the shares of Common Stock in this Exchange Offer is intended to be exempt from registration pursuant to Section 3(a)(9) of the Securities Act. We have no contract, arrangement or understanding relating to, and will not, directly or indirectly, pay any commission or other remuneration to any broker, dealer, salesperson, agent or any other person for soliciting tenders in the Exchange Offer. In addition, no broker, dealer, salesperson, agent or any other person is engaged or authorized to express any statement, opinion, recommendation or judgment with respect to the relative merits and risks of the Exchange Offer.
When securities are exchanged for other securities of an issuer under Section 3(a)(9), the securities received in essence assume the character of the exchanged securities for purposes of the Securities Act. Accordingly, the shares of our Series I Preferred Stock issued in exchange for shares of Common Stock that are freely tradable would be free of resale restrictions if held by persons that are not “affiliates” of ours within the meaning of Rule 405 of the Securities Act. Any shares of Common Stock issued in the Exchange Offer to persons or entities who are affiliated with us will not be freely tradable and any resale would have to be registered under the Securities Act, or comply with applicable exemptions under the securities laws, which may include Rule 144 under the Securities Act. You are urged to consult with your own legal counsel regarding the availability of a resale exemption from the registration requirements of the Securities Act.
WHERE YOU CAN FIND MORE INFORMATION
We are subject to the informational requirements of the Exchange Act and, in accordance therewith, file annual reports with and furnish other information to the SEC relating to our business, financial condition and other matters. The SEC maintains a website at www.sec.gov that contains reports, proxy statements and other information regarding issuers that file electronically with it.
We also have filed an Issuer Tender Offer Statement on Schedule TO with the SEC that includes additional information relating to the Offer. The Issuer Tender Offer Statement on Schedule TO, together with any exhibits and amendments thereto, may be examined and copies may be obtained at the same places and in the same manner as set forth above.
INCORPORATION BY REFERENCE
The rules of the SEC allow us to “incorporate by reference” information into this document, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The following documents contain important information about us and we incorporate them by reference (in each case, to the extent that the material contained therein is deemed “filed” rather than “furnished”):
| · | Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 15, 2026; |
52
| · | Quarterly Reports on Form 10-Q for the fiscal quarter ended March 31, 2026, filed with the SEC on May 18, 2026,the fiscal quarter ended June 30, 2026, filed with the SEC on August 19, 2026 and the fiscal quarter ended September 30, 2026 filed with the SEC on November 18, 2026; and |
| · | Current Reports on Form 8-K, filed with the SEC on January 16, 2026, January 20, 2026, February 13, 2026 (only with respect to Item 1.01), March 19, 2026, April 10, 2026, April 17, 2026 (only with respect to Item 5.03), May 11, 2026 (only with respect to Item 1.01), May 28, 2026 (only with respect to Item 1.02), June 11, 2026 (only with respect to Items 1.01 and 2.03), June 18, 2026 (only with respect to Item 1.01), June 24, 2026 (only with respect to Item 1.01), August 5, 2026, August 20, 2026, September 30, 2026, October 13, 2026 (only with respect to Item 1.01), November 9, 2026,November 16, 2026, November 17, 2026 and November 19, 2026 (only with respect to Item 5.03). |
Any statement contained in any document incorporated by reference into this Offer to Exchange shall be deemed to be modified or superseded to the extent that an inconsistent statement is made in this Offer to Exchange or any subsequently filed document. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Offer to Exchange.
You can obtain any of the documents incorporated by reference in this document from us or from the SEC’s website at the address described above. We will provide without charge to each person a copy of any and all of the documents referred to herein, who makes a written or oral request, by writing or calling us at the following address or telephone number:
Hyperscale Data, Inc.
11411 Southern Highlands Pkwy, Suite 190
Las Vegas, NV 89141
Attention: Corporate Secretary
Telephone: (949) 444-5464
Please be sure to include your complete name and address in your request. If you request any incorporated documents, we will promptly mail them to you by first class mail, or another equally prompt means. You may also find additional information by visiting our website at www.hyperscaledata.com and our investor relations website address is https://hyperscaledata.com/investor-relations. Information on or accessible through our website does not form part of the Exchange Offer and is not incorporated by reference in this Offer to Exchange.
53
The Exchange Agent for the Exchange Offer is:
Computershare Trust Company, N.A.
|
By First Class, Registered or Certified Mail: Computershare Trust Company, N.A. c/o Voluntary Corporate Actions PO Box 43011 Providence, RI 02940-3011 |
By Express or Overnight Delivery: c/o Voluntary Corporate Actions 150 Royall Street, Suite V Canton, MA 02021 |
The Information Agent for the Exchange Offer is:
51 West 52nd Street, 6th Floor
New York, NY 10019
Shareholders, Banks and Brokers
Call Toll Free: (888) 355-8425
54
Exhibit (a)(1)(B)
Letter of Transmittal to Exchange Shares of
Common Stock
HYPERSCALE DATA, INC.
for Units consisting of $2.00 in cash and one share of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock
Pursuant to its Offer to Exchange, dated November 20, 2026
The undersigned represents that I (we) have full authority to surrender without restriction the shares of Common Stock listed below. You are hereby authorized and instructed to deliver to the address indicated below (unless otherwise instructed in the boxes in the following page) units consisting of (i) a check representing a cash payment and (ii) newly issued shares of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (the “Series I Preferred Stock”) of Hyperscale Data, Inc. (“Hyperscale” or the “Company”), for each 100 shares of Class A Common Stock, par value $0.001 per share (the “Common Stock”), tendered pursuant to this Letter of Transmittal (as defined below), units consisting of (i) $2.00 in cash and (ii) one share of Series I Preferred Stock, per 100 shares of Common Stock so tendered, net to the seller and without interest and less any applicable withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Exchange, dated November 20,2026 (as amended or supplemented from time to time, the “Offer to Exchange”) and this Letter of Transmittal (as may be amended or supplemented from time to time, this “Letter of Transmittal”). The transactions described in the Offer to Exchange and this Letter of Transmittal are referred to herein as the “Exchange Offer.”
THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON DECEMBER 18, 2026 UNLESS THE EXCHANGE OFFER IS EXTENDED OR TERMINATED. |
Method of delivery of the certificate(s) is at
the option and risk of the owner thereof.
See Instruction 2.
Mail or deliver this Letter of Transmittal, together
with the certificate(s) representing your
shares of Common Stock, to:
Computershare Trust Company, N.A.
|
By First Class Mail: Computershare Trust Company, N.A. c/o Voluntary Corporate Actions PO Box 43011 Providence, RI 02940-3011 |
By Express or Overnight Delivery: c/o Voluntary Corporate Actions 150 Royall Street, Suite V Canton, MA 02021 |
Pursuant to the offer of Hyperscale to purchase up to 192,308,000 shares of Common Stock, the undersigned encloses herewith and surrenders the following shares of Common Stock:
| DESCRIPTION OF SHARES OF COMMON STOCK SURRENDERED | ||||
|
Name(s) and Address(es) of Registered Owner(s) (If blank, please fill in exactly as name(s) appear(s) on shares of Common Stock |
Shares of Common Stock Surrendered (attached additional list if necessary) | |||
| Shares of Common Stock | ||||
|
Certificate Number(s)* |
Total Number of Shares of Common Stock Represented by Certificate(s)* | Number of Shares of Common Stock Surrendered** | Book Entry Shares of Common Stock Surrendered | |
| Total Shares | ||||
| * | Need not be completed by book-entry stockholders. |
| ** | Unless otherwise indicated, it will be assumed that all shares of Common Stock are being surrendered hereby. |
| *** | Common Stock may only be tendered in increments of 100 shares, with each 100 shares of Common Stock being exchangeable in the Offer for (a) $2.00 and (b) one share of Series I Preferred Stock. |
PLEASE READ THE INSTRUCTIONS ACCOMPANYING THIS LETTER OF TRANSMITTAL CAREFULLY BEFORE COMPLETING THIS LETTER OF TRANSMITTAL.
IF YOU WOULD LIKE ADDITIONAL COPIES OF THIS LETTER OF TRANSMITTAL OR ANY OF THE OTHER OFFERING DOCUMENTS, YOU SHOULD CONTACT THE INFORMATION AGENT, GEORGESON LLC, AT (888) 355-8425.
You have received this Letter of Transmittal in connection with the offer of Hyperscale to purchase up to 192,308,000 shares of Common Stock for units consisting of (i) $2.00 in cash and (ii) one share of Series I Preferred Stock, per 100 shares of Common Stock, net to the seller and without interest and less any applicable withholding taxes, as described in the Offer to Exchange.
2
You should use this Letter of Transmittal to deliver to Computershare Trust Company, N.A. (the “Exchange Agent”) shares of Common Stock represented by stock certificates, or held in book-entry form on the books of Hyperscale, for tender. If you are delivering your shares of Common Stock by book-entry transfer to an account maintained by the Exchange Agent at The Depository Trust Company (“DTC”), you must use an Agent’s Message (as defined in Instruction 2 below). In this Letter of Transmittal, stockholders who deliver certificates representing their shares of Common Stock are referred to as “Certificate Stockholders,” and stockholders who deliver their shares of Common Stock through book-entry transfer are referred to as “Book-Entry Stockholders.”
| ☐ | CHECK HERE IF TENDERED SHARES OF COMMON STOCK ARE BEING DELIVERED BY BOOK-ENTRY TRANSFER TO THE ACCOUNT MAINTAINED BY THE EXCHANGE AGENT WITH DTC AND COMPLETE THE FOLLOWING (ONLY FINANCIAL INSTITUTIONS THAT ARE PARTICIPANTS IN DTC MAY DELIVER SHARES OF COMMON STOCK BY BOOK-ENTRY TRANSFER): |
Name of Tendering Institution:
DTC Participant Number:
Transaction Code Number:
NOTE: SIGNATURES MUST BE PROVIDED BELOW.
PLEASE READ THE ACCOMPANYING INSTRUCTIONS CAREFULLY.
3
Ladies and Gentlemen:
The undersigned hereby tenders to Hyperscale Data, Inc., a Delaware corporation (“Hyperscale” or the “Company”), the above-described shares of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”), for units consisting of (i) $2.00 in cash and (ii) one share of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (the “Series I Preferred Stock”), per 100 shares of Common Stock so tendered, net to the seller and without interest and less any applicable withholding taxes, on the terms and subject to the conditions set forth in the Offer to Exchange, dated November 20,2026 (as may be amended or supplemented from time to time, the “Offer to Exchange”), receipt of which is hereby acknowledged, and this Letter of Transmittal (as may be amended or supplemented from time to time, this “Letter of Transmittal”). Common Stock may only be tendered in increments of 100 shares. The transactions described in the Offer to Exchange and this Letter of Transmittal are referred to herein as the “Exchange Offer.”
On the terms and subject to the conditions of the Exchange Offer (including, if the Exchange Offer is extended or amended, the terms and conditions of such extension or amendment), subject to, and effective upon, acceptance for payment and payment for the shares of Common Stock validly tendered herewith, and not properly withdrawn, prior to the expiration date, in accordance with the terms of the Exchange Offer, the undersigned hereby sells, assigns and transfers to, or upon the order of, the Company, all right, title and interest in and to all of the shares Common Stock being tendered hereby and releases and discharges the Company and the officers and directors of the Company, from any and all claims the undersigned may have now, or may have in the future, arising out of, or related to, such shares of Common Stock. By tendering shares in accordance with the procedures set forth herein, the undersigned hereby irrevocably appoints the Company the true and lawful agent and attorney-in-fact and proxy of the undersigned with respect to such shares of Common Stock with full power of substitution (such proxies and power of attorney being deemed to be an irrevocable power coupled with an interest in the tendered shares) to the full extent of such stockholder’s rights with respect to such shares of Common Stock (a) to deliver certificates representing shares of Common Stock (the “Share Certificates”), or transfer of ownership of such shares of Common Stock on the account books maintained by The Depository Trust Company (“DTC”), together, in either such case, with all accompanying evidence of transfer and authenticity, to or upon the order of the Company, (b) to present such shares of Common Stock for transfer on the books of Hyperscale, and (c) to receive all benefits and otherwise exercise all rights of beneficial ownership of such shares of Common Stock, all in accordance with the terms and subject to the conditions of the Exchange Offer.
The undersigned hereby irrevocably appoints each of the designees of the Company the attorneys-in-fact and proxies of the undersigned, each with full power of substitution, to the full extent of such stockholder’s rights with respect to the shares of Common Stock tendered hereby which have been accepted for payment. The designees of the Company will, with respect to the shares of Common Stock for which the appointment is effective, be empowered to exercise all voting and any other rights of such stockholder, as they, in their sole discretion, may deem proper at any annual, special, adjourned or postponed meeting of Hyperscale’s stockholders, by written consent in lieu of any such meeting or otherwise. This proxy and power of attorney shall be irrevocable and coupled with an interest in the tendered shares of Common Stock. Such appointment is effective when, and only to the extent that, the Company accepts the shares of Common Stock tendered with this Letter of Transmittal for payment pursuant to the Exchange Offer. Upon the effectiveness of such appointment, without further action, all prior powers of attorney, proxies and consents given by the undersigned with respect to such shares of Common Stock will be revoked and no subsequent powers of attorney, proxies, consents or revocations may be given (and, if given, will not be deemed effective). The Company reserves the right to require that, in order for shares of Common Stock to be deemed validly tendered, immediately upon the Company’s acceptance for payment of such shares of Common Stock, the Company must be able to exercise full voting, consent and other rights, to the extent permitted under applicable law, with respect to such shares of Common Stock, including voting at any meeting of stockholders or executing a written consent concerning any matter.
4
The undersigned hereby represents and warrants that the undersigned has full power and authority to tender, sell, assign and transfer the shares of Common Stock tendered hereby and, when the same are accepted for payment by the Company, the Company will acquire good, marketable and unencumbered title thereto, free and clear of all liens, restrictions, charges and encumbrances and the same will not be subject to any adverse claim. The undersigned hereby represents and warrants that the undersigned is the registered owner of the shares of Common Stock, or the Share Certificates have been endorsed to the undersigned in blank, or the undersigned is a participant in DTC whose name appears on a security position listing as the owner of the shares of Common Stock. The undersigned will, upon request, execute and deliver any additional documents deemed by the Exchange Agent or the Company to be necessary or desirable to complete the sale, assignment and transfer of the shares of Common Stock tendered hereby. The undersigned hereby represents and warrants that (i) the undersigned has a net long position in the shares of Common Stock tendered hereby within the meaning of Rule 14e-4 under the Securities Exchange Act of 1934, as amended (“Rule 14e-4”) and (ii) the tender of the shares of Common Stock tendered hereby complies with Rule 14e-4.
It is understood that the undersigned will not receive payment for the shares of Common Stock unless and until the shares of Common Stock are accepted for payment and until the Share Certificate(s) owned by the undersigned are received by the Exchange Agent at the address set forth above, together with such additional documents as the Exchange Agent may require, or, in the case of share of Common Stock held in book-entry form, ownership of shares of Common Stock is validly transferred on the account books maintained by DTC, and until the same are processed for payment by the Exchange Agent.
IT IS UNDERSTOOD THAT THE METHOD OF DELIVERY OF THE SHARES OF COMMON STOCK, THE SHARE CERTIFICATE(S) AND ALL OTHER REQUIRED DOCUMENTS (INCLUDING DELIVERY THROUGH DTC) IS AT THE OPTION AND RISK OF THE UNDERSIGNED AND THAT THE RISK OF LOSS OF SUCH SHARES OF COMMON STOCK, SHARE CERTIFICATE(S) AND OTHER DOCUMENTS SHALL PASS ONLY AFTER THE EXCHANGE AGENT HAS ACTUALLY RECEIVED THE SHARES OF COMMON STOCK OR SHARE CERTIFICATE(S) (INCLUDING, IN THE CASE OF A BOOK-ENTRY TRANSFER, BY BOOK-ENTRY CONFIRMATION (AS DEFINED BELOW)). IF DELIVERY IS BY MAIL, IT IS RECOMMENDED THAT ALL SUCH DOCUMENTS BE SENT BY PROPERLY INSURED REGISTERED MAIL WITH RETURN RECEIPT REQUESTED. IN ALL CASES, SUFFICIENT TIME SHOULD BE ALLOWED TO ENSURE TIMELY DELIVERY.
All authority conferred or agreed to be conferred pursuant to this Letter of Transmittal shall not be affected by, and shall survive, the death or incapacity of the undersigned and any obligation of the undersigned hereunder shall be binding upon the heirs, executors, administrators, trustees in bankruptcy, personal representatives, successors and assigns of the undersigned. Except as stated in the Offer to Exchange, this tender is irrevocable.
The undersigned understands that the acceptance for payment by the Company of shares of Common Stock tendered pursuant to one of the procedures described in the Offer to Exchange in the section entitled “The Exchange Offer—Procedure for Tendering” and in the instructions hereto will constitute a binding agreement between the undersigned and the Company upon the terms and subject to the conditions of the Exchange Offer.
5
Unless otherwise indicated herein under “Special Payment Instructions,” please issue the check and shares of Series I Preferred Stock for the purchase price in the name(s) of, and/or return any Share Certificates representing shares of Common Stock not tendered or accepted for payment to, the registered owner(s) appearing under “Description of Common Stock Surrendered.” Similarly, unless otherwise indicated under “Special Delivery Instructions,” please mail the check and issue the shares of Series I Preferred Stock for the purchase price and/or return any Share Certificates representing shares of Common Stock not tendered or accepted for payment (and any accompanying documents, as appropriate) to the address(es) of the registered owner(s) appearing under “Description of shares of Common Stock Surrendered.” In the event that both the Special Delivery Instructions and the Special Payment Instructions are completed, please issue the check and shares of Series I Preferred Stock for the purchase price and/or issue any Share Certificates representing shares of Common Stock not tendered or accepted for payment (and any accompanying documents, as appropriate) in the name of, and deliver such check, shares of Series I Preferred Stock, and/or return such Share Certificate(s) (and any accompanying documents, as appropriate) to, the person or persons so indicated. Unless otherwise indicated herein in the box titled “Special Payment Instructions,” please credit any shares of Common Stock tendered hereby or by an Agent’s Message and delivered by book-entry transfer, but which are not purchased, by crediting the account at DTC designated above. The undersigned recognizes that the Company has no obligation pursuant to the Special Payment Instructions to transfer any shares of Common Stock from the name of the registered owner thereof if the Company does not accept for payment any of the shares of Common Stock so tendered.
6
SPECIAL PAYMENT INSTRUCTIONS
(See Instructions 1, 4, 5 and 7)
To be completed ONLY if Share Certificate(s) not tendered or not accepted for payment and/or the check or shares of Series I Preferred Stock for the purchase price in consideration of shares of Common Stock accepted for payment are to be issued in the name of someone other than the undersigned or if shares of Common Stock tendered by book-entry transfer which are not accepted for payment are to be returned by credit to an account maintained at DTC other than that designated above.
Issue: ☐ Check(s) and/or ☐ Shares of Series I Preferred Stock and/or ☐ Common Stock Share Certificates to:
| Name: | |
| (Please Print) | |
| Address: | |
| (Include Zip Code) | |
| (Tax Identification or Social Security Number) | |
| ☐ Credit shares of Common Stock tendered by book-entry transfer that are not accepted for payment to the DTC account set forth below. | |
| (DTC Account Number) | |
SPECIAL DELIVERY INSTRUCTIONS
(See Instructions 1, 4, 5 and 7)
To be completed ONLY if the Share Certificate (s) not tendered or not accepted for payment and/or the check and shares of Series I Preferred Stock for the purchase price of shares of Common Stock accepted for payment are to be sent to someone other than the undersigned or to the undersigned at an address other than that shown in the box titled “Description of Shares Surrendered” above.
Deliver: ☐ Check(s) and/or ☐ Shares of Series I Preferred Stock and/or ☐ Common Stock Share Certificates to:
| Name: | |
| (Please Print) | |
| Address: | |
| (Include Zip Code) |
7
|
IMPORTANT—SIGN HERE (U.S. Holders Please Also Complete the Enclosed IRS Form W-9) (Non-U.S. Holders Please Obtain and Complete IRS Form W-8BEN, Form W-8BEN-E or Other Applicable IRS Form W-8) | |
| (Signature(s) of Stockholder(s)) |
Dated: ______________, 2026
(Must be signed by registered owner(s) exactly as name(s) appear(s) on Share Certificate(s) or on a security position listing or by person(s) authorized to become registered owner(s) by certificates and documents transmitted herewith. If signature is by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, please set forth full title and see Instruction 5. For information concerning signature guarantees, see Instruction 1.)
| Name(s): | |
| (Please Print) | |
| Capacity (full title): | |
| Address: | |
| (Include Zip Code) | |
|
Area Code and Telephone Number: |
|
|
Tax Identification or Social Security No.: |
8
GUARANTEE OF SIGNATURE(S)
(For use by Eligible Institutions only;
see Instructions 1 and 5)
| Name of Firm: | |
| (Include Zip Code) | |
| Authorized Signature: | |
| Name: | |
| (Please Type or Print) | |
|
Area Code and Telephone Number: |
|
| Dated: _________, 2026 | |
| Place medallion guarantee in space below: |
9
INSTRUCTIONS
Forming Part of the Terms and Conditions of the Exchange Offer
1. Guarantee of Signatures. Except as otherwise provided below, all signatures on this Letter of Transmittal must be guaranteed by a financial institution (including most commercial banks, savings and loan associations and brokerage houses) that is a member in good standing of a recognized Medallion Program approved by the Securities Transfer Association, Inc., including the Security Transfer Agents Medallion Program, the New York Stock Exchange Medallion Signature Program and the Stock Exchanges Medallion Program (each, an “Eligible Institution”). Signatures on this Letter of Transmittal need not be guaranteed (a) if this Letter of Transmittal is signed by the registered owner(s) (which term, for purposes of this document, includes any participant in any of DTC’s systems whose name appears on a security position listing as the owner of the shares of Common Stock) of shares of Common Stock tendered herewith and such registered owner has not completed the box titled “Special Payment Instructions” or the box titled “Special Delivery Instructions” on this Letter of Transmittal or (b) if such shares of Common Stock are tendered for the account of an Eligible Institution. See Instruction 5.
2. Delivery of Letter of Transmittal and Certificates or Book-Entry Confirmations. This Letter of Transmittal is to be completed by stockholders if Share Certificates are to be forwarded herewith. If tenders are to be made pursuant to the procedures for tender by book-entry transfer set forth in the Offer to Exchange in the section entitled “The Exchange Offer—Procedure for Tendering”, an Agent’s Message (as defined below) must be utilized. A manually executed facsimile of this document may be used in lieu of the original. Share Certificates representing all physically tendered shares of Common Stock, or confirmation of any book-entry transfer into the Exchange Agent’s account at DTC of shares of Common Stock tendered by book-entry transfer (“Book Entry Confirmation”), as well as this Letter of Transmittal properly completed and duly executed with any required signature guarantees, or an Agent’s Message in the case of a book-entry transfer, and any other documents required by this Letter of Transmittal, must be received by the Exchange Agent at its address set forth herein prior to the expiration date. Please do not send your Share Certificates directly to the Company.
A properly completed and duly executed Letter of Transmittal (or facsimile thereof) must accompany each such delivery of Share Certificates to the Exchange Agent. The term “Agent’s Message” means a message, transmitted through electronic means by DTC to, and received by, the Exchange Agent and forming part of a Book-Entry Confirmation, which states that DTC has received an express acknowledgment from the participant in DTC tendering the shares of Common Stock which are the subject of such Book-Entry Confirmation that such participant has received and agrees to be bound by the terms of this Letter of Transmittal and that the Company may enforce such agreement against the participant. The term “Agent’s Message” also includes any hard copy printout evidencing such message generated by a computer terminal maintained at the Exchange Agent’s office.
THE METHOD OF DELIVERY OF THE SHARES OF COMMON STOCK, THIS LETTER OF TRANSMITTAL AND ALL OTHER REQUIRED DOCUMENTS, INCLUDING DELIVERY THROUGH DTC, IS AT THE ELECTION AND RISK OF THE TENDERING STOCKHOLDER. DELIVERY OF ALL SUCH DOCUMENTS WILL BE DEEMED MADE AND RISK OF LOSS OF THE SHARE CERTIFICATES SHALL PASS ONLY WHEN ACTUALLY RECEIVED BY THE EXCHANGE AGENT (INCLUDING, IN THE CASE OF A BOOK-ENTRY TRANSFER, BY BOOK-ENTRY CONFIRMATION). IF SUCH DELIVERY IS BY MAIL, IT IS RECOMMENDED THAT ALL SUCH DOCUMENTS BE SENT BY PROPERLY INSURED REGISTERED MAIL WITH RETURN RECEIPT REQUESTED. IN ALL CASES, SUFFICIENT TIME SHOULD BE ALLOWED TO ENSURE TIMELY DELIVERY.
10
No alternative, conditional or contingent tenders will be accepted. All tendering stockholders, by execution of this Letter of Transmittal (or facsimile thereof), waive any right to receive any notice of the acceptance of their shares of Common Stock for payment.
All questions as to validity, form and eligibility (including time of receipt) of the surrender of any Share Certificates hereunder, including questions as to the proper completion or execution of any Letter of Transmittal or other required documents and as to the proper form for transfer of any Share Certificates, will be determined by the Company in its sole and absolute discretion (which may delegate power in whole or in part to the Exchange Agent) which determination will be final and binding. The Company reserves the absolute right to reject any and all tenders determined by it not to be in proper form or the acceptance for payment of or payment for which may be unlawful. The Company also reserves the absolute right to waive any defect or irregularity in the surrender of any shares of Common Stock or Share Certificate(s) whether or not similar defects or irregularities are waived in the case of any other stockholder. A surrender will not be deemed to have been validly made until all defects and irregularities have been cured or waived. The Company and the Exchange Agent shall make reasonable efforts to notify any person of any defect in any Letter of Transmittal submitted to the Exchange Agent.
3. Inadequate Space. If the space provided herein is inadequate, the certificate numbers and/or the number of shares of Common Stock should be listed on a separate schedule attached hereto and separately signed on each page thereof in the same manner as this Letter of Transmittal is signed.
4. Partial Tenders (Applicable to Certificate Stockholders Only). If fewer than all the shares of Common Stock evidenced by any Share Certificate delivered to the Exchange Agent are to be tendered, fill in the number of shares of Common Stock which are to be tendered in the column titled “Number of Shares of Common Stock Surrendered” in the box titled “Description of Shares of Common Stock Surrendered.” In such cases, new certificate(s) for the remainder of the shares of Common Stock that were evidenced by the old certificate(s) but not tendered will be sent to the registered owner, unless otherwise provided in the appropriate box on this Letter of Transmittal, as soon as practicable after the expiration date. All shares of Common Stock represented by Share Certificates delivered to the Exchange Agent will be deemed to have been tendered unless otherwise indicated.
5. Signatures on Letter of Transmittal; Stock Powers and Endorsements. If this Letter of Transmittal is signed by the registered owner(s) of the shares of Common Stock tendered hereby, the signature(s) must correspond with the name(s) as written on the face of the Share Certificate(s) without alteration or any other change whatsoever.
If any shares of Common Stock tendered hereby are owned of record by two or more joint owners, all such owners must sign this Letter of Transmittal.
If any tendered shares of Common Stock are registered in the names of different holder(s), it will be necessary to complete, sign and submit as many separate Letters of Transmittal (or facsimiles thereof) as there are different registrations of such shares of Common Stock.
If this Letter of Transmittal or any certificates or stock powers are signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing, and proper evidence satisfactory to the Company of their authority so to act must be submitted.
If this Letter of Transmittal is signed by the registered owner(s) of the shares of Common Stock listed and transmitted hereby, no endorsements of Share Certificates or separate stock powers are required unless payment is to be made to, or Share Certificates representing shares of Common Stock not tendered or accepted for payment are to be issued in the name of, a person other than the registered owner(s), in which case the Share Certificates representing the shares of Common Stock tendered by this Letter of Transmittal must be endorsed or accompanied by appropriate stock powers, in either case, signed exactly as the name(s) of the registered owner(s) or holder(s) appear(s) on the Share Certificates. Signatures on such Share Certificates or stock powers must be guaranteed by an Eligible Institution.
11
If this Letter of Transmittal is signed by a person other than the registered owner(s) of the shares of Common Stock listed, the Share Certificates must be endorsed or accompanied by the appropriate stock powers, in either case, signed exactly as the name or names of the registered owner(s) or holder(s) appear(s) on the Share Certificates. Signatures on such Share Certificates or stock powers must be guaranteed by an Eligible Institution.
6. Transfer Taxes. The Company will pay any transfer taxes with respect to the transfer and sale of shares of Common Stock to it or to its order pursuant to the Exchange Offer (for the avoidance of doubt, transfer taxes do not include United States federal income, withholding, or backup withholding taxes). If, however, payment of the purchase price is to be made to, or (in the circumstances permitted hereby) if Share Certificates not tendered or accepted for payment are to be registered in the name of, any person other than the registered owner(s), or if tendered Share Certificates are registered in the name of any person other than the person signing this Letter of Transmittal, the amount of any transfer taxes (whether imposed on the registered owner(s) or such person) payable on account of the transfer to such person will be deducted from the purchase price unless satisfactory evidence of the payment of such taxes, or exemption therefrom, is submitted.
Except as provided in this Instruction 6, it will not be necessary for transfer tax stamps to be affixed to the Share Certificates listed in this Letter of Transmittal.
7. Special Payment and Delivery Instructions. If a check and/or shares of Series I Preferred Stock for the purchase price is to be issued, and/or Share Certificates representing shares of Common Stock not tendered or accepted for payment are to be issued or returned to, a person other than the signer(s) of this Letter of Transmittal or to an address other than that shown in the box titled “Description of Shares Surrendered” above, the appropriate boxes on this Letter of Transmittal should be completed. Stockholders delivering shares of Common Stock tendered hereby or by Agent’s Message by book-entry transfer may request that shares of Common Stock not purchased be credited to an account maintained at DTC as such stockholder may designate in the box titled “Special Payment Instructions” herein. If no such instructions are given, all such shares of Common Stock not purchased will be returned by crediting the same account at DTC as the account from which such shares of Common Stock were delivered.
8. Requests for Assistance or Additional Copies. Questions or requests for assistance may be directed to the Information Agent at their respective addresses and telephone numbers set forth below or to your broker, dealer, commercial bank or trust company. Additional copies of the Offer to Exchange, this Letter of Transmittal, and other tender offer materials may be obtained from either the Information Agent as set forth below, and will be furnished at the Company’s expense.
9. Backup Withholding. Under U.S. federal income tax laws, the Exchange Agent will be required to withhold a portion of any payments made to certain stockholders pursuant to the Exchange Offer, as applicable. In order to avoid such backup withholding, each tendering stockholder or payee that is a United States person (for U.S. federal income tax purposes), must provide the Exchange Agent with such stockholder’s or payee’s correct taxpayer identification number (“TIN”) and certify that such stockholder or payee is not subject to such backup withholding by completing the enclosed Form W-9. Certain stockholders or payees (including, among others, corporations, non-resident foreign individuals and foreign entities) are not subject to these backup withholding and reporting requirements. A tendering stockholder who is a foreign individual or a foreign entity (as defined for United States federal income tax purposes) should complete, sign, and submit to the Exchange Agent the appropriate Form W-8. The applicable Form W-8 may be obtained from the Exchange Agent or downloaded from the Internal Revenue Service’s website at the following address: https://www.irs.gov. Such stockholders should consult a tax advisor to determine which Form W-8 is appropriate. Failure to complete the Form W-9 will not, by itself, cause shares of Common Stock to be deemed invalidly tendered, but may require the Exchange Agent to withhold a portion of any payments made of the offer price pursuant to the Exchange Offer.
12
NOTE: FAILURE TO COMPLETE AND RETURN THE FORM W-9 MAY RESULT IN BACKUP WITHHOLDING OF A PORTION OF ANY PAYMENTS MADE TO YOU PURSUANT TO THE OFFER. PLEASE REVIEW THE “IMPORTANT TAX INFORMATION” SECTION BELOW.
10. Lost, Destroyed, Mutilated or Stolen Share Certificates. If any Share Certificate(s) has been lost, destroyed, mutilated or stolen, the stockholder should promptly notify Hyperscale’s transfer agent, Computershare Trust Company, N.A. at (800) 962-4284. The stockholder will then be instructed as to the steps that must be taken in order to replace the Share Certificate(s).
This Letter of Transmittal and related documents cannot be processed until the procedures for replacing lost, mutilated, destroyed or stolen Share Certificate(s) have been followed.
11. Waiver of Conditions. Subject to the terms and conditions of the Offer to Exchange and the applicable rules and regulations of the Securities and Exchange Commission, the conditions of the Exchange Offer may be waived by the Company in whole or in part at any time and from time to time in its sole discretion.
IMPORTANT: THIS LETTER OF TRANSMITTAL (OR A MANUALLY EXECUTED FACSIMILE COPY THEREOF) OR AN AGENT’S MESSAGE, TOGETHER WITH THE SHARE CERTIFICATE(S) OR BOOK-ENTRY CONFIRMATION AND ALL OTHER REQUIRED DOCUMENTS, MUST BE RECEIVED BY THE EXCHANGE AGENT PRIOR TO THE EXPIRATION DATE.
IMPORTANT TAX INFORMATION
Under United States federal income tax law, a stockholder that is a non-exempt United States person (for U.S. federal income tax purposes) whose tendered shares of Common Stock are accepted for payment is required by law to provide the Exchange Agent (as payer) with such stockholder’s correct TIN on the enclosed Form W-9. If such stockholder is an individual, the TIN is such stockholder’s social security number. If the Exchange Agent is not provided with the correct TIN, the stockholder may be subject to penalties imposed by the Internal Revenue Service (“IRS”) and payments that are made to such stockholder with respect to the Exchange Offer may be subject to backup withholding.
If backup withholding applies, the Exchange Agent is required to withhold 24% of any payments of the purchase price made to the stockholder. Backup withholding is not an additional tax. Rather, the tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund or credit may be obtained from the IRS provided that the required information is furnished to the IRS.
13
Form W-9
To prevent backup withholding on payments that are made to a United States stockholder pursuant to the Exchange Offer, the stockholder is required to notify the Exchange Agent of such stockholder’s correct TIN by completing Form W-9 certifying, under penalties of perjury, (i) that the TIN provided on Form W-9 is correct (or that such stockholder is awaiting a TIN), (ii) that such stockholder is not subject to backup withholding because (a) such stockholder has not been notified by the IRS that such stockholder is subject to backup withholding as a result of a failure to report all interest or dividends, (b) the IRS has notified such stockholder that such stockholder is no longer subject to backup withholding or (c) such stockholder is exempt from backup withholding, and (iii) that such stockholder is a U.S. person.
What Number to Give the Exchange Agent
Each United States stockholder is generally required to give the Exchange Agent its social security number or employer identification number.
Please consult your accountant or tax advisor for further guidance regarding the completion of IRS Form W-9, IRS Form W-8BEN or Form W-8BEN-E, or another version of IRS Form W-8 to claim exemption from backup withholding, or contact the Exchange Agent.
14

15

16

17

18

19

20
The Exchange Agent for the Offer to Exchange is:
Computershare Trust Company, N.A.
|
By First Class Mail: Computershare Trust Company, N.A. c/o Voluntary Corporate Actions PO Box 43011 Providence, RI 02940-3011 |
By Express or Overnight Delivery: c/o Voluntary Corporate Actions 150 Royall Street, Suite V Canton, MA 02021 |
Delivery of this Letter of Transmittal to an address other than as set forth above will not constitute a valid delivery to the Depositary.
Questions and requests for assistance may be directed to the Information Agent at its addresses set forth below. Additional copies of the Offer to Exchange, this Letter of Transmittal and the Notice of Guaranteed Delivery may be obtained from the Information Agent. You may also contact your bank, broker, dealer, trust company or other nominee for assistance concerning the Offer.
The Information Agent for the Offer is:
Georgeson LLC
51 West 52nd Street, 6th Floor
New York, NY 10019
Attn.: Relationship Manager
Shareholders, Banks and Brokers
Call Toll Free: (888) 355-8425
21
Exhibit (a)(1)(C)
NOTICE OF GUARANTEED DELIVERY
For Common Stock
Hyperscale Data, Inc.
Offer to Exchange up to 192,308,000 shares of its Common Stock (in 100 share increments)
for
Units Consisting of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock and Cash
This form or one substantially equivalent hereto must be used by holders of shares of outstanding Class A Common Stock, par value $0.001 per share (the “Common Stock”), of Hyperscale Data, Inc. (“Company” or “Hyperscale”) who wish to tender their shares of Common Stock in exchange for units consisting of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (“Series I Preferred Stock”) and cash, with each 100 shares of Common Stock being exchangeable in the Exchange Offer for units (the “Units”) consisting of (a) one share of Series I Preferred Stock having a liquidation preference of $24.00 per share of Series I Preferred Stock and (b) $2.00 in cash, upon the terms and subject to the conditions set forth in the Offer to Exchange (as amended and supplemented from time to time, the “Offer to Exchange”) and the related offer materials (the “Exchange Offer”) in the event the holder’s shares of Common Stock are not immediately available or if such holder cannot deliver its shares and letter of transmittal (as amended and supplemented from time to time, the “Letter of Transmittal”) (and any other documents required by the Letter of Transmittal) to Computershare Trust Company, N.A. (the “Exchange Agent”) prior to one minute following 11:59 P.M, New York City time, on December 18, 2026 unless extended by the Company (such date and time for the Exchange Offer, as the same may be extended, the “Expiration Date”) or if compliance with book entry transfer procedures cannot be effected on a timely basis.
This Notice of Guaranteed Delivery may be sent by mail to the Exchange Agent. Capitalized terms used but not defined herein have the meaning given to them in the Offer to Exchange.
The Exchange Agent for the Offer is
COMPUTERSHARE TRUST COMPANY, N.A.
|
By First Class Mail: Computershare Trust Company, N.A. c/o Voluntary Corporate Actions PO Box 43011
Providence, RI 02940-3011 |
By Express or Overnight Delivery: Computershare Trust Company, N.A. c/o Voluntary Corporate Actions 150 Royall Street, Suite V
Canton, MA 02021 |
If you have questions or need assistance, please contact Georgeson at (888) 355-8425.
DELIVERY OF THIS NOTICE OF GUARANTEED DELIVERY TO AN ADDRESS OTHER THAN AS SET FORTH ABOVE WILL NOT CONSTITUTE A VALID DELIVERY.
This Notice of Guaranteed Delivery is not to be used to guarantee signatures. If a signature on a Letter of Transmittal is required to be guaranteed by an eligible institution (as defined in the Offer to Exchange), such signature guarantee must appear in the applicable space provided on the Letter of Transmittal for Signature Guarantee.
Ladies and Gentlemen:
The undersigned hereby tenders to the Company shares of its Common Stock, upon the terms and subject to the conditions contained in the Offer to Exchange and the Letter of Transmittal, receipt of which is hereby acknowledged.
The Company urges all holders of shares of Common Stock to read the Offer to Exchange, including those sections that compare the rights, preferences, powers and privileges of the holders of Common Stock and the holders of Series I Preferred Stock.
The undersigned agrees that tenders of shares of Common Stock pursuant to the Offer to Exchange may be withdrawn at any time prior to the Expiration Date as provided in the Offer to Exchange. All authority herein conferred or agreed to be conferred by this Notice of Guaranteed Delivery shall survive the death or incapacity of the undersigned and every obligation of the undersigned under this Notice of Guaranteed Delivery shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy and other legal representatives of the undersigned.
| Name(s) and Addresses of Registered Holder(s) (Please fill-in) |
Shares of Common Stock Tendered* |
| Total |
| * | Common Stock may only be tendered in increments of 100 shares, with each 100 shares of Common Stock being exchangeable in the Exchange Offer for the Units consisting of one share of Series I Preferred Stock and $2.00 in cash. |
2
IMPORTANT: THIS NOTICE OF GUARANTEED DELIVERY MUST BE RECEIVED
BY THE EXCHANGE AGENT PRIOR TO ONE MINUTE FOLLOWING 11:59 P.M., NEW YORK CITY TIME, ON THE
EXPIRATION DATE.
PLEASE SIGN HERE
| X | 2026 | |||
| X | 2026 | |||
| X | 2026 | |||
| X | 2026 | |||
| Signature(s) of Holders | Date |
|
Area Code and Telephone Number: |
If a holder is tendering any shares of Common Stock, the above must be signed by the registered holder(s) as the name(s) appear(s) on the certificate(s) for the shares of Common Stock or by any person(s) authorized to become registered holder(s) by endorsements and documents transmitted herewith. If signature is by a trustee, executor, administrator, guardian, officer or other person acting in a fiduciary or representative capacity, please set forth full title and provide proper evidence of such fiduciary’s authority to so act.
Please print name(s) and address(es)
|
Name(s) |
|
Capacity: |
|
Address: |
| ☐ The Depository Trust Company (Check if shares will be tendered by book-entry transfer) |
|
Account Number: |
3
THE GUARANTEE ON THE FOLLOWING PAGE MUST BE
COMPLETED.
GUARANTEE OF DELIVERY
(NOT TO BE USED FOR SIGNATURE GUARANTEE)
The undersigned, an “eligible guarantor institution” and member of a recognized signature guarantee medallion program within the meaning of Rule 17Ad-15 under the Securities Exchange Act of 1934, as amended, hereby guarantees to deliver to the Exchange Agent at one of its addresses set forth above, the certificates representing the shares of Common Stock (or a confirmation of book-entry transfer of such shares of Common Stock into the Exchange Agent’s account at The Depository Trust Company), together with a properly completed and duly executed Letter of Transmittal, with any required signature guarantees, and any other documents required by the Letter of Transmittal within one New York Stock Exchange trading day after the date of execution of this Notice of Guaranteed Delivery. Participants should notify the Exchange Agent prior to covering through the submission of a physical security directly to the Exchange Agent based on a guaranteed delivery that was submitted via DTC’s PTOP platform.
| Name of Firm: | ||
| (Authorized signature) | ||
| Address: | Title: | |
| Name: | ||
| (Please type or print) | ||
| (Zip Code) | Date: | |
| Area Code and Telephone Number: |
PLACE MEDALLION GUARANTEE STAMP BELOW.
4
Exhibit (a)(1)(D)
HYPERSCALE DATA, INC.
OFFER TO EXCHANGE
up to 192,308,000 SHARES of its Common Stock (in
100 share increments)
FOR
UNITS CONISTING OF 12.00% Series I Cumulative REDEEMABLE Perpetual Preferred Stock AND
CASH
| Class A Common Stock, $0.001 par value per share (NYSE: GPUS) |
CUSIP No. 09175M879 |
Consideration Offered Units consisting of (a) $2.00 and (b) one share of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock, per 100 shares of Class A Common Stock |
THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON DECEMBER 18, 2026, UNLESS THE EXCHANGE OFFER IS EXTENDED OR TERMINATED. |
November 20, 2026
To Brokers and Other Securities Intermediaries:
Hyperscale Data, Inc. (“Hyperscale,” the “Company,” “our,” “we” or “us”) is offering to exchange (the “Exchange Offer”) units consisting of (1) newly issued shares of its 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (“Series I Preferred Stock”); and (2) cash, on the terms and conditions set forth in the Offer to Exchange, dated November 20, 2026 (as amended, supplemented or modified from time to time, the “Offer to Exchange”) and in the related Letter of Transmittal (as amended, supplemented or modified from time to time, the “Letter of Transmittal”), for up to 192,308,000 shares of its outstanding Class A Common Stock, par value $0.001 per share (the “Common Stock”) (NYSE: GPUS). Common Stock may only be tendered in increments of 100 shares.
Holders who validly tender shares of Common Stock (in 100 share increments) that are not properly withdrawn and are accepted for exchange by the Company pursuant to the offer will receive units (the “Units”) consisting of (i) $2.00 in cash and (ii) one share of Series I Preferred Stock, per 100 shares of Common Stock, net to the seller and without interest and less any applicable withholding taxes. Our obligation to purchase shares of Common Stock that are validly tendered and not properly withdrawn in the Exchange Offer is subject to the satisfaction or waiver of certain conditions as set forth in the Offer to Exchange, including the tender of at least 100,000,000 shares of Common Stock in the Exchange Offer. If all conditions to the Exchange Offer are satisfied or waived, the Company will acquire up to 192,308,000 shares of Common Stock from all holders who validly tendered and didn’t properly withdraw shares of Common stock. The description of the Exchange Offer in this letter is only a summary and is qualified by all of the terms and conditions of the Exchange Offer set forth in the Offer to Exchange and in the Letter of Transmittal.
WE URGE YOU TO CONTACT YOUR CLIENTS AS PROMPTLY AS POSSIBLE IN ORDER TO OBTAIN THEIR INSTRUCTIONS. THE OFFER WILL EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON DECEMBER 18, 2026, OR SUCH OTHER DATE TO WHICH THE OFFER MAY BE EXTENDED.
In connection with the Exchange Offer, please forward copies of the enclosed materials to your clients for whom you hold shares of Common Stock. For your information and for forwarding to your clients, we are enclosing the following documents:
| 1. | Offer to Exchange, dated November 20, 2026; |
| 2. | a separate Letter of Transmittal for the shares of Common Stock for your use and for the information of your clients; and |
| 3. | a form of letter that may be sent to your clients for whose accounts you hold shares of Common Stock registered in your name or in the name of your nominee, with space provided for obtaining such clients’ instructions with regard to the Exchange Offer. |
To participate in the offer, a duly executed and properly completed Letter of Transmittal (or a manually executed facsimile thereof or Agent’s Message in lieu thereof), with any required signature guarantees and any other required documents, should be sent to the Exchange Agent, and the book-entry transfer procedures should be complied with, all in accordance with the instructions set forth in the Offer to Exchange and the related Letter of Transmittal.
Georgeson LLC is acting as Information Agent, and Computershare Trust Company, N.A. is acting as Exchange Agent in connection with the Exchange Offer. The Information Agent may contact holders of Common Stock by mail, telephone, facsimile and personal interviews and may request brokers and securities intermediaries to forward materials relating to the Exchange Offer to beneficial owners. The Information Agent and the Exchange Agent will each receive reasonable and customary compensation for their respective services and will be reimbursed by us for reasonable out-of-pocket expenses. The Information Agent and the Exchange Agent will be indemnified against certain liabilities in connection with the Exchange Offer, including certain liabilities under the federal securities laws.
Under no circumstances will interest be paid on the consideration payable for shares of Common Stock, regardless of extension of, or amendment to, the Exchange Offer or any delay in delivering such consideration. The Company will not pay any fees or commissions to brokers, other securities intermediaries or other persons for soliciting tenders of shares of Common Stock in connection with the Exchange Offer. The Company will, however, upon request, reimburse brokers and other securities intermediaries for customary clerical and mailing expenses incurred by them in forwarding materials to their customers. Transfer taxes imposed by the United States incident to the transfer of shares of Common Stock by the tendering holder pursuant to the Exchange Offer, if any, will be paid by us, except as otherwise provided in the Offer to Exchange and the related Letter of Transmittal.
Questions regarding the terms of the Exchange Offer, and requests for assistance or for additional copies of the Offer to Exchange and any other related documents, may be directed to the Information Agent at the address and telephone numbers set forth on the back cover of the Offer to Exchange.
| Sincerely, | |
| HYPERSCALE DATA, INC. |
NOTHING CONTAINED HEREIN OR IN THE ENCLOSED DOCUMENTS SHALL RENDER YOU THE AGENT OF THE COMPANY, THE INFORMATION AGENT, THE EXCHANGE AGENT, OR THE TRANSFER AGENT, OR AUTHORIZE YOU OR ANY OTHER PERSON TO USE ANY DOCUMENT OR MAKE ANY STATEMENT ON BEHALF OF ANY OF THEM IN CONNECTION WITH THE EXCHANGE OFFER NOT CONTAINED IN THE OFFER TO EXCHANGE OR IN THE RELATED LETTER OF TRANSMITTAL.
2
Exhibit (a)(1)(E)
HYPERSCALE DATA, INC.
OFFER TO EXCHANGE
up to 192,308,000 shares of its Common Stock (in
100 share increments)
FOR
UNITS CONISTING OF 12.00% Series I Cumulative REDEEMABLE Perpetual Preferred Stock AND CASH
|
Class A Common Stock, $0.001 par value per share (NYSE: GPUS)
|
CUSIP No. 09175M879 |
Consideration Offered Units, consisting of (a) $2.00 and (b) one share of 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock, per 100 shares of Class A Common Stock |
| THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON DECEMBER 18, 2026, UNLESS THE EXCHANGE OFFER IS EXTENDED OR TERMINATED. |
November 20, 2026
To Our Clients:
Enclosed for your consideration is an Offer to Exchange, dated November 20, 2026 (as amended, supplemented or otherwise modified from time to time, the “Offer to Exchange”) and the related Letter of Transmittal (as amended, supplemented or otherwise modified from time to time, the “Letter of Transmittal”) and an Instructions From Beneficial Owner form relating to the offer of Hyperscale Data, Inc. (the “Company” or “Hyperscale”) to exchange (the “Exchange Offer”) units, consisting of (1) newly issued shares of its 12.00% Series I Cumulative Redeemable Perpetual Preferred Stock (“Series I Preferred Stock”); and (2) cash, for up to 192,308,000 shares of its outstanding Class A Common Stock, par value $0.001 per share (the “Common Stock”) (NYSE: GPUS). Common Stock may only be tendered in increments of 100 shares.
Holders who validly tender shares of Common Stock (in 100 share increments) that are not properly withdrawn and are accepted for exchange by the Company pursuant to the offer will receive Units, consisting of (i) $2.00 in cash and (ii) one share of Series I Preferred Stock, per 100 shares of Common Stock, net to the seller and without interest and less any applicable withholding taxes. Our obligation to purchase shares of Common Stock that are validly tendered and not properly withdrawn in the Exchange Offer is subject to the satisfaction or waiver of certain conditions as set forth in the Offer to Exchange. If all conditions to the Exchange Offer are satisfied or waived, the Company will acquire all shares of Common Stock from all holders who validly tendered and did not properly withdraw shares of Common Stock.
THE OFFER WILL EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON DECEMBER 18, 2026, OR SUCH OTHER DATE TO WHICH THE OFFER MAY BE EXTENDED (THE “EXPIRATION DATE”).
The description of the Exchange Offer in this letter is only a summary and is qualified by all of the terms and conditions of the Exchange Offer set forth in the Offer to Exchange and in the Letter of Transmittal. PLEASE DO NOT COMPLETE THE LETTER OF TRANSMITTAL. The enclosed Letter of Transmittal is furnished to you for your information only and cannot be used by you to tender shares of Common Stock held by us for your account.
The enclosed materials are being forwarded to you as the beneficial owner of shares of Common Stock. We hold shares of Common Stock for your account. A tender of such Common Stock can be made only by us pursuant to your instructions. Therefore, the Company urges you, as the beneficial owners of shares of Common Stock held with a broker, or other securities intermediary, to contact such broker or other securities intermediary promptly if you wish to tender your shares of Common Stock in the Exchange Offer.
We, as holders of shares of Common Stock on your behalf, are being requested to tender shares of Common Stock for acquisition by the Company pursuant to the terms and conditions of the Exchange Offer.
We, as holders of shares of Common Stock on your behalf, cannot tender your shares of Common Stock unless you instruct us to take such actions by completing, executing and returning to us the Instructions From Beneficial Owner form enclosed herein. Accordingly, we request instructions as to whether you wish us to tender on your behalf the shares of Common Stock held by us for your account, pursuant to the terms and conditions set forth in the enclosed Offer to Exchange. Your instructions should be forwarded to us as promptly as possible in order to permit us to tender the shares of Common Stock on your behalf in accordance with the terms and conditions of the Offer to Exchange. If we do not receive written instructions in accordance with the below procedures presented in the Offer to Exchange and the Letter of Transmittal, we will not tender any shares of Common Stock on your account.
Your attention is directed to the following:
| 1. | The Exchange Offer and withdrawal rights will expire at one minute after 11:59 P.M., New York City time, on December 18, 2026, unless the Company extends the Exchange Offer or the Exchange Offer is terminated. |
| 2. | If you desire to tender any shares of Common Stock pursuant to the Exchange Offer and receive the consideration therefor, we must receive your instructions in ample time to permit us to affect a tender of the shares of Common Stock on your behalf on or prior to the Expiration Date. |
| 3. | The Exchange Offer is conditioned upon the satisfaction or waiver of certain conditions as set forth in the Offer to Exchange, including the valid tender of at least 100,000,000 shares of Common Stock in the Exchange Offer. See “The Exchange Offer—Conditions of the Exchange Offer” in the Offer to Exchange. |
| 4. | Any transfer taxes imposed by the United States incident to the transfer of shares of Common Stock by the tendering holder pursuant to the Exchange Offer, if any, will be paid by the Company, except as otherwise provided in the Offer to Exchange and the related Letter of Transmittal. |
If you wish to have us tender your shares of Common Stock, please so instruct us by completing, executing and returning to us the Instructions From Beneficial Owner form affixed to the back of this letter.
2
An exchange of shares of Common Stock for Units may not be suitable for you. You must make your own decision whether to tender shares of Common Stock in the Exchange Offer. Neither we, our Board of Directors, the Information Agent, the Exchange Agent, the Transfer Agent, nor any affiliate of any of the foregoing or any other person is making any recommendation as to whether or not you should tender your shares of Common Stock in the Exchange Offer.
3
PLEASE RETURN THIS FORM TO THE BROKERAGE FIRM MAINTAINING YOUR
ACCOUNT INSTRUCTIONS FROM BENEFICIAL OWNER
WITH RESPECT TO
HYPERSCALE DATA, INC.
OFFER TO EXCHANGE
up to 192,308,000 shares of its Common Stock (in 100 share increments)
FOR
UNITS CONSISTING OF 12.00% Series I Cumulative Perpetual Preferred Stock AND CASH
THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON DECEMBER 18, 2026, UNLESS THE EXCHANGE OFFER IS EXTENDED OR TERMINATED. |
The undersigned acknowledge(s) receipt of your letter and the enclosed materials referred to therein relating to an offer of Hyperscale Data, Inc. (the “Company” or “Hyperscale”) to exchange (the “Exchange Offer”) units (“Units”), consisting of (1) newly issued shares of its 12.00% Series I Cumulative Perpetual Preferred Stock (“Series I Preferred Stock”); and (2) cash, on the terms and conditions set forth in the Offer to Exchange, dated November 20, 2026 (as amended, supplemented or modified from time to time, the “Offer to Exchange”) and in the related Letter of Transmittal (as amended, supplemented or modified from time to time, the “Letter of Transmittal”), for up to 192,308,000 shares of its outstanding Class A Common Stock, par value $0.001 per share (the “Common Stock”) (NYSE: GPUS). Common Stock may only be tendered in increments of 100 shares.
Instruction to tender shares: This will instruct you to tender the number of shares of Common Stock (in 100 share increments) set forth below and held by you for the account of the undersigned, upon and subject to the terms and conditions set forth in the Offer to Exchange.
The undersigned expressly agrees to be bound by the terms and conditions of the Exchange Offer as set forth in the Offer to Exchange and the Letter of Transmittal and such terms may be enforced against the undersigned.
Please tender ____ shares of Common Stock held by you for my account as indicated below in the Exchange Offer for units consisting of (i) $2.00 in cash and (ii) one share of Series I Preferred Stock, per 100 shares of Common Stock, net to the seller and without interest and less any applicable withholding taxes.
If no amount is provided above with respect to the number of shares of Common Stock to be tendered for Units and this Instructions From Beneficial Owner form is signed in the space provided below, you are authorized to tender with respect to the entire amount of Common Stock in which you hold an interest through The Depository Trust Company for Series I Preferred Stock for my account.
Dated: , 2026
Signature(s) of Beneficial Owner(s):
4
Name(s) of beneficial owner(s) (Please Print)
Capacity (full title)
Address
City Zip Code
Area Code and Telephone No.
Tax ID No. or Social Security No.
NONE OF THE SHARES OF COMMON STOCK HELD FOR THE BENEFICIAL OWNER’S ACCOUNT WILL BE TENDERED UNLESS WRITTEN INSTRUCTION TO DO SO IS PROVIDED.
5
Exhibit (a)(5)(E)
Hyperscale Data Commences a $50,000,000 Exchange Offer for up to 192,308,000 Shares of its Class A Common Stock (in 100 share increments) for Units Consisting of 12% Series I Cumulative Redeemable Perpetual Preferred Stock and Cash
The Exchange Offer Represents a 71% Premium to the November 19, 2026 Closing Price.
LAS VEGAS--(PR NEWSWIRE) – November 20, 2026 – Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company (“Hyperscale Data” or the “Company”), today announced the commencement of an exchange offer (the “Exchange Offer”) to purchase up to 192,308,000 shares of its Class A Common Stock, $0.001 par value per share (the “Common Stock”) in 100 share increments.
Holders who elect to exchange Common Stock in the Exchange Offer will receive, for each 100 such shares of Common Stock units consisting of, (i) $2.00 in cash and (ii) one newly issued share of 12% Series I Cumulative Redeemable Perpetual Preferred Stock with a stated value of $24.00 per share (“Series I Preferred Stock”). Common Stock may only be tendered in increments of 100 shares. The Exchange Offer values the Common Stock at $0.26 per share and represents a 71% premium to the November 19, 2026, closing price of $0.1519. The exchange of at least 100,000,000 shares of Common Stock in the Exchange Offer is a closing condition to the Exchange Offer.
The Exchange Offer is scheduled to expire at one minute after 11:59 p.m., New York City time, on December 18, 2026, and is expected to settle on or about December 22, 2026, in each case, unless the Exchange Offer is extended or terminated. Shares of Common Stock must be validly tendered (in 100 share increments) prior to the expiration of the Exchange Offer in order to participate in the Exchange Offer, and tendered shares of Common Stock may be withdrawn at any time prior to the expiration of the Exchange Offer.
The Exchange Offer is being made pursuant to an Offer to Exchange (the “Offer to Exchange”) and related documents, each dated November 20, 2026. The completion of the Exchange Offer is subject to the satisfaction or waiver of conditions described in the Offer to Exchange, including the valid tender of at least 100,000,000 shares in the Exchange Offer. Subject to applicable law, Hyperscale Data, in its sole discretion, may waive the conditions applicable to the Exchange Offer, or extend, terminate or otherwise amend the Exchange Offer.
The issuance of shares of Series I Preferred Stock as consideration for the shares of Common Stock exchanged and accepted in the Exchange Offer will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on an exemption from registration thereunder. The shares of Series I Preferred Stock received by an exchanging holder are expected to be listed on the New York Stock Exchange and freely tradable under U.S. securities laws, unless such holder is considered an “affiliate” of ours, as that term is defined in the Securities Act, or the shares of Common Stock were otherwise restricted prior to exchange.
Documents relating to the offer may be downloaded at: www.sec.gov and will be distributed to holders of shares of Common Stock who request them from Georgeson LLC, the information agent for the Offer at (888) 355-8425.
Shares of Common Stock validly tendered (in 100 share increments), not properly withdrawn and accepted by Hyperscale Data for exchange pursuant to the Exchange Offer will be delivered to Computershare Trust Company, N.A., the Exchange Agent for the Exchange Offer, and will be retired and cancelled.
This press release is for informational purposes only and shall not constitute an offer to purchase nor a solicitation of an offer to sell shares of Common Stock or any other securities. The offer is not being made to any person in any jurisdiction in which the offer, solicitation or sale is unlawful. Any offers to exchange the Common Stock will be made only by means of the Offer to Exchange and the letter of transmittal.
The complete terms and conditions of the offer are set forth in the Offer to Purchase and related Letter of Transmittal that is being furnished to holders of Common Stock and also filed with the SEC on Schedule TO. Stockholders of Hyperscale Data are strongly encouraged to read the Schedule TO and its exhibits because they contain important information about the offer. The Schedule TO and related exhibits will be available without charge at the SEC’s website at http://www.sec.gov and will be delivered without charge to all stockholders of Hyperscale Data.
For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.
About Hyperscale Data, Inc.
Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it offers colocation and hosting services for the emerging AI ecosystems and other industries. Another of Hyperscale Data’s wholly owned subsidiaries, Ault Capital Group, Inc. (“ACG”), is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.
Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets and the third wholly owned subsidiary of the Company, Omnipresent Robotics, LLC. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.
On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.
Forward-Looking Statements
This press release contains “forward-looking statements” regarding future events and our future results. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.
Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events, except as required by law. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.
Hyperscale Data Investor Relations Contact
IR@hyperscaledata.com or 1-888-753-2235
2